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Summary 
 
Retrograde transport of membranes and proteins from the cell surface is essential to maintain 
homeostasis and compartment identity. Following internalization via clathrin-dependent or -independent 
endocytosis, lipid and protein cargoes first populate early endosomes from where they are further 
redirected either along the endo-lysosomal system, recycled to the plasma membrane, or targeted to the 
trans-Golgi network (TGN) compartment. A number of distinct sorting machineries have been implicated 
in retrograde transport from endosomes to the TGN, among them the AP-1/clathrin machinery. Apart 
from an involvement in retrograde transport, AP-1/clathrin carriers have a well-established function in 
cargo export from the TGN. Even though the concept of bidirectional traffic at the TGN-to-endosome 
interface is commonly accepted, there is still uncertainty about the precise contribution of AP-1 to 
retrograde transport, since the conclusions of most studies were based on altered receptor steady-state 
distribution or mislocalization analysis upon knockdown or knockout of AP-1. Their readouts may be 
misleading, because the observed phenotype may be an indirect consequence of long-term AP-1 depletion, 
the result of upregulation of alternative pathways to compensate for the reduced or missing protein, 
thereby potentially masking the true AP-1 phenotype.  
 
To elucidate the involvement of AP-1 in endosome-to-TGN traffic, we set up a more generic 
approach allowing us to follow cargo molecules during their retrograde transport from the plasma 
membrane. To this end, we established a versatile nanobody-based approach conferring recombinant 
protein cargo to be tracked from the cell surface biochemically, by live cell imaging, and by electron 
microscopy. We engineered and bacterially expressed functionalized anti-GFP nanobodies fused to a 
sulfation consensus motif, to fluorophores, or to a peroxidase reporter. These functionalized nanobodies 
are specifically captured by EGFP-modified receptor proteins at the cell surface and transported piggyback 
to the receptor’s homing compartments. Using the sulfatable nanobody, we could biochemically 
determine the kinetics of bonafide sorting receptors, the MPRs, from the cell surface to the TGN. In 
combination with the knocksideways approach to look at the immediate and direct consequences of AP-1 
inactivation, we could also show the role of AP-1/clathrin carriers in retrograde transport of MPRs from 
endosomes to the TGN. At the same time, however, we also evidenced that an AP-1 knockdown and 
knockout produced conflicting results when compared to acute inactivation strategies. 
Collectively, the present study describes a versatile nanobody-based approach to analyze 
retrograde transport of cargo proteins from the cell surface, and moreover provides insights into the role 
of the AP-1/clathrin machinery in retrograde transport. 
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  1     Introduction 
 
 
1.1 Endocytic Pathways from the Cell Surface 
The secretory and endocytic pathway of eukaryotic cells consists of a series of tightly interconnected 
membrane compartments that are collectively referred to as the endomembrane system or network. 
Among this elaborate endomembrane network, the endoplasmic reticulum (ER), the ER-Golgi intermedi-
ate compartment (ERGIC), the Golgi complex, the trans-Golgi network (TGN) as well as a variety of 
endosomal and lysosomal compartments serve as the major protagonists in partitioning protein and lipid 
cargo either for export, import, recycling or degradation.  
In order to mediate selective transport of cargo throughout the endomembrane compartments, 
membrane-enclosed carriers are required that ferry biomolecules from one organelle to the other. In the 
biosynthetic (secretory) pathway, where cargo is moved in an anterograde manner from the ER to the 
endo-lysosomal system or to the cell surface via the Golgi complex, the repertoire of involved transport-
mediating carriers, their formation, regulation as well as sorting information for efficient transport have 
been studied in depth. 
To maintain cellular homeostasis and membrane compartment identity, it is also crucial that 
anterograde traffic is accompanied and counterbalanced by retrograde transport at each level of the 
secretory route. Particularly, knowledge about retrograde traffic from the cell surface to the TGN and 
even beyond has become of significant interest. This route is not only hijacked by bacterial and plant 
toxins to harness the host cell machineries, but is also increasingly utilized for targeted drug delivery to 
reach the interior of cells. Thus, understanding the basic molecular mechanisms and involved sorting 
machineries in retrograde transport of a variety of distinct cargo molecules from the cell surface to 
intracellular compartments is of undeniable importance.  
In the following, we are giving an overview of the two main endocytic pathways that deliver cargo 
proteins from the plasma membrane to the interior of the cell. 
 
1.1.1 Clathrin-Dependent Endocytosis 
Clathrin-dependent or -mediated endocytosis (CDE or CME) represents the major pathway of uptake 
(Fig. 1.1) and refers to the selective internalization of cargo receptors or molecules into the cell using 
clathrin-coated carriers (Kirchhausen et al., 2014; McMahon and Boucrot, 2011; Traub and Bonifacino, 
2013). Indeed, it has been previously shown that clathrin-independent pathways do not significantly 
contribute (~ 5%) to the endocytic flux (Bitsikas et al., 2014), confirming the crucial role of clathrin in 
endocytosis. Clathrin is a membrane-distal heterohexameric protein coat that has recently celebrated its 
anniversary of forty years after its initial discovery by Barbara Pearse (Pearse, 1975; Pearse, 1976; 
Robinson, 2015). Clathrin as a coat does not directly bind to the membrane or to cargo receptors and 
molecules, but interacts instead with membrane-associated adaptor complexes, cargo-specific adaptor 
proteins, and accessory factors at the site of internalization. Over the recent years, it has become clear 
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that unlike to intracellular membrane sites, where adaptor coat recruitment is initiated by members of the 
ADP-ribosylation factor (ARF) family, clathrin-coated carrier formation at the plasma membrane is 
regulated in a different manner. 
 
 
 
Figure 1.1: Clathrin-dependent and -independent internalization pathways. There are multiple endocytic path-
ways into the cells, including clathrin-dependent, caveolin-dependent, and clathrin- and caveolin-independent vesicular as well as 
tubular internalization routes (we refer to as clathrin-independent endocytosis for the two latter ones). Internalized cargo is 
transported to early endosomes, from where it is recycled to the cell surface, to other compartments of the endo-lysosomal 
system, including recycling endosomes, MVBs and lysosomes, or to the TGN. Figure modified from McMahon and Boucrot, 2011. 
 
Biochemical and ultrastructural observations have defined five stages (Fig. 1.2, step 1-5) of clath-
rin-coated carrier formation, including nucleation, cargo selection, coat assembly, scission and uncoating 
(McMahon and Boucrot, 2011).  
In the stage of nucleation (Fig. 1.2, step 1), a membrane invagination called a clathrin-coated pit 
(CCP) is formed. Which proteins actually initiate nucleation still remains a matter of debate. While a 
study from Kirchhausen and colleagues supports carrier formation to initially begin with two molecules of 
AP-2 and one clathrin triskelion as demonstrated by single molecule TIRF imaging (Cocucci et al., 2012), 
others propose the requirement of a nucleation module that defines plasma membrane sites where then 
AP-2 and clathrin will be recruited (Henne et al., 2010; Stimpson et al., 2009). This nucleation module is 
thought to selectively assemble at the plasma membrane and includes FCH domain-only (FCHO) proteins, 
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EGFR pathway substrate 15 (EPS15) and intersectins (Henne et al., 2010; Reider et al., 2009; Stimpson et 
al., 2009). Depletion of either FCHO proteins or EPS15 and intersectins has been reported to prevent 
clathrin coat recruitment. Recently published studies (Hollopeter et al., 2014; Ma et al., 2016; Merrifield, 
2012; Umasankar et al., 2014), however, favor nucleation to be started by AP-2 and clathrin, and suggest 
that proteins from the above-mentioned 'nucleation module' regulate the conformational state of AP-2 
rather than recruiting it to the site of endocytosis. 
After the site of carrier formation and internalization has been marked, AP-2 adaptors selectively 
interact with cytoplasmic tails of transmembrane receptor molecules for cargo selection (Fig. 1.2, step 
2). Apart from clathrin, AP-2 is the most abundant component of clathrin-coated carriers. There are an 
estimated three quarters of a million AP-2 adaptors present in every cell (Hirst et al., 2012b). In addition 
to AP-2, other accessory adaptors specific for endocytosis modulate and expand the cargo spectrum of 
AP-2. For instance, ARH and Dab2 are specific for LDL receptors (Garcia et al., 2001; Keyel et al., 2004; 
Mettlen et al., 2010; Mishra et al., 2002), β-arrestins bind to G-protein coupled receptors (GPCRs) 
(Ferguson et al., 1996; Smith and Rajagopal, 2016; Yu et al., 2007), HRB interacts with SNAREs (Luzio et 
al., 2010; Pryor et al., 2008), and additional ones bind to their cargo in distinct cell types to confer tissue 
specificity. All these accessory adaptors bind directly to the AP-2 adaptor appendage domains and hence 
do not impair direct cargo binding. In addition to conferring cargo specificity, the existence of diverse 
cargo adaptors ensures, when one receptor is present in high levels on the cell surface, that this does not 
disable the internalization of cargo whose receptor only has minor membrane representation. 
Once cargo receptors are selected and sequestered by AP-2 or accessory adaptors, the clathrin 
coat starts to assemble (Fig. 1.2, step 3). Thereby, clathrin triskelia are recruited from the cytosol to 
sites with high adaptor concentration on the membrane to facilitate carrier formation. The subsequent 
polymerization of clathrin is thought to stabilize membrane curvature, but is not inducing membrane 
bending and deformation (McMahon and Boucrot, 2011). Membrane bending and sculpting is instead 
mediated by curvature effectors that ensure curvature generation regardless of which cargo is selected. 
 
 
 
Figure 1.2: The five steps of clathrin-coated carrier formation. Clathrin-coated pit formation is either initiated by 
the nucleation module composed of FCHO proteins, EPS15 and intersectins, or by the AP-2 adaptor (1). AP-2 with possible 
cooperation with cargo-specific adaptors interact with cytoplasmic tails of cargo proteins and other coat components (2). Clathrin 
coat polymerization leads to carrier assembly and recruitment of BAR domain-containing curvature effectors to the neck of the 
nascent carrier (3). After coat assembly, dynamin pinches off the formed clathrin-coated membrane (4). In the last step, clathrin 
polymers are uncoated by the sequential action of auxilin and the ATPase Hsc70 (here named GAK). Figure modified from 
McMahon and Boucrot, 2011. 
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Clathrin coat formation at the membrane is followed by scission (Fig. 1.2, step 4), a process, 
which is exerted by the mechanochemical enzyme dynamin (Antonny et al., 2016; Daumke et al., 2014). 
Dynamin is recruited by BAR (Bin/Amphiphysin/Rvs) domain-containing proteins, including amphiphysins, 
endophilins or SNX9, which have a preference for the curvature at the neck of the coated pit and are 
likely to be involved in forming the membrane neck (Bendris and Schmid, 2017; Ferguson et al., 2009; 
Sundborger et al., 2011; Wigge et al., 1997). Interestingly, these curvature effectors are not only localizing 
to clathrin-coated invaginations at the plasma membrane, but also to intracellular membranes such as the 
TGN or endosomes (Huser et al., 2012). This favors these proteins to be involved more generally in the 
process of clathrin-coated carrier formation at membranes, rather than only at endocytic sites. Recruited 
dynamin polymerizes and wraps helically around the forming carrier membrane and finally undergoes a 
GTP hydrolysis-dependent conformational change to pinch off the carrier from its parental membrane 
(Bashkirov et al., 2008; Hinshaw and Schmid, 1995; Roux et al., 2006; Stowell et al., 1999; Sweitzer and 
Hinshaw, 1998).  
To recycle clathrin machinery components for additional rounds of carrier formation and budding, 
the detached membrane has to loose its coat (Fig. 1.2, step 5). Since, after scission, the clathrin cage is 
incomplete at the zone where the neck was attached to the parental membrane (McMahon and Boucrot, 
2011), auxilin can bind at this position to clathrin and recruits the ATPase Hsc70 (GAK) that catalyzes the 
disassembly of the clathrin shell (Fotin et al., 2004; Massol et al., 2006; Rapoport et al., 2008; Scheele et al., 
2001; Taylor et al., 2011; Ungewickell et al., 1995; Xing et al., 2010). Subsequent changes in the phospho-
inositide composition, for instance by the phosphatase synaptojanin (Cremona, 2001; Cremona et al., 
1999), are also required to terminate the uncoating process and to liberate the coat components. 
However, whether this occurs already before or after auxilin recruitment is not clear.  
    
1.1.2 Clathrin-Independent Endocytosis 
Since endocytic uptake is not entirely blocked in the absence of clathrin, it has become clear that clathrin-
dependent endocytosis does not represent the exclusive pathway to internalize cargo from the cell 
surface. We refer to all of these non-clathrin internalization pathways as clathrin-independent endocytosis 
(CIE). Compared to clathrin-driven endocytosis, detailed understanding of CIE pathways has lagged behind, 
mainly because (i) wealth of attention has been addressed to CME only, (ii) the fact that CIE pathways are 
typically not constitutive and only activated upon specific stimuli, (iii) the repertoire of molecular players 
are mostly lacking, (iv) and some CIE events might be too slow or too fast to be recorded by classical 
methods applied to investigate endocytosis (Watanabe and Boucrot, 2017).  
Among CIE pathways themselves, even internalization mechanisms with distinct features exist, 
including whether uptake is of small-scale or large-scale nature (Doherty and McMahon, 2009; Johannes et 
al., 2015; Mayor and Pagano, 2007; Mayor et al., 2014). Large-scale CIE pathways include macropino-
cytosis and phagocytosis (Fig. 1.3), two endocytic processes with membrane dimensions in the large 
micrometer-scale. Small-scale CIE pathways can be neatly classified whether they require dynamin 
(dynamin-dependent) or not (dynamin-independent). Another relevant classification criterion is the pres-
ence or absence of a morphological coat that marks the internalized patch of the membrane, and in those 
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that lack a defined coat, it is a small GTPase that regulates productive CIE (Mayor et al., 2014). In the 
following, we are giving a short overview of the reported small-scale CIE pathways that mediate uptake of 
distinct cargo proteins. 
 
 
 
Figure 1.3: Pathways of clathrin-independent endocytosis. Large-scale particles can be taken up by phagocytosis, 
whereas fluid uptake occurs by macropinocytosis. Both processes are thought to be clathrin-independent. In comparison with 
other CIE endocytic pathways (1-4), the size of the carriers formed by phagocytosis and macropinocytosis is much larger. Small-
scale CIE pathways are mainly characterized by the features whether internalization is dynamin-dependent and whether they have a 
morphologically characterized coat. Figure modified from Mayor and Pagano, 2007.    
 
The best-studied CIE internalization route is the dynamin-dependent caveloar endocytic pathway 
(Fig. 1.3, 1). Caveolae are 50-80 nm flask-shaped plasma membrane invaginations and are characterized 
by ~ 140 copies of the oligomeric transmembrane protein caveolin-1 (CAV1), 30-70 molecules of 
caveolin-2 (CAV2), and a peripheral protein coat complex composed of cavins (Cheng and Nichols, 2016; 
Hansen and Nichols, 2010; Hayer et al., 2010; Parton and del Pozo, 2013). Even though unclear for a long 
time, it has become evident that caveolae are not immobile structures that just decorate the plasma 
membrane, but can dynamically detach from membrane sites to form endocytic caveloar carriers 
(Boucrot et al., 2011; Hill et al., 2008; Moren et al., 2012; Stoeber et al., 2012). The precise physiological 
importance and function of caveloae, and the spectrum of transported cargo are not yet that well 
established as for CME (Mayor and Pagano, 2007; Mayor et al., 2014). However, recent reports suggested 
caveolae to play a role in membrane stretching (Ariotti et al., 2015b; Lo et al., 2016; Lo et al., 2015).   
Other dynamin-dependent CIE routes are the interleukin-2 receptor (IL-2R) and the epidermal 
growth factor receptor (EGFR) endocytic pathway (Fig. 1.3, 2). The former internalization pathway is 
dependent on the small GTPase RhoA and on lipid raft microdomains (Gesbert et al., 2004; Lamaze et al., 
2001). Ultrastructural studies showed that IL-2 receptors as well as other cytokine receptors are 
concentrated and then internalized via small non-coated invaginations. Thus, both the specific concentra-
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tion of the receptors and the uniform size of the endocytic carrier implicate a putative machinery involved 
in pit formation (Mayor et al., 2014). Interestingly, the amyloid precursor protein (APP) also seems to use 
this pathway to some extent under certain physiological conditions (Saavedra et al., 2007). 
While EGFR is directed to CME pathways at low doses of its ligand (EGF), it appears that the 
receptor uses a distinct CIE pathway (Fig. 1.3, 2) at high doses (Sigismund et al., 2013; Sigismund et al., 
2008; Sigismund et al., 2005). Then, enhanced ligand-dependent receptor ubiquitination has been 
proposed to operate as a regulatory pathway switch that detours EGFR towards a clathrin-independent 
endocytic route, possibly involving an ubiquitin adaptor (Sigismund et al., 2013). Recent evidence, 
however, suggested that IL-2R and EGFR internalization actually belongs to the same clathrin-independent 
endocytic pathway (Watanabe and Boucrot, 2017). This pathway is proposed to be mediated by the 
protein endophilin that induces the formation of endocytic carriers quickly upon certain stimuli. Due to 
the fast mode of action, this recently described CIE pathway is named fast endophilin-mediated 
endocytosis, or just shortly FEME (Boucrot et al., 2015; Renard et al., 2015). The FEME pathway is also 
taken by bacterial toxins to enter host cells (Renard et al., 2015). The precise mechanisms by which 
endophilin primes membranes for CIE remain to be further investigated. 
Among the coat- and dynamin-independent CIE pathways, there is the CLIC/GEEC pathway (Fig. 
1.3, 3) and the ARF6-associated pathway (Fig. 1.3, 4). The former is involved in the uptake of lipid-
anchored proteins, such as glycosylphosphatidylinositol-anchored proteins (GPI-AP), into distinct early 
endosomal compartments that also accommodate a major fraction of internalized fluid phase (Kirkham 
and Parton, 2005; Sabharanjak et al., 2002). Due to the nature of high local GPI-AP concentrations, these 
endosomes are referred to as GEECs (GPI-AP enriched endocytic compartments), and they result from 
fusion of primary uncoated tubulovesicular carriers called CLICs (clathrin-independent carriers), which 
are directly derived from the plasma membrane (Kirkham and Parton, 2005; Mayor et al., 2014; Mayor 
and Riezman, 2004). Controversially, the molecular machinery of the CLIC/GEEC pathway was reported 
to depend on ARF1 (Gupta et al., 2009; Kumari and Mayor, 2008), a protein that usually only localizes to 
intracellular membranes. 
Another mode of CIE (Fig. 1.3, 4) that does not have any visible coat and that is also dynamin-
independent is the mentioned ARF6-associated pathway (Grant and Donaldson, 2009; Radhakrishna and 
Donaldson, 1997). In steady-state, ARF6 localizes to the cell surface and in many cells also to endosomes 
that contain CIE cargo protein. The ARF6-associated pathway resembles the CLIC/GEEC pathway in that 
it also internalizes GPI-APs (Eyster et al., 2009; Howes et al., 2010a; Howes et al., 2010b). It is not certain 
whether they represent the same or a distinct mode of internalization. Apart from these two pathways, 
another dynamin-independent endocytic pathway internalizes GPI-APs. This pathway depends on proteins 
termed flotilins (Glebov et al., 2006), whose precise function in CIE remains to be determined. 
Though mechanistically, structurally and functionally completely different, CME and CIE have both 
in common that their cargo finally reaches early endosomes.  
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1.2 Endo-Lysosomal Pathways along Endocytic Compartments 
 
The endocytic compartments of the endo-lysosomal system can be temporally, morphologically and 
biochemically subdivided into early endosomes, late endosomes and lysosomes (Fig 1.4), temporally 
based on the sequential order in which endocytosed cargo reaches these compartments, morphologically 
based on their degree in tubular-vacuolar appearance with or without intraluminal vesicles (ILVs), and 
biochemically based on recruited Rab marker proteins and membrane lipid identity. Among them, early 
endosomes represent a major hub of bifurcated traffic, since internalized protein and lipid cargo is 
shuttled either further along the endo-lysosomal system, recycled to the plasma membrane, delivered to 
the TGN, or also receives material from the biosynthetic route. 
 
1.2.1 Early Endosomes  
The term 'early endosomes' actually describes two distinct endosomal organelles, that are sorting and 
recycling endosomes (Maxfield and McGraw, 2004). Depending on the literature and authors, however, 
the terminology 'early endosomes' and 'sorting endosomes' are used synonymously.  
 
Sorting Endosomes  
Sorting endosomes represent the first endocytic compartments that accept protein and lipid cargo 
internalized from the plasma membrane. It is thought that endocytic carriers derived from CME or CIE, 
respectively, fuse with each other to give rise to a primary early sorting endosome. These initial struc-
tures in turn undergo homotypic fusion and by this start to grow (Huotari and Helenius, 2011; Mills et al., 
1999; Scott et al., 2014). Sorting endosomes are heterogeneous in terms of localization, composition, 
morphology and function (Lakadamyali et al., 2006; Miaczynska et al., 2004; van Meel and Klumperman, 
2008). The overall distribution of sorting endosomes is cell type-dependent. Most of them localize to the 
periphery of the cell in close vicinity to the plasma membrane, but also to the perinuclear region. Sorting 
endosomes typically have a slightly acidic lumen with a pH of around 6. Individual sorting endosomes have 
a complex structure and morphology with tubular and vacuolar domains. Most of the membrane surface 
area is part of the tubular elements, and much of the volume is in the globular part (Gruenberg, 2001; 
Huotari and Helenius, 2011). While the globular part matures into late endosomes, the tubular extensions 
give rise to early recycling endosomes (Mellman, 1996). Recycling receptors, such as the transferrin 
receptor (TfR), which constitutively capture ligands from the extracellular environment to deliver them 
into the cell, can either migrate back to the cell surface directly via sorting endosomes (fast recycling) or 
indirectly via recycling endosomes (slow recycling) (Hao and Maxfield, 2000; van Dam et al., 2002). The 
other main function of sorting endosomes is to target cargo either further along the endo-lysosomal 
system or to transport them to the TGN. 
A major criterion to define sorting endosomes is by the presence membrane-associated markers 
(Fig 1.4). Sorting endosomes are positive for Rab5 and its cognate downstream effectors, such as the 
early endosomal antigen 1 (EEA1) or rabaptin5, for instance (Stenmark, 2009; Stenmark et al., 1995; 
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Wandinger-Ness and Zerial, 2014; Zerial and McBride, 2001; Zhen and Stenmark, 2015). In addition, Rab4 
also localizes to sorting endosomes (van der Sluijs et al., 1992), but likewise to Rab11-positive recycling 
endosomes (Trischler et al., 1999). While recycling endosomes deliver their material back to the plasma 
membrane, sorting endosomes mature to late endosomes, which are also called multivesicular bodies 
(MVBs). So far, it was believed that Rab5 triggers initial effector recruitment to mature a sorting to a late 
endosome. Recent evidence, however, contradicted this notion and suggested Rab4 rather than Rab5 to 
initiate endosome conversion (Kalin et al., 2016; Kalin et al., 2015).   
Apart from morphology, pH and recruited cytosolic factors, organelles are also defined by their 
lipid content. Sorting endosomes are typically characterized by the presence of phosphatidylinositol-3-
phosphate (PI(3)P) (Behnia and Munro, 2005). Recently, even more 'exotic' and different (sorting) 
endosomes have been described that are delivering a subset of selected cargo to the nuclear envelope 
(Chaumet et al., 2015). Due to their close association with the nucleus, these endosomes were termed 
nuclear envelope-associated endosomes (NAE).          
 
 
Figure 1.4: Sorting along the endo-lysosomal system. The primary endocytic CME or CIE carriers deliver their 
contents and their membranes to sorting endosomes in the periphery of the cell. Depending on the cargo’s function, it is either 
recycled, further transported along the endo-lysosomal pathway or trafficked to the TGN. Recycling can occur from sorting 
endosomes in a Rab4-dependent manner (fast recycling) or from recycling endosomes in a Rab11-dependent manner (slow 
recycling). Maturation from a sorting to a late endosome is initiated by a Rab5-to-Rab7 conversion. Apart from the Rab7-positive 
vacuolar domain, late endosomes also contain Rab9-positive tubular elements that confer recycling/retrieval of MPRs to the TGN. 
Late endosomes also acquire intraluminal vesicles (ILVs) to facilitate degradation of selected transmembrane proteins. Fusion of a 
late endosome with a lysosome forms a hybrid organelle, the endolysosome, in which active degradation takes place. The 
endolysosome in turn is converted into a classical dense storage lysosome. Figure modified from Stenmark, 2009.       
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Recycling Endosomes  
As mentioned earlier, recycling endosomes are derived from tubular extensions of sorting endosomes. 
Recycling from these tubular elements to the cell surface is termed slow recycling since cargo receptors 
apparently take a longer route than they would do from sorting endosomes. Recycling endosomes are 
characterized by a pH of ~ 6.5, slightly less acidic than sorting endosomes (Taguchi, 2013), and by the 
presence of Rab11 (Trischler et al., 1999). Many ligand receptors seem to use the slow Rab11-dependent 
recycling pathway in addition to the fast Rab4-dependent recycling route, including TfR, LDLR and the 
asialoglycoprotein receptor (ASGPR) subunit H1 (Maxfield and McGraw, 2004; Pagano et al., 2004). Apart 
from cargo molecules that have to recycle back to the cell surface to exert their function as ligand 
receptors, there is also evidence that some other cargo commute via recycling endosomes to reach the 
TGN, including bacterial toxins and a subset of endogenous proteins, among them TGN38 (Matsudaira et 
al., 2013; McKenzie et al., 2012; Taguchi, 2013; Uchida et al., 2011). 
 
1.2.2 Late Endosomes  
Late endosomes are derived from the vacuolar domains of sorting endosomes by maturation. Maturation 
is initiated by a Rab5-to-Rab7 conversion, which in turn remodels the identity of the endosomal 
membrane by recruitment of additional Rab effectors with concomitant loss of others (Poteryaev et al., 
2010; Rink et al., 2005). Mature late endosomes typically localize to the perinuclear region and have a pH 
in the range of 5-6 (Maxfield and Yamashiro, 1987). Late endosomes are not only positive for Rab7, but 
also for Rab9 (Kucera et al., 2016a; Lombardi et al., 1993). As for sorting endosomes, late endosomes to 
some extent also have a vacuolar and tubular domain. Rab7 and Rab9 use different machineries for their 
recruitment to late endosomes and this possibly explains why Rab7 preferentially associates with the 
vacuolar domain and Rab9 with the tubular elements. The greatest distinction, however, between these 
two late endosomal Rab proteins is that Rab9 has been predominantly reported in the retrieval of the 
mannose-6-phosphate receptors (MPRs) to the TGN, and not directly involved in the process of 
endosome maturation. Recent evidence has shown that Rab9 enters the endosomal pathway at the Rab5-
to-Rab7 transition (Kucera et al., 2016a; Kucera et al., 2016b).     
Late endosomes are typically also characterized by the high lipid content for PI(3,5)P2 and already 
contain some lysosomal hydrolases. Proteins destined for degradation follow their route by further 
maturation of the vacuolar domain, while proteins selected for retrieval enter the Rab9-positive tubular 
domains of late endosomes (Huotari and Helenius, 2011).    
Another striking morphological feature of late endosomes is that they contain numerous 
intraluminal vesicles. A subset of transmembrane proteins and lipids are directed into these vesicles for 
facilitated degradation by active lysosomal hydrolases. The machinery involved in intraluminal vesicle 
formation is called ESCRT complex (endosomal sorting complex required for transport) that is composed 
of ESCRT-0, ESCRT-I, ESCRT-II and ESCRT-III complexes as well as a number of additional accessory 
factors (Henne et al., 2013; Hurley and Emr, 2006; Schoneberg et al., 2017).  
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1.2.3 Lysosomes   
Lysosomes are organelles of heterogeneous size and represent the main sites for intracellular digestion of 
macromolecules in the endomembrane system (Sorkin and von Zastrow, 2009; Staudt et al., 2016; 
Wartosch et al., 2015). Whether lysosomal biogenesis occurs by maturation of late endosomes/MVBs or 
whether prelysosomal compartments fuse in a homo- or heterotypic manner with each other to give rise 
to lysosomes is not fully clear (Bright et al., 2005; Luzio et al., 2007; Mullins and Bonifacino, 2001). 
Lysosomes typically have a luminal pH of 4.5-5, perinuclear localization and are positive for the integral 
membrane protein LAMP-1 (lysosome-associated membrane protein-1). Other proteins found in 
lysosomes to exert their dedicated function are a number of acid hydrolases and other integral lysosomal 
membrane proteins (LMPs). Among them, LAMP-1 represents the most well characterized protein among 
the LMPs. To degrade biomolecules, lysosomes contain about 50 types of acid hydrolases including 
proteases, nucleases, glycosidases, lipases, phospholipases, phosphatases and sulfatases (Kroemer and 
Jaattela, 2005). Newly synthesized acid hydrolases are selectively shuttled to lysosomes by the MPRs. 
While the lysosomal hydrolases reside in the lumen of lysosomes, LMPs are embedded in the lysosomal 
limiting membrane. The mammalian lysosome comprises around 25 heavily glycosylated LMPs with diverse 
functions, including lysosomal acidification, protein import from the cytosol, transporters to release 
digested products into the cytosol as well as constituents mediating fusion events (Saftig and Klumperman, 
2009).                   
As in other fields of membrane traffic, the idea how things are operating is often questioned, 
reconceptualized or newly interpreted, as it is true for lysosomes with regard to degradation. A recent 
model suggests not lysosomes to be the compartment of degradation, but rather a hybrid compartment 
termed 'endolysosome' that is the result of the fusion of a late endosome with a storage lysosome. It is 
thought that the terminal endocytic compartment is composed of acid hydrolase-active, acidic endolyso-
somes and acid hydrolase-inactive, non-acidic, terminal storage lysosomes, which are linked and function 
in a lysosome regeneration cycle (Bright et al., 2016).  
In this subchapter (subchapter 1.2), we have had a glimpse at unidirectional transport events along 
the endo-lysosomal route. However, as already mentioned, other pathways can branch off along these 
endo-lysosomal compartments. In the following subchapter (subchapter 1.3), we are focusing on 
retrograde sorting pathways conferring transport from endosomes to the TGN.  
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1.3 Retrograde Transport from Endosomes to the TGN 
 
The TGN is a major traffic hub of the cell, as it regulates protein sorting from the biosynthetic pathway as 
well as it receives cargo molecules by retrograde transport from endocytic compartments. Retrograde 
transport from endosomes to the TGN is important for recycling of membrane proteins which regulate a 
number of cellular and developmental functions. In the following, we will discuss how retrograde 
transport was 'discovered', stress its function and transported cargo, as well as outline the protein sorting 
machineries involved in endosome-to-TGN transport.   
 
1.3.1 Overview and Discovery of Retrograde Transport  
The initial discovery of cargo undergoing retrograde traffic to intracellular compartments and subsequent 
advances using a set of biochemical and imaging approaches have led to the identification of retrograde 
transport pathways. But which landmark discoveries have paved the way for our current understanding of 
retrograde transport from the cell surface to the TGN and even beyond?  
Investigating how the plant toxin ricin enters the cell to exert its cytotoxicity led to the discovery 
of retrograde transport. In 1972, Olsnes and Pihl (Olsnes and Pihl, 1972) have presented evidence that 
ricin inhibits protein biosynthesis by modifying ribosomal RNA of infected cells (Montanaro et al., 1973). 
Using ricin-horseradish peroxidase (HRP) as reporter, Avrameas and colleagues (Gonatas et al., 1975) 
subsequently detected ricin in the Golgi complex of target cells, probably because endocytic uptake was 
mediated by host cell factors. 
The idea that host cell surface proteins might shuttle toxins into cells was inspiring these days and 
has stimulated the search for endogenous proteins undergoing themselves retrograde transport. Snider 
and Rogers in turn were the first in 1985 who described a cellular protein, TfR, to traffic from the plasma 
membrane to the Golgi (Snider and Rogers, 1985). Several other reports followed soon using approaches 
based on Golgi-specific modifications. Of these, the findings by Duncan and Kornfeld on MPRs came to 
light (Duncan and Kornfeld, 1988). Duncan and Kornfeld provided direct evidence for a model in which 
trafficking between endosomes and the TGN is part of the functional cycle of MPRs. MPR’s function is to 
ferry lysosomal enzymes from the TGN to endosomes, from where the empty cargo receptor then 
returns to the TGN for a new transport cycle. 
Following the discovery of endogenous proteins to traffic from endosomes to the TGN, the next 
step to look at intracellular organelles beyond the Golgi was envisaged using a toxin as model tool. 
Sandvig and collaborators showed in 1992 for the first time that bacterial Shiga toxin could even reach the 
ER by retrograde transport with transit through the Golgi (Sandvig et al., 1992). 
Next, we would like to briefly outline the importance and significance of endosome-to-TGN 
transport by listing a number of essential cellular functions it regulates.    
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1.3.2 Function and Importance of Retrograde Transport  
As secretory cargo is exported from the TGN, anterograde cargo receptors (e.g. MPRs) and vesicle 
targeting and fusion factors (e.g. SNAREs) are depleted from the donor compartment and must be 
replenished to maintain TGN function. It is thus crucial that anterograde transport from the TGN is 
accompanied and counterbalanced by retrograde traffic from endosomes. This is not only essential for 
transport from endosomes, as illustrated here, but at each section of the secretory route. Retrograde 
transport is also important to retrieve resident proteins that have escaped from their compartments of 
function. A system lacking any retrieval mechanisms based on retrograde transport carriers would not 
only result in loss of compartment identity, but would affect also whole cell homeostasis. 
Understanding the mechanisms and machineries involved in retrograde transport represents a field 
of high significance and interest. Retrograde transport does not only have pivotal housekeeping, physio-
logical, and developmental functions, their dysregulation is also associated with disease, and the route is 
exploited as entry portal into the cell by a number of bacterial and plant toxins. We first consider the 
function and importance of retrograde transport by means of two examples. 
A first example for the physiological function of retrograde transport is the maintenance of insulin-
regulated trafficking. In skeletal muscle and adipocytes, insulin signaling results in the recruitment and 
translocation of the major insulin-responsive glucose transporter, GLUT4, to the plasma membrane. 
There, GLUT4 facilitates the cellular uptake of glucose and thus regulates blood glucose levels (Burd, 
2011; Leto and Saltiel, 2012; Stockli et al., 2011). In the state with basal glucose levels, GLUT4 and a 
number of additional proteins are sequestered in special organelles termed 'GLUT4 storage 
compartments (GSC)' where they await stimuli for exocytosis. GSCs are produced from the TGN 
(Bryant et al., 2002), highlighting that a number of compartment components undergo retrograde 
transport to the TGN. The sorting receptor sortilin was shown to be an abundant component of GSCs 
and also to be essential for their formation (Jedrychowski et al., 2010; Shi and Kandror, 2005). After 
insulin-stimulated translocation to the cell surface, GSC proteins are internalized from the cell surface and 
then shuttled via the retrograde pathway to endosomes and the TGN where GSCs are then reassembled 
de novo (Bogan and Kandror, 2010). Efficient retrograde sorting is hence essential for glucose 
homeostasis through its role in reassembling GSCs for other rounds of GLUT4 exocytosis. 
A second example illustrating the physiological importance of retrograde transport is synaptic 
plasticity generation at neurons for learning and memory formation. Synapse formation, remodeling and 
activity strongly depend on a broad spectrum of transmembrane proteins including adhesion proteins and 
receptor molecules. Receptors mediating synaptic plasticity include the NMDA and AMPA receptors. 
Synaptic plasticity describes the ability of pre- and postsynaptic terminals to strengthen or weaken over 
time in response to neuronal cues. Thus, the repertoire of NMDA and AMPA receptors at the cell 
surface, their orchestrated action and activity determines the extent of plasticity and memory formation 
(Chater and Goda, 2014; Derkach et al., 2007; Henley and Wilkinson, 2013; Henley and Wilkinson, 2016). 
Modulation of synaptic plasticity might be accomplished by exocytosis or by retrieval or downregulation 
of these receptors by retrograde transport to the TGN.   
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Retrograde transport is also important during development where intercellular communication is 
vital to give rise to a multicellular organism out of single cells. The Wnt proteins represent a family of 
conserved signaling molecules that are involved in establishing positional cues and cell fate decision during 
development (Burd, 2011). After biosynthesis at the ER, Wnts undergo palmitoylation, and probably 
because of this posttranslational modification (PTM), secretion of Wnts requires the receptor Wntless 
(WLS) as escort factor. At steady-state, WLS localizes to the ER, Golgi and plasma membrane, suggesting 
that it traffics along all these compartments (Yu et al., 2014). In cells with deficient retrograde sorting 
machineries, Wnt molecules are still produced, but fail to be efficiently secreted due to impairment of 
WLS cycling. Thus, retrograde transport of WLS to the ER is required to escort newly synthesized Wnts 
to the plasma membrane to ensure proper development (Harterink and Korswagen, 2012; Herr et al., 
2012; Port et al., 2008).      
Apart from the cellular function of retrograde transport in physiology and development, dysregu-
lation of sorting machineries mediating endosome-to-TGN traffic or toxin invasion have been associated 
with a variety of diseases. A study of Teasdale and colleagues (Follett et al., 2016) has shown that when 
the retromer complex sorting machinery, a transport pathway that will be discussed later on more 
extensively, is blocked, there was an accumulation of α-synuclein-positive aggregates. Such aggregates 
containing α-synuclein are hallmark features of Parkinson’s disease (Chua and Tang, 2006). Another 
neurological disorder is Alzheimer’s disease, a disease that is characterized by the deposition of β-amyloid 
plaques in the brain. The β-amyloid peptides are derived from the amyloid precursor protein (APP) that 
traffics in post-Golgi compartments. Current data suggest that perturbations to the endosomal sorting 
pathway promote production of β-amyloid out of APP. Thereby, APP processing is mainly dependent on 
its residence time in the individual endosomal compartments, on additional APP escort proteins such as 
SorLA, as well as on the localization of APP cleaving enzymes in the endosomal network. 
 
1.3.3 Cargo Proteins in Retrograde Transport  
In the subchapter above, we discussed the importance of retrograde transport in regulating cell function 
and homeostasis and thereby also depicted some illustrative examples. In the following, we are having a 
brief look at cargo proteins undergoing retrograde transport from the cell surface. Retrograde transport 
cargoes vary considerably in their function and structure, but they can be basically classified into five 
distinct groups, including cargo receptors, SNARE proteins, integral membrane proteases, nutrient 
transporters, and other transmembrane proteins. In addition to these, bacterial and plant toxins as well as 
viral proteins can also be considered retrograde transport proteins, however, they constitute a class of 
exogenous rather than of endogenous cargoes (see also Tab. 1.1). 
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Table 1.1: Retrograde transport cargo proteins. Retrograde transport cargo proteins can be classified into different 
categories, including cargo receptors, SNAREs, integral membrane proteases, nutrient transporters, other endogenous transmem-
brane proteins as well as exogenous proteins. The depicted list of retrograde cargo molecules is incomplete, a selected number of 
proteins has been taken for illustration purposes. Abbreviations: CD/CIMPR, cation-dependent/-independent mannose-6-
phosphate receptor; SorLA, sortilin-related receptor with LDLR class A repeats; WLS, Wntless; vti1a/b, vesicle transport through 
interaction with t-SNARE homolog 1a/b; BACE1/2, β site APP cleavage enzyme 1/2; GLUT4, glucose transporter 4; DMT1, divalent 
metal ion transporter 1; TGN protein, trans-Golgi network integral membrane protein; APP, amyloid precursor protein; ANK, 
progressive ankylosis protein. 
 
Cargo Class Retrograde Cargo Protein Cellular Function 
Cargo receptors 
  
 
MPRs (CDMPR and CIMPR) Hydrolase cargo receptor 
 Sortilin Biogenesis of GSCs 
 SorLA Escorting other cargo (e.g. APP) 
 WLS Wnt cargo receptor 
SNAREs   
 vti1a Membrane targeting and fusion 
 vti1b Membrane targeting and fusion 
 Syntaxins Membrane targeting and fusion 
Integral membrane proteases   
 Furin Proenzyme maturation 
 Carboxypeptidase D Proenzyme maturation 
 BACE1/2 Processing of APP 
Nutrient transporters   
 GLUT4 Glucose transporter 
 Menkes protein (ATP7A/B) Copper transporter 
 DMT1 Iron transporter 
Other transmembrane proteins   
 TGN38/46/48/51 Unknown function 
 APP Unknown function 
 ANK Unknown, PPi transporter 
Exogenous cargo   
 Shiga toxin Inhibition of translation 
 Cholera toxin Regulation of adenylyl cyclase 
 Ricin Inhibition of translation 
 Abrin Inhibition of translation 
 
 
Cargo Receptors 
One of the best characterized and most abundant retrograde transport cargo proteins (Tab. 1.1) in 
mammalian cells represent the mannose-6-phosphate receptors (MPRs) (Ghosh et al., 2003a). To undergo 
additional rounds of cargo delivery, MPRs need to be retrieved from post-Golgi compartments. Even 
though different in cargo recognition, yeast also has an analogous MPR-like receptor, Vps10p, which 
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shuttles proteins destined for vacuoles. Mammalian MPRs have type I transmembrane topology and exist 
in two different isoforms, a short variant known as cation-dependent MPR (CDMPR) of ~ 46 kDa, and a 
long variant termed cation-independent MPR (CIMPR) of ~ 300 kDa. As their names indicate, MPRs bind 
cargo decorated with a M6P-tag on glycans, and hence it is not surprising that both receptor isoforms 
have at least one M6P-binding site in their extracytoplasmic domain (Garmroudi et al., 1996; Hancock et 
al., 2002; Marron-Terada et al., 2000; Schmidt et al., 1995). The cytoplasmic tail of both receptors 
contains numerous determinants, some of which are modified by palmitoylation and phosphorylation 
(Meresse et al., 1990; Rosorius et al., 1993; Schweizer et al., 1996; Schweizer et al., 1997). The CDMPR is 
predomi-nantly present as a non-covalent homodimer, while CIMPR seems to be a dimer in the 
membrane, too, even though it behaves as a monomer in detergent solutions under most circumstances. 
Both isoforms have a similar intracellular distribution, with the receptor to be present in the TGN, early 
endosomes, late endosomes as well as in the plasma membrane. The trafficking between these 
membranes is directed by a number of diverse sorting signals present the cytoplasmic tail. These sorting 
determinants interact with transport machineries that facilitate efficient anterograde and retrograde 
transport. The involved machineries mediating retrograde transport of MPRs are described in subchapter 
1.3.4. 
Apart from MPRs, other cargo receptors travel along the retrograde transport route, among them 
WLS, sortilin and SorLA (Johannes and Popoff, 2008). As discussed above in subchapter 1.3.2, WLS 
undergoes retrograde transport to the TGN and then subsequently to the ER to escort newly 
synthesized Wnt ligands for secretion (Yu et al., 2014). Up to the collaborative study of Bard and Virshup 
(Yu et al., 2014), it was generally believed that retrograde transport of WLS to the TGN was sufficient to 
mediate Wnt secretion. This notion was based on experiments with C-terminally tagged WLS that 
predominantly localized to the Golgi complex in steady-state. Native and untagged WLS, in contrast, 
localizes mainly to the ER. The discrepancy between these two different steady-state localizations could 
be resolved by the finding that C-terminal tagging masked an ER retrieval motif and prevented WLS 
interaction with the COPI machinery. 
Sortilin is a sorting receptor that has been implicated in escorting and trafficking of diverse proteins, 
inlcuding other transmembrane proteins, hydrolases or sphingolipid activator proteins (SAPs) (Canuel et 
al., 2008; Hermey, 2009; Lefrancois et al., 2003; Pallesen and Vaegter, 2012). Since the cytoplasmic tails of 
MPR and sortilin exhibit functional and sequence homology, it is hypothesized that both receptors share a 
conserved sorting and trafficking mechanism (Nielsen et al., 2001). As mentioned before (subchapter 
1.3.2), sortilin has been shown to convey GLUT4 into GSCs for their de novo assembly (Leto and Saltiel, 
2012). 
Similar to sortilin, the SorLA receptor is also involved in trafficking of a broader spectrum of 
lumenal and transmembrane cargo (Schmidt et al., 2017). Recently, additional interest has been addressed 
to SorLA, mainly because it has been associated with Alzheimer’s disease. The receptor has emerged as a 
central regulator of trafficking and processing of APP. SorLA has interaction with a number of cytosolic 
adaptors for anterograde and retrograde movement of APP between the TGN and early endosomes, and 
thereby is supposed to restrict delivery of the precursor to compartments that favor amyloidogenic 
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processing. Any impairment with SorLA trafficking and its interacting adaptors resulted in transport 
defects and enhanced amyloid processing of APP, the major risk factor to promote Alzheimer’s disease 
(Willnow and Andersen, 2013).   
For completeness sake, it should be mentioned that the TfR was the first endogenous cargo 
proposed to undergo retrograde transport based on resialylation (Snider and Rogers, 1985). This 
transport was, however, characterized by relatively slow kinetics. Subsequently, no further indication of 
retrograde traffic was found anymore.  
 
SNAREs 
SNARE proteins (soluble N-ethylmaleimide-sensitive fusion factor attachment receptors) constitute a 
large protein superfamily with more than 60 members in mammals (see also Tab 1.1) (Hong, 2005; 
Sudhof and Rizo, 2011). From the structural point of view, SNAREs are transmembrane proteins that are 
characterized by a C-terminal hydrophobic region that functions as membrane anchor, so that the protein 
is mainly oriented towards the cytoplasm. The function of SNAREs is to mediate membrane fusion. In the 
basic model of SNARE function, transport carriers that bud from the TGN carry specific vesicle-SNAREs 
(v-SNAREs) that interact with endosomal target-SNAREs (t-SNAREs) to mediate membrane fusion. After 
disassembly of the v-/t-SNARE complex, the v-SNARE must be reshuttled to the TGN for reuse. 
Depending on which retrograde sorting carrier is used, different SNAREs are required to mediate 
endosome-to-TGN transport. For example, efficient endosome-to-TGN traffic of MPRs requires syntaxin 
16 and vti1a (Amessou et al., 2007; Medigeshi and Schu, 2003; Saint-Pol et al., 2004), while the bacterial 
Shiga toxin requires another set of SNAREs for retrograde transport. Other SNAREs, such as vti1b, 
mediate membrane fusion events at other membranes (Hong, 2005).     
 
Integral Membrane Proteases 
Integral membrane proteases include proprotein convertases that cycle between the TGN and the endo-
lysosomal system. These enzymes typically have a type I membrane topology with an N-terminal lumenal 
protease domain that processes proprotein precursor domains of immature proteins, a transmembrane 
domain, and a cytoplasmic tail containing sorting determinants for targeted transport (Burd, 2011). Furin 
and carboxypeptidase D belong to this category of retrograde transport cargo (Chia et al., 2011; 
Varlamov and Fricker, 1998). Although these enzymes predominantly localize to the TGN, they also 
migrate to endosomes for not yet fully understood reasons. It might be that cycling allows these 
convertases to function on numerous substrates that traverse the TGN and endosomes, similar to the 
APP processing enzymes. It is not known, however, whether these enzymes are actively sorted into 
TGN-derived carriers, as it is the case for MPRs at the TGN, or whether they simply leak out and need 
to be actively retrieved. 
 
Nutrient Transporters 
The localization of nutrient transporters is mainly regulated by metabolic cues. This regulation optimizes 
the capacity of nutrient uptake, sustains intracellular nutrient homeostasis and also protects the cell from 
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toxic amounts of nutrients (Burd, 2011). Retrograde transport cargo proteins belonging to this class are 
for instance GLUT4, Menkes proteins and DMT1 (Tab 1.1).  
As discussed above (subchapter 1.3.2), the GLUT4 transporter is translocated to the cell surface in 
insulin-responsive cells where the protein facilitates glucose uptake. Decreasing levels of glucose and thus 
of insulin triggers the nutrient transporter to undergo retrograde transport and storage in GSCs to await 
the next stimuli. While GLUT4 trafficking for glucose uptake is governed by the levels of insulin, Menkes 
proteins (also known as ATP7A/B) are part of the mammalian copper transport pathway where they 
continuously cycle between the Golgi complex and the plasma membrane (La Fontaine and Mercer, 2007; 
Polishchuk and Lutsenko, 2013). In cells sensing low extracellular copper concentrations, exit of the 
transporter from the TGN is slower than retrograde retrieval from the cell surface. Menkes copper 
transporters thus localize to the TGN in steady-state. When, however, the copper concentrations are 
increased, the rate of Menkes protein exocytosis increases as well, and leads to transporter redistribution 
to the plasma membrane. Increased cell surface expression of the transporter probably increases the 
efficiency of copper removal from cells (Petris and Mercer, 1999). 
DMT1 is another member of the family of nutrient transporters. It is a divalent metal ion 
transporter that mediates the transport of divalent metal ions, inlcuding iron, from the lumen of 
compartments into the cytosol (Garrick et al., 2003; Tabuchi et al., 2002). Even though TfR and DMT1 
functionally cooperate in iron uptake, they have distinct retrograde sorting itineraries. While TfR is 
recycled to the cell surface from early endosomes, DMT1 undergoes first export to the TGN and is then 
delivered back to the plasma membrane (Tabuchi et al., 2010). Different sorting itineraries of cooperating 
TfR and DMT1 might provide a mechanism to dose the amount of iron in the cytosol to avoid toxicity. 
Thus, retrograde transport is very important to regulate nutrient homeostasis. 
 
Other Transmembrane Proteins 
This category includes all kind of integral membrane proteins that cannot be classified as hydrolase or 
hydrolase-like cargo receptors, SNARE proteins, integral membrane proteases or as nutrient transporters 
(Tab 1.1). Among these are the trans-Golgi network integral membrane protein TGN46 and its 
isoforms (TGN38, TGN48 and TGN51), and APP. Recently, a novel retrograde transport cargo, ANK, 
with unknown, but predicted PPi transport function, has been described (Seifert et al., 2016). 
In steady-state, TGN46 and its isoforms exclusively localize to the TGN, suggesting these cargoes 
to be TGN-resident proteins. Previous studies, however, could report that TGN46 and isoforms are also 
present at the cell surface from where they can be retrieved again (Banting et al., 1998; Banting and 
Ponnambalam, 1997; Ponnambalam et al., 1996; Ponnambalam et al., 1994; Rajasekaran et al., 1994). 
Recently, also the TGN-derived carriers involved in anterograde transport of TGN46 and isoforms have 
been described (Wakana et al., 2012), as well as the sorting machinery mediating their retrograde traffic 
from endosomes (Lieu et al., 2007; Lieu and Gleeson, 2010; Saint-Pol et al., 2004). TGN46 and isoforms 
are type I single-spanning transmembrane proteins with yet unknown function.   
APP also has type I topology and is a well-characterized cargo molecule, probably mainly due to its 
association with Alzheimer’s disease. The functional role and importance of APP in the cell is unknown 
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and remains to be determined (Agostinho et al., 2015; Grimm et al., 2017), however, its absence or its 
processing by enzymes may have fatal consequences. Since some of APP’s processing is reported to occur 
in the TGN (Choy et al., 2012), retrograde transport from endosomes to this compartment is required. 
As discussed above (subchapter 1.3.2), the sortilin-related receptor SorLA has been described to escort 
APP along distinct post-Golgi compartments. In this regard, APP could also be considered a cargo of 
SorLA.      
 
Exogenous Cargo Proteins 
Apart from endogenous cargo, a subgroup of toxins and viral proteins also enter cells by retrograde 
transport from the cell surface (Bonifacino and Rojas, 2006; Johannes and Popoff, 2008). Protein toxins 
include such that are secreted by bacteria (e.g. Shiga and cholera toxin) and plants (e.g. ricin and abrin). 
Most of these toxins have a modular organization, a ligand moiety that confers binding to cell surface 
glycoproteins or glycosphingolipids, and an enzymatically active domain that inhibits host cell reactions in 
the cytosol. After binding to the cell surface, the toxins are internalized into endosomes either by CME or 
CIE. Toxins then traverse the TGN and the Golgi complex to reach the ER, where the ligand and 
enzymatic domain then separate from each other. The enzymatic moiety in turn gains access to the 
cytosol by retrotranslocation where it exerts its toxicity (Johannes and Goud, 1998; Johannes and Goud, 
2000; Sandvig and van Deurs, 1994; Sandvig and van Deurs, 1996; Sandvig and van Deurs, 2002; Sandvig 
and van Deurs, 2005). 
However, not all toxins undergo passage through the TGN. It was recently shown that the toxin 
'Pseudomonas exotoxin (PE) A' undergoes a novel endosomal route via NAEs to reach the host 
nucleoplasm (Chaumet et al., 2015). It remains to be investigated to which extent this pathway 
contributes to toxin delivery in general. 
 
1.3.4 Sorting Machineries Involved in Retrograde Transport 
After internalization by CME or CIE, early endosomes are populated before cargo is subsequently segre-
gated for recycling, sorted further along the endo-lysosomal pathway or transported to the TGN. Endo-
some-to-TGN transport is not only occurring from early endosomes, but can also occur from late 
endosomes. As for other intracellular pathways, retrograde transport between these endocytic compart-
ments and the TGN requires the formation of membrane-enclosed transport carriers. Therefore, 
molecular components needed for the formation of selective transport carriers must be recruited from 
the cytosol to specific domains of the endosomal membrane to confer retrograde transport. A number of 
distinct sorting pathways have been described, among them the AP-1-, epsinR-, retromer complex- and 
Rab9/TIP47-dependent pathway (Fig. 1.5). In the following, these retrograde endosome-to-TGN sorting 
machineries will be discussed. 
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Figure 1.5: Pathways that mediate retrograde transport from endosomes to the TGN. Following 
internalization by CME or CIE, several pathways exist that sort cargo to the TGN. Cargo sorting can either occur from early or 
late endosomes. Retrograde endosome-derived transport carriers have been described to bud from the tubular rather than the 
vacuolar domains. Due to the network-forming character of these tubular elements, the name 'tubular endosomal network (TEN)' 
has been coined. It is the TEN from where transport machineries, including AP-1, epsinR and retromer complex, operate to 
deliver cargo to the TGN. Similar tubular elements arise from late endosomes to give rise to Rab9/TIP47-dependent carriers. 
Figure modified from Bonifacino and Rojas, 2006.       
        
AP-1 Pathway  
Like AP-2, AP-1 is a member of the heterotetrameric cargo adaptor protein (AP) complex family, a family 
that also comprises AP-3, AP-4 and AP-5. Each of these five AP complexes localize to distinct intracellular 
compartments and have specific, but in part also overlapping cargo recognition function (Hirst et al., 
2012b). In their role as cargo adaptors, they are recruited to their target membranes to mediate 
formation of specific transport carriers containing selected cargo proteins. The evolutionary tree of APs 
shows AP-5 diverging first, followed by AP-3 and AP-4, while AP-1 and AP-2 are most closely related 
(Dacks and Robinson, 2017; Hirst et al., 2014). 
Each of the AP complexes is composed of two distinct large subunits (~ 100-130 kDa) termed β(1-
5)-adaptin and γ-,α-,δ-,ε- or ζ-adaptin, a medium µ(1-5)-subunit (~ 50 kDa), as well as of a small σ(1-5)-
subunit (~ 20 kDa) existing in different isoforms (Fig. 1.6). In the case of AP-1, the complex is made up 
of a β1-, γ-, µ1-, and σ1-adaptin subunit. The presence of individual AP-1 adaptin isoforms is cell type-
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specific. In polarized cells, for instance, there are two different µ1 subunits, µ1A and µ1B, with 
overlapping, but also separate functions (Bonifacino, 2014; Gravotta et al., 2012a; Zizioli et al., 2010). 
Recently, a second γ-subunit has been more thoroughly characterized, thereby giving rise to a γ1- and γ2-
isoform-containing AP-1 complex (Zizioli et al., 2017). While the AP-1/γ1 complex is expressed in all 
eukaryotes, AP-1/γ2 expression only occurs in vertebrates and plants. They both have different functions 
in development and traffic and do not functionally compensate for each other (Zizioli et al., 2017). To 
avoid any confusion when talking about the γ-subunit of AP-1, we always refer to the ubiquitous γ1 and 
not to the other isoform (Lewin et al., 1998; Takatsu et al., 1998; Zizioli et al., 2017; Zizioli et al., 1999). 
Regarding structure, the two large subunits (γ and β1) can be subdivided into a C-terminal ear-like 
appendage domain connected to the N-terminal core domain via a flexible and unstructured linker 
sequence (Canagarajah et al., 2013; Kirchhausen, 1999; Owen et al., 2004; Robinson, 2004).  
 
 
 
Figure 1.6: Structural organization of the five adaptor protein (AP) complexes. The AP complexes are 
heterotetrameric protein complexes composed of two large subunits (β(1-5)-adaptin and γ-,α-,δ-,ε- or ζ-adaptin), a medium µ(1-
5)-subunit and a σ(1-5)-subunit. Some adaptins exist in different isoforms that are in part expressed in a tissue-specific manner. AP 
complexes are structurally organized into a C-terminal appendage domain, and an N-terminal trunk domain that are linked via a 
flexible hinge. Since AP-1 is of importance later on, it is highlighted in different colors than the other APs. Figure in the style 
derived from Canagarajah et al., 2013. 
 
AP-1 mainly localizes to the TGN and to tubular early endosomes, indicating a dual distribution 
pattern and the involvement in distinct sorting pathways. Membrane recruitment of AP-1 is dependent on 
activated ARF GTPases, where the adaptor binds tyrosine- or dileucine-based sorting signals on cargo 
proteins via the µ1 subunit or the γ/σ1-hemicomplex (Doray et al., 2007; Ohno et al., 1995; Owen and 
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Evans, 1998). While AP-1 and AP-2 functionally cooperate with clathrin and are thus bonafide 
components of clathrin-coated carriers (CCVs), this is less clear for AP-3, AP-4 and AP-5 (Hirst et al., 
2012b; Robinson, 2004). After AP-2, AP-1 is the second most abundant cargo adaptor with a copy 
number of about 370'000 per cell (Hirst et al., 2012b).  
 
After the brief and incomplete structural excursion on AP-1, we would like to focus now more on 
its functional role in cargo traffic. What is the cargo adaptor precisely doing in retrograde traffic from 
early endosomes? Apart from the well-established involvement in anterograde TGN-to-endosome 
transport (Ghosh et al., 2003b; Hinners and Tooze, 2003; Puertollano et al., 2001; Puertollano et al., 
2003), AP-1 was also described in retrieval of cargo receptors to the TGN, in particular of the MPRs. 
Schu and colleagues reported that the steady-state distribution of both CDMPR and CIMPR in µ1A 
subunit-deficient fibroblasts derived from knockout mouse embryos was shifted to early endosomes at 
the expense of the TGN (Meyer et al., 2000). If AP-1 exclusively mediated anterograde transport from 
the TGN to endosomes, one would expect that in AP-1 knockouts both MPRs would accumulate in the 
TGN. MPRs, however, do exit the TGN in the absence of AP-1, reach the cell surface and are re-
endocytosed from there, but accumulate to some extent in EEA1-positive compartments. Schu and 
colleagues also provided biochemical evidence for defective MPR retrieval from endosomes to the TGN 
using a resialylation assay (Meyer et al., 2000). 
In an additional study of Schu (Medigeshi and Schu, 2003), it was further demonstrated that 
membranes isolated from AP-1-deficient cells have a reduced transport competence in an in vitro 
retrograde endosome-to-TGN transport assay. These observations from Schu and coworkers supported 
a potential role of AP-1 in retrograde endosome-to-TGN traffic. 
Another readout for AP-1 dysfunction is the general observation that the lysosomal hydrolase 
precursor cathepsin D is preferentially missorted into the medium rather than being delivered to 
lysosomes (Hirst et al., 2005; Hirst et al., 2003; Mardones et al., 2007; Meyer et al., 2000). If M6P-
mediated lysosomal hydrolase delivery were really dependent on MPRs for TGN exit, then also these 
cargo proteins should accumulate in the TGN, however, they do not. Lysosomal hydrolases exit the TGN 
independently of AP-1 and MPR localization. 
Apart from sorting of MPRs in the retrograde direction, other endocytosed cargo (e.g. cholera 
toxin) has been described to require AP-1 to reach the TGN (Matsudaira et al., 2015). AP-1-dependent 
transport from endosomes is not only restricted to deliver cargo proteins along the retrograde route, but 
has been implicated also in receptor recycling to the plasma membrane in polarized MDCK cells (Pagano 
et al., 2004).   
Due to the ambivalent character of AP-1, acting anterogradely and retrogradely, the concept of 
bidirectional traffic has emerged, that is AP-1 to mediate both TGN-to-endosome transport and vice 
versa. However, most of what we know about the involvement of AP-1 in bidirectional traffic at the 
TGN-to-endosome interface is based on knockdown and knockout studies, and clearly, these studies 
influenced our understanding how the cargo adaptor operates. A major disadvantage of gradual or long-
term protein depletion strategies is that compensatory or indirect effects may occur, either due to 
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cellular adaptation or altered steady-state distribution of involved factors. In particular, in the case of a 
cargo adaptor like AP-1 that permanently shuttles proteins between two intracellular compartments, the 
question about directionality is more challenging to tackle, since the observed phenotype might not be a 
direct consequence of AP-1 dysfunction. 
Using a novel strategy for rapid protein inactivation termed 'knocksideways (KS)' (see also sub-
chapter 1.4), Robinson and coworkers readdressed the function of AP-1 in bidirectional traffic at the 
TGN-to-endosome interface (Robinson et al., 2010). Using such a technique that eliminates possible 
compensatory or indirect effects, Robinson and colleagues could not only confirm AP-1 to function in 
endosome-to-TGN retrieval of MPRs, but also highlighted that gradual depletion (knockdown) and rapid 
depletion (knocksideways) can result in different readouts. While the protein levels of CIMPR present in 
clathrin-coated vesicles (CCVs) were substantially reduced in the knocksideways condition, almost no 
reduction was found in the knockdown condition (Robinson et al., 2010). It seems that other transport 
carriers fractionating with CCVs compensate for AP-1 loss during the period of a knockdown, but they 
do not appear in the knocksideways situation since upregulatory changes would take longer than minutes 
to eventuate. 
The concept of AP-1 to be involved in bidirectional transport was further corroborated in a follow-
up study by Robinson and coworkers (Hirst et al., 2012a) using quantitative proteomics. The study 
demonstrated that AP-1 in cooperation with GGA2, a monomeric adaptor at the TGN, facilitates cargo 
sorting of lysosomal proteins with their receptors for anterograde transport, while AP-1 alone operates 
in the selective retrieval of the empty cargo receptors in the retrograde direction (Hirst et al., 2012a). 
The idea of the orchestrated action of AP-1 and GGA adaptors at the TGN has been already suggested 
by Kornfeld and colleagues (Doray et al., 2002), however, quantitative data for this concept have been 
lacking. Also very interesting is the fact that not only cargo receptors and well-established AP-1 binding 
partners were depleted from the isolated CCV fraction, but also endosomally associated proteins such as 
Rab4 and rabaptin5 (Hirst et al., 2012a). This again points to AP-1 carriers budding from early endosomes. 
The knocksideways approach (see also subchapter 1.4), in particular for AP-1, is thus an extremely 
powerful tool since acute depletion can provide unprecedented insights into protein function that are not 
apparent when proteins are depleted gradually. 
 
EpsinR Pathway  
Another clathrin adaptor operating at early endosomes apart from AP-1 is epsinR (derived from epsin-
related). EpsinR, also termed CLINT1, epsin4 or enthoprotin, is a monomeric adaptor protein of ~ 70 
kDa with an epsin N-terminal homology (ENTH) domain, a structural domain that is present in epsins 
operating in CME (Bonifacino and Traub, 2003). 
EpsinR was originally discovered in a pull-down screen for proteins interacting with the appendage 
domain of the γ-subunit of AP-1 (Hirst et al., 2003). Since epsinR interacts with AP-1 in vitro and in vivo, 
it was not surprising that they have a nearly identical intracellular distribution pattern. Association of 
epsinR with membranes, however, is independent of AP-1, since epsinR localizes normally in AP-1-
deficient cells. The same argument holds true for the opposite case. RNAi-mediated depletion of epsinR 
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also does not affect the subcellular localization of AP-1. Like AP-1, epsinR is recruited to the TGN and 
early endosomal membranes by members of the ARF GTPase family and the phosphoinositide PI(4)P 
(Hirst et al., 2003). 
What is the function of epsinR in retrograde transport? The first cargo that was found to bind 
epsinR in a yeast two-hybrid screen was the SNARE protein vti1b (Chidambaram et al., 2004), an 
interaction that was subsequently corroborated in vivo (Hirst et al., 2004). It was shown that depletion of 
epsinR altered the steady-state distribution of vti1b as well as of vti1a, a SNARE which is 33% identical to 
vti1b, from a perinuclear to a more scattered peripheral labeling pattern. Thus, these SNARE proteins 
were proposed to be most likely involved in membrane targeting and fusion events at the TGN-to-
endosome interface. Since vti1b, but not vti1a, was also strongly reduced in CCV fractions isolated from 
epsinR-depleted cells, epsinR was characterized as a SNARE-specific cargo adaptor that most likely 
operates in endosome-to-TGN retrieval of vti1b. 
That epsinR/clathrin is not exclusively acting as SNARE-specific adaptor, but functioning in 
endosome-to-TGN cargo transport more generally was demonstrated by a study of Johannes and 
colleagues (Saint-Pol et al., 2004). Using a sulfation assay, they showed that cells depleted of epsinR had 
deficits in delivering Shiga toxin, CIMPR as well as TGN38/46 from TfR-positive compartments to the 
TGN (Saint-Pol et al., 2004). 
Recently, Robinson and colleagues established an epsinR knocksideways cell line to analyze the 
immediate consequences of epsinR inactivation on clathrin-mediated intracellular traffic (Hirst et al., 2015). 
Similar to their former study (Hirst et al., 2012a), they isolated CCVs from cells where epsinR was rapidly 
inactivated, followed by quantitative CCV proteome analysis. Surprisingly, it was found that the epsinR 
knocksideways had a more global effect on intracellular CCV cargoes, similar to the effect of an AP-1 
knocksideways. Top hits of depleted proteins were not only epsinR itself and predicted cargo proteins 
(e.g. vti1b), but also other coat components such as GGA2, AP-1 and clathrin, suggesting that, like AP-1, 
epsinR acts as a linchpin factor in the formation of an entire CCV population (Hirst et al., 2015). 
Interestingly, several cargo proteins that depend on AP-1 and/or GGAs (e.g. hydrolase receptors) were 
depleted even more strongly from CCVs isolated from epsinR KS than from AP-1 KS cells. 
The observation that epsinR concomitantly depletes AP-1 from CCVs and vice versa suggests that 
they might operate cooperatively in intracellular CCV formation. It thus might be that epsinR and AP-1 
belong to the same transport pathway, apart from their independent cellular function.      
 
Retromer Complex Pathway  
The retromer complex is an evolutionary conserved multimeric protein coat that is considered a master 
conductor in the orchestration of multiple cargo sorting events within the tubular endosomal network 
(TEN) (Bonifacino and Hurley, 2008; Cullen and Korswagen, 2011; Gallon and Cullen, 2015; Mukadam and 
Seaman, 2015; Seaman, 2012). Unlike to classical coats such as COPI or COPII as well as clathrin, the 
retromer complex does not form a visible electron dense layer on membranes by electron microscopy 
(Arighi et al., 2004; Popoff et al., 2007a; Seaman, 2004). Even though the terminology 'retro'-mer complex 
suggests its exclusive role in retrograde transport, it actually facilitates also endosomal cargo recycling to 
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the plasma membrane. Though conserved between kingdoms, the retromer complex in mammalian cells 
features some subtle functional and structural particularities that yeast do not have. 
The retromer complex was initially identified almost 20 years ago in Saccharomyces cerevisiae to 
be required for endosome-to-TGN retrieval of the carboxypeptidase Y (CPY) receptor Vps10p, 'yeast’s 
MPR'. In yeast, the retromer complex is made up of two different subcomplexes, a heterotrimer of 
Vps26p, Vps29p, Vps35p, and a heterodimer of Vps5p and Vps17p (Horazdovsky et al., 1997; Seaman et 
al., 1997; Seaman et al., 1998). In mammalian cells, genes encoding Vps5p and Vps17p have diversified such 
that the sorting nexin 1 and sorting nexin 2 (SNX1 and SNX2) are the mammalian homologues of Vps5p, 
while SNX5, SNX6 and most likely also SNX32 are the counterparts of Vps17p. Any combination of 
SNX1 or SNX2 with SNX5 or SNX6 can assemble to the heterodimeric subcomplex (Rojas et al., 2007b; 
Wassmer et al., 2007). 
A particular feature of these SNXs is that they comprise a C-terminal Bin/Amphiphysin/Rvs (BAR) 
domain, and hence are termed SNX-BARs (Carlton et al., 2004). These BAR domains enable SNX-BARs 
to form specific homo- and heterodimers and, in this structural arrangement, can sense, model and drive 
membrane curvature for the formation of tubular-vesicular carriers (Frost et al., 2008; Frost et al., 2009; 
van Weering et al., 2012; Zimmerberg and McLaughlin, 2004). In addition, SNX-BARs of the retromer 
subcomplex also comprise a phagocytic oxidase (phox) homology (PX) domain (Teasdale and Collins, 
2012), a domain specifically binding to PI(3)P-enriched membranes. As a result of coincidence detection of 
PI(3)P and curvature, SNX-BARs preferentially associate with tubular-vacuolar membranes of early 
endosomes. The heterodimeric subcomplex in its organization and function is often referred to as the 
SNX-BAR subcomplex or the 'tubulation complex' (Gallon and Cullen, 2015; Trousdale and Kim, 2015).   
Discrimination of the retromer complex into two distinct subcomplexes is necessary. Then even 
though the SNX-BAR subcomplex interacts strongly with the heterotrimeric subcomplex in yeast, this 
interaction appears to be less robust in mammalian cells. It thus seems that the two subcomplexes in 
mammals only transiently interact with each other, similar to AP complexes with clathrin on the 
respective membranes during carrier formation. Since the heterotrimeric Vps26-Vps29-Vps35 
subcomplex together with various other factors select cargo for transport, it is often referred to as 'cargo 
selective complex (CSC)', 'cargo recognition complex (CRC)' or 'retromer'. We will use the terminology 
retromer and, hence, the retromer subcomplex and the SNX-BAR subcomplex form together the '(SNX-
BAR-) retromer complex'.  
Similar to other cargo coats such as the AP complexes, retromer complex selectively recognizes 
short linear amino acid stretches in the cytoplasmic tail of transmembrane proteins. Vps35 is thought to 
select cargo, specifically CIMPR and sortilin, by association with a [FW]L[MV] motif (Seaman, 2007). 
Similarly, Vps26 binds the sequence FANSHY in the cytoplasmic tail of SorLA (Fjorback et al., 2012). 
Recently, several lines of evidence suggested that SNX components might also be involved in cargo 
recognition (Harterink et al., 2011; Steinberg et al., 2013; Strochlic et al., 2007; Temkin et al., 2011; Zhang 
et al., 2011). However, generic amino acid motifs as cargo sorting determinants are unknown and remain 
to be determined. The few reports of interactions with cargo do not explain the number of processes in 
which retromer complex is implicated to be involved. Other accessory factors downstream of retromer 
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complex recruitment might cooperate in cargo selection and facilitate binding of a broader repertoire of 
transmembrane proteins with distinct sorting motifs (Gallon and Cullen, 2015).  
 
 
Figure 1.7: Distinct retromer complexes involved in endosome-to-TGN transport and recycling to the 
plasma membrane. The mammalian retromer complex mediates at least three distinct pathways from endosomes. The 
'canonical' SNX-BAR-retromer complex (1), comprising the core retromer trimer (Vps26-Vps29-Vps35) and the SNX-BAR 
subcomplex, mediates retrograde transport of cargo such as CIMPR to the TGN. The SNX3-retromer complex (2), comprising 
the core retromer trimer and SNX3, shuttles cargo such as WLS from endosomes to the TGN. The SNX27-retromer complex, 
comprising the core retromer trimer and SNX27 (3), traffics cargo such as the β2 adrenergic receptor from endosomes to the 
plasma membrane. Figure modified from Cullen and Korswagen, 2011.       
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The retromer complex as such cannot bind to PI(3)P-enriched early endosomes on its own since it 
lacks a lipid-binding domain. Instead, retromer requires Rab7a for membrane recruitment, most probably 
via Vps35 (Nakada-Tsukui et al., 2005; Rojas et al., 2008; Seaman et al., 2009). As commented elsewhere 
(Johannes and Wunder, 2011), this finding was found rather puzzling since Rab7 is associated with late 
rather than early endosomes. It is thus believed that cargo sorting by retromer complex is a progressive 
process that is part of endosomal maturation during the Rab5-to-Rab7 switch (Rojas et al., 2008). Along 
with Rab7a, SNX3 has also been implicated in the recruitment of retromer (Harterink et al., 2011). Unlike 
the SNX-BARs, SNX3 belongs to the SNX-PX subfamily of SNXs since it only has a PX, but not a BAR 
domain (Gallon and Cullen, 2015; Yu and Lemmon, 2001). Unlike the 'canonical retromer complex', the 
SNX3-retromer complex represents a heterotetrameric and not a heteropentameric assembly complex, 
which has been reported in the selective transport of WLS.  
 
After the brief and by far incomplete excursion on retromer complex biology, we would like to 
focus now more on its functional role in cargo traffic. The characterization and involvement of SNX family 
proteins and additional factors allowed defining at least three distinct exit routes from endosomes (Fig. 
1.7), including the canonical SNX-BAR-retromer complex (Fig. 1.7, 1) that mediates transport to the 
TGN from tubular regions of endosomes, the SNX3-retromer complex (Fig. 1.7, 2) that facilitates 
endosome-to-TGN transport of WLS, and last but not least, the SNX27-retromer complex (Fig. 1.7, 3) 
that traffics cargoes from endosomes to the plasma membrane (Gallon and Cullen, 2015). We are only 
interested in the pathways mediated by the SNX-BAR-retromer and SNX3-retromer complex (Fig. 1.5 
and Fig. 1.7) since they are delivering cargo destined to the TGN. 
Compared to retrograde transport mediated by AP-1, epsinR and other machineries, retromer 
complex-driven sorting is probably the most thoroughly characterized retrograde endosome-to-TGN 
pathway. Therefore, it is not a surprise that myriads of cargo proteins have been described that are 
sorted by the retromer complex. Most of the proteins listed in Table 1.1 have been reported to be 
recognized and sorted by the retromer complex. Probably the best-characterized cargo of the SNX-BAR 
retromer complex is CIMPR. In the study by Seaman (Seaman, 2004), it was investigated whether the 
mammalian retromer complex fulfills the same function as in yeast regarding endosome-to-TGN retrieval 
of the mammalian homologue of Vps10p, CIMPR. Using cells derived from transgenic mice deleted for 
mammalian Vps26 and through the application of RNAi to knockdown expression of Vps26, it was found 
that the absence of the retromer subunit resulted in a range of phenotypes consistent with a defect in 
endosome-to-Golgi retrieval. Similar to a knockdown or knockout of AP-1 (Hirst et al., 2005; Meyer et al., 
2000), Vps26 depletion caused CIMPR redistribution to EEA1-positive endosomes and defects in 
cathepsin D maturation (Seaman, 2004). Parallel to the study of Seaman, Bonifacino and colleagues 
reported similar phenotypes for cells depleted of Vps35 (Arighi et al., 2004). It thus seems that ligand-free 
CIMPR, or MPRs in general, is dependent on more than just one retrograde sorting machinery. Whether 
for instance the AP-1/clathrin and retromer complex are separate or cooperative sorting machineries will 
be discussed further below. 
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Apart from MPRs, the other two listed cargo receptors (Tab 1.1), sortilin and SorLA, are also 
trafficked from endosomes to the TGN in an SNX-BAR-retromer-dependent manner (Fjorback et al., 
2012; Nielsen et al., 2007; Seaman, 2004). 
Other endosome-to-TGN cargoes sorted by retromer complex are DMT1, TGN38 and WLS (Bai 
and Grant, 2015; Belenkaya et al., 2008; Tabuchi et al., 2010). However, unlike MPR and MPR-like cargo 
receptors, DMT1, TGN38 and WLS transport is mediated by the SNX3-retromer complex. Also here, it 
has to be mentioned that TGN38 is trafficked to the TGN by an alternative route, namely by the epsinR 
pathway (Saint-Pol et al., 2004). 
Endosome-to-PM recycling by retromer complex has been reported for the β2 adrenergic receptor 
(β2AR) and TfR. Direct recycling of β2AR to the cell surface involves the SNX27-retromer complex and 
Rab4, while TfR recycling was proposed to be indirect via recycling endosomes but to require SNX3 
(Chen et al., 2013b; Temkin et al., 2011). Even though there are more cargo proteins relying on retromer 
complex for correct localization, these few examples illustrate the importance of the complex in endo-
somal sorting. 
As briefly touched above, some cargoes (e.g. MPRs or TGN38 and isoforms) seem to use more 
than just one transport route for correct membrane localization. Together with the fact that retromer 
complex has been appreciated not only as cargo coat but also as 'recruiting hub' for multiple factors, the 
idea has raised that retromer complex is linked to clathrin coat formation on endosomes (Burd and 
Cullen, 2014; Gallon and Cullen, 2015; Seaman, 2012). Clathrin-coated structures on endosomes in close 
vicinity to retromer complex have been indeed reported, and proteomics-based studies have identified 
retromer complex subunits to be present in semi-pure preparations of CCVs (Borner et al., 2006; Popoff 
et al., 2009; Popoff et al., 2007a; Shi et al., 2009). In contrast to these observations, however, a finding 
from Robinson and colleagues was that clathrin and retromer complex subunits are present on distinct 
transport intermediates (Borner et al., 2012). In addition to that, there are currently no reports of any 
direct interactions between clathrin and retromer or the SNX subunits (McGough and Cullen, 2011; 
McGough and Cullen, 2013). Thus, whether clathrin and retromer complex operate together in 
endosomal protein sorting requires further investigation. Retromer complex has also been linked to the 
ESCRT machinery since SNX1 binds to Hrs-1, an ESCRT-0 component. But as for the clathrin machinery, 
more evidence is needed to link retromer complex to the ESCRT machinery.  
 
Rab9/TIP47 Pathway  
The first discovered pathway that mediates retrograde transport from an endocytic compartment to the 
TGN was the Rab9/TIP47 pathway (Pfeffer, 2009). The GTPase Rab9 has been initially shown by Pfeffer 
and colleagues to localize to tubular late endosomes and to be required for efficient transport of MPRs to 
the TGN (Lombardi et al., 1993; Soldati et al., 1993). With the subsequent search for additional factors 
using a yeast two-hybrid screen, Diaz and Pfeffer identified a protein of 47 kDa, that they named tail-
interacting protein, or briefly TIP47 (Diaz and Pfeffer, 1998). In follow-up studies after the discovery of 
TIP47, it was then shown that Rab9 and TIP47 are operating in an intertwined process where active Rab9 
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acts as crucial hub to recruit downstream effectors, including TIP47, to mediate late endosome-to-TGN 
transport (Carroll et al., 2001). 
Further characterization by Pfeffer and colleagues demonstrated that depletion of TIP47 using 
antisense oligonucleotides or siRNA strongly destabilized MPRs in living cells (Diaz and Pfeffer, 1998; 
Ganley et al., 2004), and antibody depletion of TIP47 from cytosol led to a partial loss of cytosol activity in 
terms of its ability to support in vitro transport of MPRs from endosomes to the TGN (Diaz et al., 1997). 
The association of TIP47 with purified endosome-enriched membranes was impaired by antibodies binding 
to the cytoplasmic domain of MPRs, implicating TIP47 to specifically recognize MPRs (Krise et al., 2000; 
Orsel et al., 2000). Also, binding of TIP47 to CIMPR was reported to be somewhat stronger than to 
CDMPR, suggesting minute trafficking differences between the two receptors in retrieval (Krise et al., 
2000). TIP47 expression was also shown to stimulate MPR transport from late endosomes to the TGN, 
and the presence of Rab9 even increased the affinity with which TIP47 bound MPR tails (Sincock et al., 
2003). The importance of TIP47 in Rab9 function was further highlighted by the striking observation that 
depletion of TIP47 destabilized the GTPase (Ganley et al., 2004). Although the total levels of Rab9 did not 
change, the rates of turnover and new synthesis did. 
Taking together all these findings, Pfeffer and coworkers proposed the Rab9-recruited protein 
TIP47 to act as a cargo selection device for MPRs in late endosome-to-TGN transport (Pfeffer, 2009). 
Apart from TIP47, other Rab9 effectors are required for efficient MPR retrieval from late endosomes, 
including p40 and GCC185 (Derby et al., 2007; Diaz et al., 1997). While p40’s function in transport is 
unclear, GCC185 has been shown to be a tether for vesicle docking and fusion at the TGN.    
While AP-1, epsinR and retromer complex seem to cover a spectrum of cargo, including MPRs, for 
retrograde transport from early endosomes, TIP47 seems to specifically traffic only MPRs from late 
endosomes. Despite the considerable body of evidence, the role and function of TIP47 in cargo traffic 
from late endosomes has been recently challenged. In particular because TIP47 has also been reported in 
lipid droplet biosynthesis (Wolins et al., 2001). In addition to that, other groups argue against the 
involvement of TIP47 in retrograde transport of MPRs from late endosomes (Bulankina et al., 2009). 
Höning and colleagues failed to reproduce some of the initially described functions of Rab9 and TIP47. 
They showed that TIP47 does not colocalize with MPRs, Rab9 and other marker proteins of the secretory 
and endocytic pathways. Also, depletion of TIP47 did not affect the steady-state distribution of MPRs, as it 
does during interference with the retromer complex or the AP-1 machinery.  
Along with the fact that TIP47 does not have any obvious adaptor coat organization, like AP-2 or 
AP-1, or any corresponding membrane-distal coat, such as clathrin, the function of TIP47 as selective 
cargo device remains in question. Clearly, further attempts are required to resolve the discrepancy of 
TIP47 function in lipid droplet biogenesis and retrograde transport from late endosomes. At least, the 
name TIP47 has become scarce, instead the name perlipin-3 (PLIN3) has gained acceptance. Perlipin-3 
belongs to the perlipin protein family and shares significant homology to other proteins of this family, such 
as adipophilin, a well-characterized protein of lipid droplets (Itabe et al., 2017; Pol et al., 2014; Wilfling et 
al., 2014). 
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Adaptor protein localization to endosomes may suggest a function in cargo recycling to the plasma 
membrane or retrieval to the TGN. Other cargo adaptor molecules reported to be present on 
endosomes are the Golgi-localized, γ-ear-containing, ADP ribosylation factor (ARF)-binding proteins, 
briefly GGAs (Bonifacino, 2004). In the study of Walter and coworkers (Wahle et al., 2005), it was shown 
that GGA1, one out of three GGAs (GGA1-3), is involved in retrograde transport of the processing 
enzyme BACE1 from early endosomes to the TGN. Some other lines of evidence confirming GGA 
localization and function on endosomes were reported by Casanova and colleagues (D'Souza et al., 2014). 
They showed that GGA3 localizes onto dynamic Rab4-enriched tubular domains of early endosomes. It 
has to be stressed, however, that GGAs are mainly known to operate in anterograde cargo traffic from 
the TGN. In particular, GGA proteins were described as adaptor proteins cooperating with AP-1 to 
package MPRs with bound lysosomal hydrolases into AP-1-containing coated carriers (see also 'AP-1 
pathway') (Doray et al., 2002; Ghosh and Kornfeld, 2004; Hirst et al., 2012a). The significance of GGAs in 
retrograde transport from early endosomes to the TGN is due to only a few number of studies hard to 
assess.  
 
We have seen that multiple trafficking routes exist that confer transport from endosomal 
compartments to the TGN. Most of the studies dominating today’s conception of each transport route 
were based on steady-state localization readouts after interference with the respective sorting 
machineries. Ideally, kinetics of transport to the TGN rather than misdistribution analysis of cargo 
reporters in the TGN/endosomal network are potentially of more meaningful value since we can track 
proteins in action. In addition, RNAi-mediated depletion or knockout strategies entail a number of 
drawbacks that can make it very challenging to interpret the observed data. During the period of gradual 
protein depletion for instance, it is difficult to see whether the observed phenotype is a direct result of 
protein loss, or whether mislocalization of other factors, that are dependent on the depleted protein, are 
responsible. In case of the latter, we speak about indirect or secondary effects. To study PM-to-TGN 
retrograde transport kinetics more precisely and reliably, tools are required allowing rapid inactivation of 
sorting machineries. 
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1.4 Rapid Protein Inactivation by Knocksideways 
 
Knocksideways (KS) describes the rapid inactivation of proteins by trapping them onto mitochondria. 
Unlike other methods to inactivate proteins, including knockdown with interference on the mRNA level 
or knockout by CRISPR/Cas9-mediated editing on the genomic level, knocksideways occurs on the 
protein level. The knocksideways approach has been pioneered by Margaret Robinson and colleagues 
(Robinson and Hirst, 2013; Robinson et al., 2010), but has in the meantime found increasing application by 
a number of other laboratories (Birnbaum et al., 2017; Cheeseman et al., 2013; Garay et al., 2015; 
Giorgino and De Fabritiis, 2011; Hughes and Waters, 2017; Renard et al., 2015; Willett et al., 2014; 
Willox and Royle, 2012). The system can be principally used on any protein of interest that is either 
cytosolic or transiently membrane-associated. Since knocksideways is considerably faster (typically within 
minutes) than a knockdown or knockout (Robinson and Hirst, 2013), one can look at the immediate 
consequences of inactivating a protein of interest. This has the benefit of more clear-cut results than 
those obtained with a knockdown or knockout, since there is much less time for indirect and/or 
compensatory events to come into play. Above all in the case of sorting machineries that regulate protein 
traffic between two intracellular organelles, fast inactivation can provide more significant readouts since 
gradual or long-term depletion might just reflect the accumulation of indirect effects. 
But how is the knocksideways approach working? The approach is based on the ability of 
rapamycin or rapalogs to form non-covalent heterodimers between proteins modified with a FKBP or 
FRB domain (Fig. 1.8). One of the domains, for instance FRB, is anchored in the outer mitochondrial 
membrane, while the FKBP domain is attached to the protein to be inactivated. In such a setup, 
knocksideways thus mediates the rapid sequestration and thus immobilization of FKBP-modified target 
prey proteins onto mitochondria by rapamycin/rapalog-induced heterodimerization with the FRB-tagged 
outer mitochondrial bait protein. Since the mitochondrial protein acts as trap for the cytosolic FKBP-
modified preys, it is referred to as Mitotrap (Robinson and Hirst, 2013). Since the dissociation time of t1/2 
~ 17.5 hr for rapamycin and its analogues is extremely slow (Hosoi et al., 1999), one can consider 
mitochondrial rerouting as irreversible. 
Apart from FKBP and FRB domains, other protein modules conferring ligand-triggered heterodi-
merization can be essentially used. Although not yet published for KS approaches, prey and bait proteins 
tagged with a SNAP-tag or Halo-tag can be introduced to achieve crosslinking using the recently describ-
ed heterodivalent compound HaXS and in its variants (Erhart et al., 2013; Zimmermann et al., 2014). 
Apart from introducing recombinant prey and baits into the system, it is also a requirement to 
deplete the endogenous counterpart of the prey protein without affecting the recombinant one. This is 
normally achieved by making the prey construct RNAi-resistant. Thus, to start the actual knocksideways 
procedure, it is necessary to deplete the endogenous counterpart of the protein of interest (POI) first. 
Most importantly, the recombinant FKBP-tagged prey construct thereby has to functionally compensate 
for the role of the endogenous protein. Alternatively, the recombinant prey construct can be rendered 
single guide (sg) RNA-resistant so that subsequent CRISPR/Cas9-mediated gene editing will abolish endo-
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genous expression. Gene editing could be principally also used to knock in the FKBP domain into the 
target locus, retaining essentially endogenous expression levels.    
 
 
Figure 1.8: Schematic diagram of the knocksideways approach. The prey (pink) and bait proteins (violet) have FKBP 
and FRB domains that can bind a small molecule, such as rapamycin and analogs, for non-covalent heterodimerization. Preys are 
typically modified with a FKBP domain, baits with a FRB domain. Apart from the FRB domain, the bait is modified so that it 
localizes to the outer mitochondrial membrane. The prey is the protein of interest (POI) to be inactivated, and that cycles between 
the cytosol and a membrane or other cellular structures. Administration of the small molecule causes the prey to be immobilized 
on mitochondria where it cannot perform its function anymore. Figure in the style derived from Robinson and Hirst, 2013.            
 
Even though KD and KS can culminate in identical readouts, as shown for AP-1 with regard to the 
accumulation of CIMPR in early endosomes in anti-CIMPR antibody uptake experiments (Meyer et al., 
2000; Robinson et al., 2010), there is also a body of evidence that the two inactivation strategies result in 
different readouts. In the same study by Robinson (Robinson et al., 2010), it was shown that isolated 
CCVs from AP-1 KS cells had a strong depletion of CIMPR, while this was not the case in AP-1 KD cells. 
This observation suggested that during the period of a gradual knockdown, CIMPR was presumably 
trafficked by other transport intermediates to find its way to its target compartment (see also 'AP-1 
pathway' subchapter). The same CCV isolation experiment further showed that there is more α-adaptin 
associated with vesicles prepared from AP-1 KD cells, whereas levels in AP-1 KS cells were unaltered. 
This observation is thought to reflect an attempt by the cells to compensate for the loss of AP-1 
(Robinson et al., 2010). 
A more striking difference between KS and KD readouts was shown in a follow-up study by 
Robinson and colleagues (Hirst et al., 2012a). With the aim to tease apart the interrelationship between 
AP-1 and GGA2 in cargo packaging at the TGN, Hirst and coauthors isolated CCVs from AP-1 KS and 
GGA2 KS cells. Interestingly, while GGA2 copurified with CCVs isolated from AP-1 KD cells in control 
cells, it is strongly depleted from CCVs prepared from AP-1 KS cells. It thus seems that during the period 
of a knockdown, something happens that allows the cell to nevertheless recruit GGA2 onto CCVs. In 
addition, in a recent study of Robinson and coworkers (Navarro Negredo et al., 2017), proteomics 
profiling of CCVs isolated from AP-1 KS and AP-1 KO cells demonstrated that ARF1 was lost from the 
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vesicles when AP-1 was acutely inactivated, while the GTPase was barely affected from the membrane 
fraction when isolated from AP-1 KO cells. The phenomena of such different readouts between KS and 
KD or KO are difficult to interpret, since it can be hardly predicted how cells react if they face gradual 
AP-1 depletion. For the experimenter, hence, 'unforeseen' signaling events might occur during the typical 
time of ~ 72-96 h of a knockdown, thereby enabling the cell to compensate and/or adapt. Only by 
combining the knocksideways technique with CCV profiling, it was possible to show that AP-1 may act as 
a linchpin in the formation of intracellular CCVs, and that if AP-1 is rapidly lost, no such carriers can form.  
A similar importance in intracellular CCV formation could be assigned to the epsinR adaptor (see 
also 'EpsinR pathway'). EpsinR knocksideways did not only affect its cargo protein vti1b, but more globally 
a broad range of cargo (Hirst et al., 2015). This observation was mainly possible due to the rapidity of the 
knocksideways approach. A second protein that Hirst and coauthors investigated in the respective study 
was gadkin. Gadkin is a CCV component that provides a connection between AP-1 and the cytoskeleton. 
Knocksideways of gadkin also resulted in phenotypes different from knockdowns or knockouts 
(Laulagnier et al., 2011; Maritzen et al., 2012). Clearly, the manner and time of inactivation can produce 
different readouts. If one has to believe in one of the two experimental out-comes, i.e. 'knocksideways' 
versus 'knockdown/knockout', then it is plausible to trust the KS readout more since it is free of any 
indirect or compensatory effects, at least specifically with regard to AP-1, while other KDs/KOs should 
not be discredited from the beginning.   
Which other proteins have been studied with the knocksideways technique apart from AP-1, 
GGA2, epsinR and gadkin? Willox and Royle used FKBP-modified stonin2, an endocytic adaptor specific to 
neurons, and clathrin to look at synaptic vesicle retrieval (Willox and Royle, 2012). Rapid rerouting of 
stonin2 and clathrin allowed the authors to switch endocytically competent synapses to a blocked state 
on the timescale of minutes. 
In another study of Royle and coworkers (Cheeseman et al., 2013), the protein TACC3 was 
investigated. TACC3 was reported to be an essential non-motor protein that associates with the 
microtubule polymerase ch-TOG and brings it to spindle fibers during mitosis. It was proposed that 
TACC3-ch-TOG complexes are crucial for promoting spindle assembly, a process that is also dependent 
on clathrin. To specifically remove TACC3-ch-TOG-clathrin complexes from mitotic spindles after 
normal spindle assembly, an FKBP-tagged TACC3 fusion was used. Using the knocksideways technique, it 
was possible to remove TACC3-ch-TOG-clathrin at different stages of mitosis. The use of RNAi to study 
the function of spindle proteins is complicated because the cell may have undergone a number of cell 
cycles with gradual reduction of the proteins. During this time, the cell might adapt and/or upregulate 
alternative pathways to compensate for the depleted protein.  
Other studies using the knocksideways approach came from Lupashin and colleagues who studied 
the mobility of the conserved oligomeric Golgi (COG) complex (Willett et al., 2014), a complex that 
orchestrates tethering and fusion of intra-Golgi carriers with Golgi membranes. Using the knocksideways 
approach, the authors found that the COG complex is tightly associated with Golgi membranes since it is 
not significantly relocated onto mitochondria in the presence of rapamycin within 24 h.     
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In the study of Renard and colleagues, rapid rerouting of endophilin-A2 was performed to study its 
function in membrane scission during CIE (Renard et al., 2015). It is now clear that endophilin-A2 is part 
of a separate CIE pathway termed FEME. We briefly discussed this CIE pathway in subchapter 1.1.   
Antonescu and colleagues (Garay et al., 2015) used the knocksideways approach to perturb clathrin 
function and to monitor its consequences on EGF-stimulated Akt phosphorylation. It was shown that 
clathrin rerouting resulted in inhibition of EGF-stimulated Akt phosphorylation. Antonescu and coworkers 
could not only show that clathrin is required for EGFR signaling finally resulting in Akt phosphorylation, 
but also that the requirement for clathrin is functionally independent from its role in EGFR endocytosis.  
Knocksideways has not only been applied on cultured cells, but also on other model systems, such 
as on Plasmodium falciparum (Birnbaum et al., 2017; Hughes and Waters, 2017). The protozoan 
Plasmodium falciparum, a parasite leading to the most severe form of malaria, was used to selectively 
knock in FKBP into loci of its essential genes. Inactivating these proteins allowed the authors to get 
insights into their in vivo function in the progression of malaria disease.      
 
Knocksideways has a number of advantages in comparison to a knockdown and/or knockout, that 
are its versatility, its rapidity, and the reduced risk of indirect or compensatory effects. In particular in 
order to study protein traffic, it is favorable to have acute inactivation strategies to immediately interfere 
with the sorting machinery without indirect effects to prevail. 
Membrane traffic between two compartments can be investigated best when we label reporter 
proteins in the donor compartment, acutely inactivate the sorting machinery by knocksideways, and then 
look at arrival in the acceptor membrane. In order to elucidate the role of AP-1 in coated vesicle 
biogenesis at the TGN and early endosomes, Robinson and colleagues (Hirst et al., 2012a; Robinson et al., 
2010) combined CCV isolation with quantitative proteomics in cells where AP-1 was acutely lost. An 
alternative approach to CCV isolation to study anterograde traffic from the TGN is sulfation, a 
modification restricted to this compartment. Likewise, to assess transport from the cell surface to the 
TGN, sulfation can be used as arrival indicator. This alternative approach would require specific cell 
surface modification of proteins to render them sulfatable. Furthermore, in comparison to CCV isolation, 
sulfation has the benefit to make statements about directionality.           
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1.5 Protein Binders as Tool to Analyze Retrograde Transport 
 
1.5.1 Overview of Protein Binders  
Studying retrograde traffic from the cell surface requires specific surface labeling of proteins of interest. 
An approach to label proteins in vivo and in vitro in general is the use of protein binders, proteins that 
bind to a specific target. Such protein binders not only function to study protein-protein interactions, but 
also to modulate or inhibit their activity as well as to visualize dynamic changes of cellular localization in 
living cells. 
Apart from the most established protein binders, the conventional antibodies, new approaches 
have been developed to generate additional highly specific binders. As a result, a number of small protein 
scaffolds were adapted or engineered, leading to the establishment of scFVs, nanobodies, DARPins, and 
more. In the following, an overview of each of these protein binder scaffolds is given. It has to be 
mentioned that this subchapter of the PhD thesis only provides a very short glimpse at protein binders. 
For a more detailed picture of protein binders, a number of excellent reviews have been published over 
the last three years (Bieli et al., 2016; De Meyer et al., 2014; Helma et al., 2015; Kaiser et al., 2014; 
Pluckthun, 2015). In addition, it has to be emphasized already here that the use of such protein binders 
has a great potential as tool in basic research, including in the field of protein and membrane traffic within 
the secretory and endocytic pathways.     
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Figure 1.9 (see previous page): Schematic illustration of conventional antibodies, scFvs, Fab, camelid 
hcAbs and DARPins. (IgG) Conventional antibodies (IgGs) contain constant regions from the heavy chains (CH1-3) and light 
chains (CL), as well as variable regions from heavy (VH) and light chains (VL). The paratope, the entity conferring antigen-specificity, 
is represented by the VH and VL. Disulfide bonds present in IgGs are depicted in grey lines. (scFv) Single-chain variable fragments 
are only composed of the variable regions (VH and VL) of IgGs that are connected to each other via a synthetic linker. (Fab) 
Antigen-binding fragments (Fab) are composed of one constant (CH1 and CL) and one variable domain (VH and VL) of each of the 
heavy and the light chain. (hcAbs) Heavy chain antibodies (hcAbs) lack light chains and CH1, instead CH2 is directly fused to the 
variable domain (VHH) of the heavy chain antibody. A schematic drawing of the VHH domain is depicted. The so-called conserved 
framework regions (FR1-4) are depicted in grey, the complementarity determining regions (CDR1-3) are shown in other colors. 
(DARPins) Designed Ankyrin Repeat Proteins (DARPins) are composed of three to six ankyrin repeats (AR) that are flanked by 
a N-terminal and C-terminal cap. The cartoon depicts a DARPin with three ankyrin repeats (AR1-3, in green) and the respective 
caps (in blue). Figure modified from Bieli et al., 2016.      
 
1.5.2 Conventional Antibodies, scFvs and Fab  
Conventional antibodies (IgGs) are the most commonly known protein binders since they have myriads of 
applications in cell biology. IgGs are typically composed of two identical large heavy (H) chains (~ 50 KDa) 
and two identical small light (L) chains (~ 25 kDa). Each of these H and L chains comprises constant (C) 
and variable (V) regions (Fig. 1.9). The H and L polypeptide chains are connected to each other via 
disulfide bonds, and by this assemble to a heterotetrameric protein complex (~ 150 kDa). For synthetic 
protein engineering or expression approaches, such a complex organization with various inter- and 
intramolecular disulfide bridges is of disadvantage. Disulfide bonds can only be formed in an oxidizing 
environment, such as the ER. In addition, assembly and correct folding of four polypeptide chains to a 
functional antibody is a complex process. 
To circumvent some of these drawbacks, derivatives of IgGs, such as scFvs or Fab fragments, have 
been constructed (Fig. 1.9). The so-called single-chain variable fragment (scFv) is actually not a fragment 
of an antibody as it might insinuate, but represents a fusion protein of the variable regions of the heavy 
(VH) and light chains (VL) of an IgG. Thereby, VH and VL are connected with a synthetic short linker 
peptide, which typically contains glycine residues for flexibility and serine or threonine residues for 
solubility (Bird et al., 1988; Chen et al., 2013c; Nelson, 2010), and can either bridge the N-terminus of the 
VH with the C-terminus of the VL, or the opposite direction. Since the VH of the H and L chain are the 
functional entities binding to target epitopes, scFvs still retain their specificity despite the absence of the 
constant regions (CH1-3, CL). scFvs represent one of the most used small protein binder scaffolds, 
however, they did not find many applications in cell and developmental biology because of a variety of 
technical caveats, including aggregation, insolubility, and misfolding upon expression in the cytoplasm (Bieli 
et al., 2016; Cattaneo and Biocca, 1999; Visintin et al., 1999). 
Unlike scFvs, antigen-binding fragments (Fab) of IgGs, that are produced by partial proteolysis, are 
composed of one constant and one variable domain of the H and L chain (Rader, 2009). Even though 
conventional antibodies, scFvs, and Fab act as useful protein binders, they have the disadvantage that they 
cannot be expressed in the cytoplasm and are difficult to be synthesized with bacterial expression systems. 
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1.5.3 Nanobodies   
Apart from the expression of heterotetrameric antibodies during immune responses, animals from the 
family of Camelidae (e.g. camels, Ilama, alpacas, etc.) and cartilaginous fishes (e.g. nurse sharks) produce a 
distinct set of antibodies. These antibodies lack light chains and are thus also called homodimeric heavy 
chain antibodies (hcAbs). 
As a result of the above-mentioned limitations of IgGs and their derivatives, the discovery of these 
naturally occurring hcAbs almost 25 years ago has raised great attraction in the recombinant antibody 
field (Greenberg et al., 1995; Hamers-Casterman et al., 1993). Due to the lack of variable light chain 
domains, the functional antigen-binding unit of hcAbs is confined to the variable domain of the heavy chain 
(VHH). The variable domain of these hcAbs is often referred to as single-domain antibody (sdAb) or 
more commonly as nanobody. In hcAbs, VHH can be regarded as the functional equivalent of the variable 
regions (FV) of conventional antibodies. Since the VHH consists only of one polypeptide chain, it is 
considerably smaller in size (~ 15 kDa) than the Fv fragment. When mentioning hcAbs, we always refer to 
the homodimeric heavy chain antibodies derived from camelids, because hcAbs from cartilaginous fishes 
(the so-called IgNARs) have a slightly different organization in their variable and constant regions. 
Nanobodies have numerous technological advantages compared to other small antibody fragments 
like scFv or Fab. First, only one domain has to be cloned and expressed to generate a functional protein 
binder. There is no need to assemble to higher oligomeric structures to gain antigen specificity. Second, 
specific nanobodies can be selected with standard screening technologies. Nowadays, companies (e.g. the 
company Hybribody) produce VHHs on demand and select them using the phage display or yeast two-
hybrid technology. And third, nanobodies are highly soluble, stable (heat-stable to ~ 70°C) and 
characterized by high affinity after selection (Kaiser et al., 2014; Muyldermans, 2001).  
All nanobodies share a common conserved framework (FR) structure consisting of 9 β-strands that 
fold into two 4- and 5-stranded β-sheets, yielding a so-called β-sandwich structure (Fig. 1.9). Apart from 
the FR, nanobodies typically contain three hypervariable regions that are called complementarity-
determining regions (CDRs). The CDRs are present within the loops that connect one β-strand to the 
next to form a continuous surface mediating recognition of the target antigen (Muyldermans, 2013; 
Muyldermans et al., 1994). While the paratope of conventional antibodies consists of six CDR loops 
(three each from VH and VL), the paratope of nanobodies comprises three loops only. The CDR loops 
from nanobodies, however, are considerably longer and confer similar variability and specificity as those 
present in conventional antibodies (Bieli et al., 2016; Muyldermans, 2013). As the CDR loops are longer, 
they have to be stabilized, and this is mainly conferred by an intramolecular disulfide bond between CDR1 
and CDR3. This intramolecular single cystine has been shown to favor a strong paratope-epitope 
interaction (Muyldermans, 2013). However, bacterially or cytosolically expressed selected nanobodies do 
not seem to necessarily require this disulfide bond to confer proper epitope recognition, though. 
Most of the nanobodies so far characterized bind to three-dimensional folded structures of 
antigens, which make them suitable to study proteins in living cells. Since nanobodies have a small size, 
high solubility, specificity, and stability, they are ideal protein binder scaffolds that can be further 
functionalized depending on the research interests.  
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1.5.4 DARPins  
To operate like nanobodies as suitable protein scaffolds, other scaffold derivatives must replicate the 
virtues of antibodies and overcome their shortcomings. Repeat proteins turned out to be a very attractive 
choice for protein binders, since in nature repetitive structural motifs were found in a considerable 
number of proteins to be involved in specific protein-protein interactions. Repeat proteins are typically 
composed of repeat modules that tightly stack on each other to give rise to a compact folded structure 
with variable surface residues to create an extended paratope-epitope interface. 
The probably most developed protein repeat scaffold is based on ankyrin repeats, and thus this 
class of protein binders is called DARPins, derived from Designed Ankyrin Repeat Proteins (Pluckthun, 
2015). The structural repeats of DARPins are comprised of two anti-parallel α-helices, one β-turn and 
one loop (Kohl et al., 2003) with a length of 33 amino acids in total. DARPins contain three to six of these 
structural motifs, resulting in a molecular weight of about 14-22 kDa. To enhance solubility and stability of 
DARPins, the stacked repeats are modified with N-terminal and C-terminal hydrophilic synthetic caps. 
Capping is crucial, otherwise DARPins cannot properly fold when expressed in bacteria (Interlandi et al., 
2008). Apart from the need of capping, capping also brings along the advantage to create a larger 
interaction surface to bind to even more possible epitopes (Schilling et al., 2014).  
Due to their compact, stacked and unique structure, DARPins are extremely stable and less prone 
to aggregation. Compared to nanobodies, DARPins lack any disulfide bonds, which makes it easy to 
express these protein binders in bacteria or in the cytoplasm of any model system. Since their initial 
description mainly by Andreas Plückthun, DARPins have found quite a number of applications in basic and 
medical research (Pluckthun, 2015).   
 
1.5.5 Other Protein Binder Scaffolds 
The description and application of nanobodies and DARPins has stimulated the search for additional 
scaffolds with similar or additional features. Therefore, it is not surprising that over 50 different scaffolds 
have been reported so far (Helma et al., 2015). Depending on the type of scaffold, a number of different 
protein binders have been established, among them adhirons, affimers, alphabodies, anticalins, centryins, 
obodies, pronectins, repebodies, and more (Skrlec et al., 2015). Since most of these belong to the 
youngest generation of protein binders, they are not that well established as nanobodies or DARPins.     
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1.6 Aim of the Thesis 
 
At all levels of the secretory pathway, anterograde transport of membranes and cargo is counterbalanced 
by retrograde traffic to maintain compartment identity and whole cell homeostasis. In particular, retrieval 
of ligand-free cargo receptors from endosomes is essential in order to replenish receptor pools in the 
TGN, thus allowing receptors to capture newly synthesized ligands for export. A number of distinct 
sorting machineries have been shown to confer retrograde transport from endosomes to the TGN, 
including the AP-1/clathrin machinery. Importantly, the AP-1/clathrin machinery plays an exceptional role, 
since it has not only been reported to mediate retrograde transport from endosomes to the TGN, but 
also anterograde TGN-to-endosome traffic. 
While anterograde traffic mediated by AP-1 is well established, there is still uncertainty about its 
involvement in retrograde transport, mainly because there are other well described sorting machineries, 
or because most of the reported findings were based on indirect readouts (KD and KO). Such readouts 
may be misleading, because the observed phenotype can be an indirect effect of AP-1 depletion. 
Additionally, cells might upregulate alternative pathways to compensate for the reduced or missing 
protein, thereby potentially masking the true phenotype. Although there are also several AP-1 readouts 
based on acute inactivation of the trafficking complex, it is hard to interpret them since they have been 
obtained from quantitative proteomics profiling. Directional and more rapid approaches, such as 
biochemically tracking AP-1-dependent cargo from endosomes to the TGN, have not been established on 
a routine basis. 
With the aim to study the contribution of AP-1 in endosome-to-TGN transport, we sought to set 
up a more generic approach to follow proteins during their retrograde itinerary from the plasma 
membrane. To this end, we defined the following two aims: 
 
§ Establishment of a versatile nanobody-based approach conferring recombinant protein cargo to be 
tracked from the cell surface by biochemical techniques, by live cell imaging, and by electron 
microscopy. 
§ Investigation of the involvement of AP-1 in endosome-to-TGN transport by using the knocksideways 
technique in combination with the here established approach based on functionalized nanobodies.  
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  2     Material and Methods 
 
 
2.1 Material 
 
2.1.1 Primary Antibodies 
Antibody Host Used for Dilution  Supplier Product Number 
Anti-GFP 
Mouse 
monoclonal 
WB  1:5000 Sigma-Aldrich 
11814460001-
Roche 
Anti-GFP 
Rabbit  
polyclonal 
EM 1:100 Abcam ab6556 
Anti-myc 
Rabbit  
polyclonal 
WB 1:5000 Sigma-Aldrich C3956 
Anti-myc 
Rabbit  
polyclonal 
EM 1:2000 Abcam ab9106 
Anti-HA 
Mouse 
monoclonal 
WB 1:10000 Homebrew 
12CA5 
hybridoma 
Anti-HA 
Mouse 
monoclonal 
IF 1:1000 GeneTex GTX115044 
Anti-FLAG 
Rabbit 
polyclonal 
IF 1:500 
Cell Signaling 
Technology 
2368 
Anti-FLAG 
Mouse 
monoclonal 
WB 1:1000 
Cell Signaling 
Technology 
8146 
Anti-His6 
Rabbit 
polyclonal 
WB 1:10000 
Bethyl 
Laboratories 
A190-114A 
Anti-T7 
Rabbit 
polyclonal 
WB 1:10000 
Bethyl 
Laboratories 
A190-117A 
Anti-SNX1 
Mouse 
monoclonal 
WB 1:500 BD Biosciences 611482 
Anti-VPS26 
Rabbit 
polyclonal 
WB 1:1000 
Bethyl 
Laboratories 
A304-801A 
Anti-VPS35 
Rabbit 
polyclonal 
WB 1:1000 
Bethyl 
Laboratories 
A304-727A 
Anti-SNX2 
Rabbit 
polyclonal 
WB 1:2000 
Bethyl 
Laboratories 
A304-544A-M 
Anti-MTCO2 
Mouse 
monoclonal 
IF 1:1000 Abcam ab3298 
Anti-Actin 
Mouse 
monoclonal 
WB 1:100000 EMD Millipore MAB1501 
Anti-γ-adaptin (100/3) 
Mouse 
monoclonal 
IF/WB 
1:500/ 
1:5000 
Homebrew 
100/3 
hybridoma 
Anti-γ-adaptin 
Mouse 
monoclonal 
WB 1:5000 BD Biosciences 610385 
Anti-α-adaptin 
Mouse 
monoclonal 
WB 1:5000 BD Biosciences 610501 
Anti-µ1-adaptin 
Mouse 
polyclonal 
WB 1:1000 Abnova H00008907-A01 
Anti-CHC17 
Mouse 
monoclonal 
WB 1:200 Homebrew 
TD.1 
hybridoma 
Anti-TfR (H68.4) 
Mouse 
monoclonal 
WB 1:1000 
Thermo Fisher 
Scientific 
13-6890 
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Antibody Host Used for Dilution  Supplier Product Number 
Anti-TfR 
Mouse 
monoclonal 
IF 1:1000 Homebrew 
OKT8 
hybridoma 
Anti-TGN46 
Sheep 
polyclonal 
IF/WB 1:1000 Bio-Rad AHP500GT 
Anti-CDMPR46 
Mouse 
monoclonal 
IF 1:200 Jack Rohrer 
22D4 
hybridoma 
Anti-CIMPR (2G11) 
Mouse 
monoclonal 
IF 1:1000 Abcam ab2733 
Anti-CIMPR  
Rabbit 
polyclonal 
WB 1:1000 GeneTex GTX130109 
Anti-TIP47 
Rabbit 
polyclonal 
WB  1:1000 Proteintech 10694-1-AP 
Anti-LAMP1 
Rabbit  
monoclonal 
WB 1:1000 
Cell Signaling 
Technology 
9091 
Anti-Calnexin 
Mouse 
monoclonal 
WB 1:2000 BD Biosciences 610523 
Anti-LAMP1 
Rabbit 
monoclonal 
WB 1:1000 
Cell Signaling 
Technology 
9091 
Anti-Tom20 
Mouse 
monoclonal 
WB 1:1000 BD Biosciences 612278 
Anti-vti1a 
Mouse 
monoclonal 
WB 1:1000 BD Biosciences 611220 
Anti-vti1b 
Mouse 
monoclonal 
WB 1:1000 BD Biosciences 611404 
Anti-Rab4 
Rabbit 
polyclonal 
WB 1:5000 Bruno Goud n.a. 
Anti-Rab5 
Mouse 
monoclonal 
WB 1:1000 
Cell Signaling 
Technology 
3547 
Anti-Rab7 
Rabbit 
monoclonal 
WB 1:1000 
Cell Signaling 
Technology 
9367 
Anti-Rab9 
Rabbit 
monoclonal 
WB 1:1000 
Cell Signaling 
Technology 
5118 
Anti-GM130 
Rabbit 
monoclonal 
IF 1:1000 
Cell Signaling 
Technology 
12480 
Anti-α-adaptin 
Goat 
polyclonal 
IF 1:1000 Everest Biotech EB11875 
Anti-β-1,4-GalT 
Rabbit 
polyclonal 
WB 1:1000 
Novus 
Biologicals 
NBP1-88654 
Anti-TPST1 
Rabbit 
polyclonal 
WB 1:2500 Abcam Ab100972 
Anti-TPST2 
Rabbit 
polyclonal 
WB 1:1000 GeneTex GTX46685 
Anti-α-mannosidase II 
Rabbit 
polyclonal 
WB 1:1000 
LifeSpan 
BioSciences 
LS-C163982 
Anti-CD44 
Mouse 
monoclonal 
WB 1:2500 
Novus 
Biologicals 
NBP1-47386SS 
Anti-phospho S6 
(Ser235/236) 
Rabbit 
monoclonal 
WB 1:2500 
Cell Signaling 
Technology 
2211 
Anti-S6  
Rabbit 
monoclonal 
WB 1:2500 
Cell Signaling 
Technology 
2217 
Anti-COXIV 
Rabbit 
monoclonal 
WB 1:2500 
Cell Signaling 
Technology 
4850 
Anti-GAPDH 
Rabbit 
monoclonal 
WB 1:10000 
Cell Signaling 
Technology 
5174 
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Antibody Host Used for Dilution  Supplier Product Number 
Anti-β-1/2-adaptin 
Mouse 
monoclonal 
WB 1:5000 BD Biosciences 610381 
Anti-σ1-adaptin 
Rabbit 
polyclonal 
WB 1:1000 
Bethyl 
Laboratories 
A305-396A-M 
Anti-FKBP12 
Mouse 
monoclonal 
IF 1:250 BD Biosciences 610808 
Anti-FKBP12  
goat 
polyclonal 
IF 1:250 
Santa Cruz 
Biotechnology 
sc-6174 
Anti-FKBP12 (DmrA) 
Mouse 
monoclonal 
IF 1:250 
Clontech 
(Takara Bio) 
635089 
Anti-EEA1 
Mouse 
monoclonal 
IF 1:1000 BD Biosciences 610456 
Anti-PGK1/2 
Mouse 
monoclonal 
WB 1:10000 
Santa Cruz 
Biotechnology 
sc-166432 
 
2.1.2 Secondary Antibodies 
Antibody Host Used for Dilution  Supplier Product Number 
Anti-mouse  
Alexa 488 
Donkey 
polyclonal 
IF 1:500 
Thermo Fisher 
Scientific 
A-21202 
Anti-rabbit  
Alexa 488 
Donkey 
polyclonal 
IF 1:500 
Thermo Fisher 
Scientific 
A-21206 
Anti-goat  
Alexa 488 
Donkey 
polyclonal 
IF 1:500 
Thermo Fisher 
Scientific 
A-11055 
Anti-mouse  
Alexa 568 
Donkey 
polyclonal 
IF 1:500 
Thermo Fisher 
Scientific 
A-10037 
Anti-rabbit  
Alexa 568 
Donkey 
polyclonal 
IF 1:500 
Thermo Fisher 
Scientific 
A-10042 
Anti-rabbit  
Alexa 647 
Donkey 
polyclonal 
IF 1:500 
Thermo Fisher 
Scientific 
A-31573 
Anti-Sheep Cy3 
Donkey 
polyclonal 
IF 1:200 
Jackson 
Laboratories 
713-165-147 
Streptavidin-HRP 
not 
applicable 
WB 1:10000 
Thermo Fisher 
Scientific 
434323 
Anti-rabbit HRP 
Goat 
polyclonal 
WB 1:10000 Sigma-Aldrich A-0545 
Anti-mouse HRP 
Goat 
polyclonal 
WB 1:10000 Sigma-Aldrich A-0168 
Anti-sheep HRP 
Donkey 
polyclonal 
WB 1:5000 Sigma-Aldrich A-3415 
 
2.1.3 Fluorochromes 
Antibody Specificity Used for Dilution  Supplier Product Number 
DAPI Nuclei IF 1:1000 Sigma-Aldrich D9542 
Transferrin Alexa 568 TfR IF 20 µg/mL 
Thermo Fisher 
Scientific 
T-23365 
Streptavidin Alexa 
647 
Biotinylated 
proteins 
IF 
Assay-
dependent 
Thermo Fisher 
Scientific 
S-32357 
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2.1.4 Functionalized Nanobodies  
Name of Nanobody Specificity Epitope and Domain Organization 
VHHGFP-control GFP and variants thereof  T7-VHHGFP-HA-BAP-His6 
VHHGFP-TEV-control GFP and variants thereof  T7-VHHGFP-TEV-HA-BAP-His6 
VHHGFP-myc GFP and variants thereof T7-VHHGFP-myc-HA-BAP-His6 
VHHGFP-1xTS GFP and variants thereof T7-VHHGFP-1xTS-HA-BAP-His6 
VHHGFP-2xTS GFP and variants thereof T7-VHHGFP-2xTS-HA-BAP-His6 
VHHGFP-TEV-2xTS GFP and variants thereof T7-VHHGFP-TEV-2xTS-HA-BAP-His6 
TS-VHHGFP-TS GFP and variants thereof T7-1xTS-VHHGFP-HA-BAP-1xTS-His6 
VHHGFP-APEX2 GFP and variants thereof T7-VHHGFP-APEX2-HA-BAP-His6 
VHHGFP-TEV-APEX2 GFP and variants thereof T7-VHHGFP-TEV-APEX2-HA-BAP-His6 
VHHGFP-mCherry GFP and variants thereof T7-VHHGFP-mCherry-HA-BAP-His6 
 
2.1.5 Chemicals and Reagents  
Chemical or Reagent Supplier Product Number 
DMSO (for cell culture) Applichem A3672 
D-biotin Sigma-Aldrich B4501 
5-aminolevuilnic acid hydrochloride Sigma-Aldrich A3785 
Hexadimethrine bromide (polybrene) Sigma-Aldrich H9268 
DAB tetrahydrochloride hydrate Sigma-Aldrich D5637 
Sodium cacodylate trihydrate Sigma-Aldrich C0250 
DNaseI from bovine pancreas Applichem A3778 
AP21967 (A/C Heterodimerizer) Clontech (Takara Bio) 635056 
Rapamycin Sigma-Aldrich R0395 
Biotin-Phenol (biotin tyramide) Adipogen/Chemodex CDX-B0270 
Sodium ascorbate Sigma-Aldrich A7631 
Sodium azide Applichem A1430 
Trolox Sigma-Aldrich 238813 
Brefeldin A (BFA) Sigma-Aldrich B5936 
Lysozyme  Sigma-Aldrich 000000018037059001-Roche 
ProTEV Plus Promega V6101 
Factor X activated (Xa) Sigma-Aldrich F9302 
Hygromycin B Invivogen ant-hg-5 
Puromycin  Invivogen ant-pr-1 
Blasticidin  Invivogen ant-bl-1 
Penicillin/Streptomycin BioConcept  4-01F00-H 
L-glutamine Applichem A3704 
DMEM - high glucose 4500 mg/L Sigma-Aldrich D5796 
DMEM - high glucose 4500 mg/L (-pr) Sigma-Aldrich D1145 
Opti-MEM I Thermo Fisher Scientific 31985070 
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Chemical or Reagent Supplier Product Number 
Sodium pyruvate  Sigma-Aldrich S8636 
Hydrogen peroxide (H2O2) Sigma-Aldrich 216763 
Sulfur-35 as sodium sulfate Hartmann Analytics ARS0105 
FuGENE HD  Promega E2311 
Lipofectamine RNAiMAX Thermo Fisher Scientific 13778150 
IPTG Applichem A1008 
Carbenicillin  Applichem A1491 
Kanamycin Applichem A1493 
Coomassie-R (Brilliant Blue) Sigma-Aldrich B-0149 
Trypsin-EDTA (10x) Sigma-Aldrich T4174 
Formaldehyde solution  Sigma-Aldrich F8775 
Paraformaldehyde (PFA) Applichem A3813 
Glutaraldehyde (GA) Sigma-Aldrich G7651 
Osmium tetroxide solution  Sigma-Aldrich 75632 
Bovine serum albumin (BSA) Sigma-Aldrich 000000010711454001-Roche 
Fetal calf serum (FCS) Biowest S181B-500 
UA conjugate - streptavidin 5 nm gold BBI solutions EM.STP5 
Fluoromount-G Southern Biotech 0100-01 
Ni Sepharose High Performance GE Healthcare 17-5268-01 
HC Streptavidin Agarose Resin Thermo Fisher Scientific 20357 
Phusion HF DNA Polymerase New England BioLabs M0530L 
Q5 HF DNA Polymerase New England BioLabs M0491S 
DNA ligase T4 Sigma-Aldrich 10481220001-Roche 
 
2.1.6 Kits and Others  
Kits Supplier Product Number 
His GraviTrap columns GE Healthcare GE11-0033-99 
His buffer kit GE Healthcare GE11-0034-00 
Disposable PD10 desalting columns GE Healthcare GE17-0851-01 
NucleoSpin plasmid kit Macherey-Nagel 740588.50 
Jetstar plasmid purification kit Genomed 210050 
iDimerize heterodimerization system Takara Bio (Clontech) 635067 
Pierce BCA protein assay kit Thermo Fisher Scientific 23225 
Mini-Protean TGX gels, 4-20%, 15-well Bio-Rad 456-1096 
Immobilon Western HRP substrate  Merck-Millipore WBKLS0500 
GOLD Conjugation Kit (10 nm, 20 OD) abcam ab201808 
GOLD Conjugation Kit (20 nm, 20 OD) abcam ab188215 
His-Spin Protein Miniprep Zymo Research P2001 
Micro spin desalting columns Thermo Fisher Scientific 89877 
µ-slide dishes (4-well, ibiTreat) Vitaris 80426-IBI 
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2.2 Methods 
 
2.2.1 Plasmids and Molecular Cloning 
Empty Retro-X vectors, pQCXIH and pQCXIP, as well as the iDimerize Inducible Heterodimer System 
were purchased from Takara Bio. The vector pQCXIB w297-1 (Addgene plasmid #22800) was a gift from 
Eric Campeau (Program in Gene Function and Expression, University of Massachusetts Medical School, 
Worcester, USA). Template AP-1 KS plasmids encoding siRNA-resistant γ-FKBP (pLXIN-Ap1g1-FKBP, 
Addgene plasmid #46946) and Mitotrap (pEYFP-Mitotrap, Addgene plasmid #46942) were previously 
described (Robinson et al., 2010) and kindly provided by Margaret Robinson (CIMR, Cambridge, United 
Kingdom). The plasmid encoding GFP-CI-MPR (pCIpreEGFP-CIMPRtail) was previously published (Waguri 
et al., 2003) and kindly provided by Bernard Hoflack and Mihaela Anitei (Biotechnology Center, 
Technische Universität Dresden, Germany). A plasmid containing the anti-GFP nanobody (NSlmb-
vhhGFP4) was formerly described (Caussinus et al., 2011; Caussinus et al., 2013) and generously provided 
by Emmanuel Caussinus (Institute of Molecular Life Sciences, University of Zurich, Switzerland) and 
Markus Affolter (Biozentrum, University of Basel, Switzerland). The pET-24a template vector containing 
an anti-GFP nanobody fusion construct, and a template plasmid containing BirA was mercifully provided 
by Dietmar Schreiner (Institut für Neuroanatomie und Zellbiologie, Medizinische Hochschule Hannover, 
Germany). The cDNA for APEX2 was obtained from the input vector pcDNA3 APEX2-NES (Addgene 
plasmid #49386) and was a generous gift from Alice Ting (Department of Chemistry, MIT, Cambridge, 
USA). The sequences containing TPST1-EGFP (Addgene plasmid #66617) or TPST2-EGFP (Addgene 
plasmid #66618) were kind gifts from David Stephens. A plasmid containing a cDNA encoding MBP-TEV 
(pRK1043) was a kind gift from David Waugh (Addgene plasmid #8835). A vector encoding the mCherry 
nanobody (Addgene plasmid #70696), iRFP670 (Addgene plasmid #45466), TagRFP657 (Addgene plasmid 
#31959), mCardinal2 (Addgene plasmid #52631), mNeptune2.5 (Addgene plasmid #51310), or mTagBFP2 
(Addgene plasmid #55322) were kindly provided by Kazuhisa Nakayama, Vladislav Verkhusha (2x), Michael 
Lin (2x) or Michael Davidson, respectively. EGFP-ERGIC53 was previously described (Ben-Tekaya et al., 
2005) and kindly provided by Houchaima Ben-Tekaya. A sequence encoding clathrin light chain a (CLCa) 
was a generous gift of Steve Royle (WMS –Cell Development Biology, University of Warwick, Coventry, 
UK). A sequence template encoding GalT-EGFP was kindly provided by Jennifer Lippincott-Schwartz (Cell 
Biology and Metabolism Branch, NIH, Bethesda, USA). The sequence encoding human full-length calnexin 
(SC108288) was purchased from Origene. All other cDNA templates were resources from the Spiess 
Laboratory. 
To generate EGFP reporters and other fusion proteins as presented in this study, they were 
initially assembled in the pCMV6 entry vector (Origene) or in another CMV promoter-based expression 
vector from the iDimerize kit (Takara Bio) with standard molecular cloning techniques using polymerase 
chain reaction (PCR) and restriction enzyme digestion. All PCRs were performed using Phusion or Q5 
High-Fidelity DNA polymerase (NEB). Primers with restriction enzyme overhangs were synthesized and 
purchased from Microsynth. Amplified PCR products and digested vectors were purified from agarose 
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gels with the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel) according to the manufacturer’s 
instructions. Purified constructs were cut with restriction enzymes (NEB and/or Roche) and ligation was 
performed using T4 DNA ligase (Roche). The resulting constructs were transformed into chemo-
competent E. Coli TOP10 cells. All sequences were verified using Barcode Economy Run Service Sanger 
sequencing (Microsynth). 
For generating AP-1 KS cell lines using retroviral transduction, the generated Mitotrap sequence 
(Tom70-FRB-3xFLAG) was subcloned into the pQCXIH vector using NotI and PacI restriction sites, and 
the obtained γ-FKBP was inserted into the pQCXIP vector using overhangs for PacI and EcoRI. EGFP 
reporters were inserted into the pQCXIP vector via NotI and PacI restriction ends. In addition, EGFP-
CDMPR and EGFP-CIMPR were also subcloned into the pQCXIB vector to establish reporter-expressing 
AP-1 KS cells using the same restriction overhangs. The molecular cloning of the used functionalized 
nanobodies is described below (see 2.2.4).   
 
2.2.2 Cell Culture and Retroviral Transduction 
Parental and retrovirally transduced HeLa α cells were maintained in high glucose Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS), 100 units/mL streptomycin, 2 mM 
L-glutamine and proper selection antibiotics at 37°C in 7.5% CO2. HeLa α cells stably expressing EGFP 
reporter proteins were grown in complete medium containing 1.5 µg/mL puromycin, AP-1 KS HeLaα cells 
in complete medium containing 1.5 µg/mL puromycin and 1000 µg/mL hygromycin B, and AP-1 KS cells 
stably expressing EGFP-CIMPR or EGFP-CDMPR in complete medium containing 1.5 µg/mL puromycin, 
1000 µg/mL hygromycin B and 7.5 µg/mL blasticidin. Phoenix Ampho packaging cells (kind gift of Erich 
Nigg, Biozentrum, University of Basel, Switzerland) were grown only for a few passages in complete 
medium supplemented with 1 mM sodium pyruvate. Selection antibiotics (hygromycin B and Diphtheria 
toxin) were excluded due to short culturing periods for this cell line.         
To generate stable cell lines, packaging cells were transiently transfected with genes of interest in 
Retro-X Q vectors conferring resistance against puromycin (pQCXIP), hygromycin B (pQCXIH) or 
blasticidin (pQCXIB) as outlined above. Phoenix Ampho cells were transiently transfected with 15-20 µg 
plasmid DNA and 30-40 µL FuGENE HD (Promega) per 100 mm cell culture plate. After 48-72 h of 
transfection, the viral supernatant was harvested, passed through a 0.45 µm filter, supplemented with 15 
µg/mL polybrene and added to target HeLa α cells overnight. In case target HeLa α cells were maintained 
in any antibiotics beforehand, the medium was accordingly supplemented during the transduction period. 
Selection was started by refreshing cells with complete medium containing the proper selection 
antibiotics one or two days after retroviral transduction. 
Cell lines stably expressing EGFP reporters were subjected to cell sorting (FACSAria IIIu) for 
having a genetically heterogeneous, but expression-wise homogenous cell pool. To achieve an AP-1 KS 
system in our cell line, single clones were analyzed on the basis of expression and the ability to sequester 
γ-FKBP on mitochondria after rapamycin addition. For AP-1 KS experiments, we typically used 
concentrations at 500 nM rapamycin.    
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2.2.3 RNA Interference, DNA Transfections and CRISPR/Cas9 Knockout 
For RNA interference experiments, cells were reverse-transfected with target siRNA in Opti-MEM I using 
Lipofectamine RNAiMAX (both Thermo Fisher Scientific) following the manufacturer’s instructions. To 
silence γ-adaptin in AP-1 KS experiments, the siRNA sequence 5’-GAAGAUAGAAUUCACCUUUrUrU-3’ 
as previously described (Hirst et al., 2012a; Robinson et al., 2010) was used. The siRNA for knocking 
down endogenous γ-adaptin was applied at a final concentration of 100 nM, and cells were transfected 
twice (day 1 and 3) and assayed at day 5 after a 96 h-interval of knockdown. 
For a conventional knockdown of AP-1, the sequence 5’-AAGGCAUCAAGUAUCGGAAGAdTdT-3’ 
against the µ1A-subunit of the heterotetrameric complex was used as formerly reported (Hirst et al., 
2005; Hirst et al., 2003; Hirst et al., 2009). For RNA interference with retromer complex, we applied 
siRNA duplexes with the sequence 5’-AACUCCUGUAACCCUUGAGdTdT-3’ targeting Vps26 as 
described in previous studies (Popoff et al., 2009; Popoff et al., 2007a). To specifically silence Rab9 or 
TIP47, we applied the siRNA sequence 5’-GUUUGAUACCCAGCUCUUCdTdT 3’ for Rab9 (Ganley et al., 
2004; Kucera et al., 2016b; Reddy et al., 2006) or 5’-CCCGGGGCUCAUUUCAAACdTdT-3’ for TIP47 
(Bulankina et al., 2009). We used the non-targeting siRNA 5’-UAAGGCUAUGAAGAGAUACdTdT-3’ as 
control siRNA (Salazar et al., 2009). All siRNAs were used at a final concentration of 50 nM and were 
purchased from Microsynth. 
Transient plasmid transfections into HeLa α cells were performed using FuGENE HD (Promega) 
according to the supplier’s instructions. Experiments were performed 24 h post transfection. 
To generate a γ-adaptin KO HeLa α cell line, we purchased a CRISPR/Cas9 knockout plasmid from 
Santa Cruz Biotechnology (sc-403986). Briefly, cells were transfected with 2 µg γ-adaptin KO plasmid 
containing a GFP cassette and 4 µL FuGENE HD (Promega) in a six-well cluster. After 24 h of expression, 
cells were subjected to fluorescence-activated cell sorting (FACS) and single cell clones or a pool of GFP-
positive cells were collected in a 96-well plate or 100 mm cell culture dish, respectively. After isolation of 
expanded single clones or pooled clones, lack of γ-adaptin expression was assessed by Western blotting. 
To avoid problems and risks with single cell clones, we used a pool of cells having reduced γ-adaptin 
expression.   
      
2.2.4 Bacterial Expression and Purification of Functionalized Nanobodies 
All described VHHGFP nanobody fusions or myc-BirA were prepared in pET-24a or pET-21d vectors 
(Novagen, Merck Millipore), respectively, with standard molecular cloning techniques using polymerase 
chain reaction (PCR) and restriction enzymes. 
The established control nanobody termed VHHGFP-control contains SpeI and EcoRI restriction sites 
between VHHGFP and the C-terminal tag cassette. Using these sites, annealed oligonucleotides encoding a 
single or tandem tyrosine sulfation (TS) consensus of procholecystokinin, amplified mCherry or APEX2 
could be subcloned. 
For bacterial protein expression and purification, nanobody fusions together with myc-BirA were 
transformed into Rosetta DE3 chemocompetent cells and plated on LB plates supplemented with 50 
Material and Methods 65 	  
µg/mL kanamycin and 50 µg/mL carbenicillin. A single colony was picked and inoculated overnight in 20 
mL LB medium containing the respective antibiotics. The overnight culture was further diluted in 1 L LB 
medium with antibiotics and grown to an OD600 of 0.6-0.7 at 37°C. Expression of myc-BirA and 
functionalized nanobodies was then induced with 1 mM isopropyl-β-D-thiogalactopyranosid (IPTG). To 
allow site-specific biotinylation of all fusions by coexpressed myc-BirA, the 1 L LB culture was supple-
mented with 200 µM D-Biotin. For APEX2-nanobody derivatives, the LB medium was additionally 
complemented with 1 mM 5-aminolevulinic acid hydrochloride to promote higher heme incorporation as 
previously described (Delcarte et al., 2003; Kery et al., 1995; Lam et al., 2015). Depending on the VHHGFP 
nanobody fusion derivatives, IPTG induction and thus expression was performed either at 16°C overnight 
(VHHGFP-mCherry), at 20°C overnight (VHHGFP-APEX2 and VHHGFP-TEV-APEX2) or at 30°C for 4 h 
(VHHGFP-control, VHHGFP-TEV-control, VHHGFP-myc, VHH-1xTS, VHHGFP-2xTS, VHHGFP-TEV-2xTS and 
TS-VHHGFP-TS). 
Following protein expression, bacteria were pelleted at 5’000 x g at 4°C for 45 min. If not stored at 
-80°C, the bacterial pellet was directly prepared for protein isolation and purification using immobilized 
metal affinity chromatography (IMAC) according to the manufacturer’s instructions (His GraviTrap 
columns and His buffer kit, GE Healthcare Life Sciences). Briefly, the pellet obtained from 1 L was 
resuspended in a total volume of 30 mL sample binding buffer (PBS with 20 mM imidazole). To perform 
enzymatic lysis of the bacterial suspension, the binding buffer was modified with 200 µg/mL lysozyme, 20 
µg/mL DNase I, 1 mM MgCl2 and 1 mM PMSF, incubated for 10 min at RT, followed by 1 h at 4°C at an 
end-over-end rotator. Next, mechanical lysis was carried out using a tip sonicator with 3 x 30 sec 
continuous pulses and cooling periods of 1 min. The enzymatically and mechanically broken cells were 
then spun for 1 h at 15’000 x g at 4°C to pellet unbroken cells and debris. The cleared lysates were then 
loaded onto equilibrated His GraviTrap columns, washed with sample binding buffer, and His6-tagged 
VHHGFP nanobody fusions were finally eluted with 2 mL PBS supplemented with 500 mM imidazole. To 
remove the excess of imidazole from the eluate, the purified nanobody was loaded onto a PBS-
equilibrated PD-10 desalting column. Desalted and purified nanobody fusions were subsequently eluted 
with 2 mL PBS and protein concentration was determined using a BCA assay. Aliquots of recombinant 
fusions were concentrated, flash-frozen in liquid nitrogen and stored at -80°C. 
Apart from VHHGFP derivatives and myc-BirA, also maltose binding protein (MBP)-tagged TEV 
protease was bacterially expressed by subcloning it into pET24-a. Induction was performed for 4 h at 
30°C and the recombinant protein was isolated as described above. However, following buffer exchange 
using a PD-10 desalting column, the MBP moiety was specifically removed by incubation with factor Xa to 
yield tag-free TEV protease. Typically, 1 mg of MBP-TEV fusion protein was incubated with 10 µg of factor 
Xa for 2.5 h at 37°C. Depending on the yield, factor Xa was proportionally upscaled. After proteolytic 
removal of the MBP-tag by factor Xa, the reaction was diluted in PBS to a volume of 30 mL and again 
passed through a His GraviTrap and PD-10 desalting column. Purified TEV protease was stored in 50 mM 
HEPES (pH 7.5), 300 mM NaCl, 1 mM DTT, 1 mM EDTA, 50% glycerol, 0.1% Triton X-100 or in PBS. 
Since no activity difference between MBP-tagged or -free TEV protease was observed, we conducted our 
experiments mainly with the tagged version.       
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2.2.5 Uptake of Functionalized Nanobodies 
For all uptake assays, cells were usually harvested with lysis buffer (1% Triton X-100, 0.5% deoxycholate 
in PBS) supplemented with 2 mM PMSF and 1 x protease inhibitor cocktail (PIC) if not differently stated. 
Following centrifugation at 20’000 x g for 15 min to obtain the postnuclear supernatant, the concentration 
of the lysates was measured using a BCA assay and accordingly adjusted. The samples were mixed with 
SDS sample buffer containing reducing agents and boiled at 95°C for 5 min for subsequent SDS-PAGE.  
For uptake of functionalized nanobodies by EGFP reporter-expressing cell lines, complete medium 
containing the respective antibiotics was supplemented with 2-5 µg/mL of purified nanobody as indicated. 
To measure endocytic uptake kinetics into steady-state, 2 µg/mL (~ 100 nM) of VHHGFP-control was 
added to cells grown in 30 mm dishes that were then harvested with supplemented lysis buffer after the 
indicated time points. Uptake was stopped by placing dishes onto ice, immediately followed by five washes 
with ice-cold PBS to remove any free nanobody. Internalization of VHHGFP-1xTS and -2xTS for 
subsequent Western blot analysis was also performed at a concentration of 2 µg/mL. If not differently 
stated, VHHGFP-mCherry and -APEX2 uptakes were performed at a concentration of 5 µg/mL to keep 
equimolar ratios (~ 100 nM). Purified MBP-TEV protease was used at a concentration of 50-100 µg/mL. 
 
2.2.6 SDS-PAGE, Western Blotting and Coomassie Staining  
Protein samples were run on 5-15% polyacrylamide separating gels or on 4-20% Mini-PROTEAN TGX 
precast gels (Bio-Rad). For immunoblotting, separated proteins were transferred to Immobilon-PSQ PVDF 
membranes (Millipore), followed by blocking with 5% non-fat dry milk in TBS with 0.1% Tween-20 (TBST) 
for 1 h. The membranes were probed with primary antibodies in 1% BSA in TBST for 2 h at RT or 
overnight at 4°C, and subsequently incubated with HRP-coupled secondary antibodies in 1% BSA in TBST 
for 1 h at RT. 
For protein detection, Immobilon Western Chemiluminescent HRP Substrate (Millipore) was used 
and membranes were imaged using a Fusion Vilber Lourmat Imaging System (Witec). For Coomassie 
stainings, separated proteins were incubated with 5% of 10g/L Coomassie-R solution in fixation solution 
(45% methanol, 10% acetic acid) for 30-60 min and destained with destaining solution (15% methanol, 
7.5% acetic acid) overnight or up to several days. The gel was imaged using a Fusion Vilber Lourmat 
Imaging System (Witec) in combination with a conversion screen. Signals from Western blots and 
Coomassie stainings were analyzed using the Fiji software.  
       
2.2.7 Immunofluorescence and Confocal Microscopy  
For immunofluorescence staining, cells were grown on 18 mm coverslips (No. 1.5H) in six-well clusters 
and fixed with 3% paraformaldehyde (PFA) for 10 min at RT. After three washes with PBS, fixed cells 
were incubated with 50 mM NH4Cl in PBS for 5 min to quench the unreacted PFA. Cells were then 
permeabilized with 0.1% Triton X-100 in PBS for 10 min, washed three times and blocked with 1% BSA in 
PBS for 15 min. Coverslips with fixed cells were incubated upside down on a droplet of primary antibody 
in 1% BSA in PBS for 2 h, washed three times and stained with fluorochrome-tagged secondary antibodies 
Material and Methods 67 	  
in 1% BSA in PBS for 1 h. After a 5 min staining with DAPI and several washes with PBS, coverslips were 
mounted in Fluoromount-G (Southern Biotech). Staining patterns were imaged using a Zeiss Point 
Scanning Confocal LSM700 upright microscope.        
 
2.2.8 Live Cell Imaging, Image Processing and Data Analysis   
To determine uptake kinetics of EGFP-labeled reporters to steady-state, stable cells were seeded into 
ibidi µ-slide dishes one day before the actual experiment started. Uptake was initiated by adding pre-
warmed 150 µL of VHHGFP-mCherry (2 x) diluted in complete cell culture medium lacking phenol red to 
cells in 150 µL of the same medium. Live cell imaging was performed on an automated inverted widefield 
microscope (FEI MORE) equipped with a sCMOS camera (Hamamatsu ORCA flash 4.0) using an U Plan S 
Apo 100 x NA 1.4 oil objective at 37°C and 5% CO2. EGFP (mCherry) fluorescence was excited at 
470/24 nm (550/15 nm) and the emitted light was collected at 517/20 nm (590/20 nm) using an LED 
lightsource (SpectraX) and single band pass filters (AHF), respectively. Per condition > 10 fields of view 
(FOV) with an average of 3-4 cells per FOV were recorded before (1 frame) and after VHHGFP-mCherry 
addition for about 100 frames every ~ 36 seconds (EGFP-CDMPR) or 60 frames every ~ 39 seconds (TfR-
EGFP) in both channels sequentially. 
Subsequent image processing was performed in ImageJ. Time laps images acquired after nanobody 
addition were corrected for lateral drift using the MultiStackReg plugin on the EGFP channel and the 
resulting transformation was reused for the mCherry channel. Regions of interest (ROI) were selected 
manually per image and cell (i.e. whole cell) and their average intensity per frame in both channels was 
measured across all images before and after nanobody addition. 
Data analysis was performed in python on the measured means per ROI and time point. To correct 
for background and autofluorescence, the mCherry signal before nanobody addition was subtracted from 
the mCherry signal after. In a second step, the mCherry signal was divided  (i.e. normalized) by the EGFP 
signal to additionally account for intensity fluctuations other than nanobody uptake (e.g. by organelle 
movement, cell contraction, axial drift, illumination instabilities etc.). Artifacts at the beginning (e.g. from 
medium addition) or end (e.g bleaching) of the time laps were excluded from the analysis. Resulting curves 
were modeled to a first order kinetic process that results from assuming two reaction compartments (i.e. 
outside and inside of a cell) and fit individually to a single exponential decay function  
 I t = A ∙ (1 − e!!(!!!!)), 
where I(t) is the normalized intensity at time t, and t0 accounts for the time delay between nanobody 
addition and the start of the time laps recording (Phair and Misteli, 2001). Each accumulation process is 
then described by its unique rate constant k and amplitude A. In contrast, t0 was treated as a global 
variable across all ROIs and FOVs within an experiment. From the rate constant k, the half-life τ1/2  of the 
process can be calculated as 
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The end of the uptake process is then defined after 5⋅τ1/2 , where 97% of the reaction is completed. As a 
simple 'two compartments' model described the recorded data well, we refrained from modeling further 
compartments in order to avoid overfitting. 
In order to convert time laps images to movies, ImageJ was used. Representative raw time laps 
images were adjusted for optimal display as follows. In the mCherry channel, the minimum display value 
was set to slightly above the autofluorescence as measured in the reference image, while the maximum 
display value was set to ~ 66% of the maximum intensity value across the time laps. In the EGFP channel, 
the display values were set to the minimum and 66% of the maximum intensity value across the respective 
time laps. MP4 movie files were then saved using the SaveAsMovie plugin at 5 frames per second. 
 
2.2.9 Sulfation Analysis, Kinetics and Autoradiography 
To analyze retrograde transport and kinetics of EGFP-labeled reporters to the compartment of sulfation, 
HeLa α or AP-1 KS cells were incubated with 1 mL sulfate-free medium for 1 h at 37°C and 7.5% CO2, 
and then pulse-labeled with sulfate-free medium reconstituted with 0.5 mCi/mL [35S]sulfate (Hartmann 
Analytics) that was supplemented with 2 µg/mL of purified nanobody (VHHGFP-control, VHHGFP-1xTS, 
VHHGFP-2xTS or TS-VHHGFP-TS) for the indicated time. 
For experiments with AP-1 KS cells or BFA treatment, the labeling medium containing VHHGFP-
2xTS was additionally modified with 500 nM rapamycin or 2 µg/mL BFA, respectively. After the pulse, cells 
were washed twice with ice-cold PBS, lysed in 1 mL lysis buffer supplemented with 2 mM PMSF and 1 x 
PIC, scraped and transferred into microcentrifuge tubes. After centrifugation at ∼ 10’000 x g for 15 min at 
4°C, postnuclear supernatants were collected and incubated with 20 µL Nickel sepharose high 
performance beads to affinity-isolate sulfated VHHGFP-2xTS. A fraction (∼ 50-100 µL) of the postnuclear 
supernatant was saved as reference for the total amount of cell-associated VHHGFP-2xTS or as loading 
control. After 1 h of incubation, beads were washed at least three times with supplemented lysis buffer 
containing 20 mM imidazole, boiled in SDS sample buffer and analyzed by 12.5% polyacrylamide SDS midi 
gel electrophoresis and autoradiography on BAS Storage Phosphor Screens (GE Healthcare Life Sciences). 
Signals were detected with a Typhoon FLA7000 IP phosphorimager (GE Healthcare Life Sciences) and 
quantified using Fiji.  
 
2.2.10 Biochemical Inactivation of Compartments 
To inactivate intracellular compartments of EGFP reporter proteins by DAB crosslinking, we used a 
modified protocol established by Stoorvogel and collaborators (Stoorvogel, 1998; Stoorvogel et al., 1989; 
Stoorvogel et al., 1988). Cells stably expressing EGFP reporter proteins were seeded into 6-well clusters 
and incubated in complete DMEM containing 5 µg/mL of purified VHHGFP-APEX2 for 1 h at 37°C to reach 
steady-state. After three washes with ice-cold PBS, cells were incubated with either 1 mg/mL DAB or 
0.03% H2O2 separately as controls, or with a combination thereof in PBS to yield a productive ablation 
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reaction. After 90 min of incubation at 4°C in the dark, cells were washed twice with ice-cold PBS-5% 
BSA to stop the DAB crosslinking reaction, followed by three additional washes before lysis. 
 
2.2.11 Electron Microscopy  
To label the retrograde route of EGFP-modified reporters by a DAB-based peroxidase reaction, stable 
cells were grown in 100 mm culture dishes and incubated with 5 µg/mL VHHGFP-APEX2 for 1 h to reach 
steady-state. Cells were then subsequently washed twice with buffer (100 mM sodium cacodylate with 2 
mM CaCl2, pH 7.4), fixed using RT 2% glutaraldehyde in buffer and further processed with minor 
modifications according to a protocol as previously published by Ting and collaborators (Hung et al., 
2017; Hung et al., 2016; Lam et al., 2015; Martell et al., 2012). Following 45 min of fixation, cells were 
moved onto ice, rinsed 5 x 2 min each in chilled buffer, treated with 20 mM glycine in chilled buffer for 5 
min to quench remaining glutaraldehyde, and subsequently rinsed by another 5 x 2 min incubations in 
chilled buffer. To peroxidase-label retrograde transport compartments, a freshly prepared and filtered 
solution of 1 mg/mL DAB tetrahydrochloride hydrate was combined with 0.03% H2O2 in chilled buffer, 
and the solution was added to cells for 30-60 min. To stop the reaction, the DAB/H2O2 mixture was 
removed and cells were immediately rinsed 5 x 2 min with chilled buffer. Postfixation staining was 
performed with 2% (w/v) osmium tetroxide for 1 h in chilled buffer. Cells were rinsed 5 x 2 min each in 
chilled distilled water and then placed in chilled 2% (w/v) uranyl acetate (Electron Microscopy Sciences) in 
ddH2O overnight. Cells were brought to RT, washed in distilled water, and then carefully scraped off the 
dish, resuspended, and centrifuged at 700 x g for 1 min to generate a cell pellet. The supernatant was 
removed, and the pellet was dehydrated in a graded ethanol series (20%, 50%, 75%, 90%, 95%, 100%, 
100%, 100%, 100%), for 10 min each time, then infiltrated in EMBED-812 (Electron Microscopy Sciences) 
using 1:1 (v/v) resin and anhydrous ethanol for 1 h, followed by two changes into 100% resin before 
letting sit overnight. Finally, the sample was exchanged once more with 100% resin before transfer to 
fresh resin and polymerization at 60°C for 48 h. Embedded cell pellets were cut with a diamond knife into 
70 nm sections and imaged on a Phillips CM100 electron microscope.    
For immunoelectron microscopy, EGFP-modified reporter cell lines were grown in 100 mm culture 
dishes and incubated with 2 µg/mL VHHGFP-myc for 1 h to reach steady-state. Cells were then washed 
twice with 1 x PBS, and fixed in 3% formaldehyde and 0.2% glutaraldehyde overnight at 4°C. Cells were 
then scraped, pelleted, resuspended, and washed three times in PBS, incubated with 50 mM NH4Cl in PBS 
for 30 min, washed three times in PBS, dehydrated and infiltrated with LR-GOLD resin according to the 
manufacturer’s instructions (London Resin, London, UK), and allowed to polymerize for one day at -10°C. 
For immunogold labeling, sections of 60-70 nm were collected on carbon-coated Formvar-Ni-grids, and 
then incubated overnight with an anti-GFP and an anti-myc antibody that were preconjugated to either 10 
nm- or 20 nm-sized (abcam) gold nanoparticles according to the manufacturer’s instructions. Grids were 
washed five times for 5 min in PBS, and then five times in H2O, before staining for 10 min in 4% uranyl 
acetate and 2 minutes with lead citrate (Reynolds solution). Sections were viewed with a Phillips CM100 
electron microscope.  
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2.2.12 Crude Isolation of Mitochondria from Cell Culture 
To isolate crude mitochondria from cell culture, two 100 mm plates of confluent AP-1 KS cells were 
prepared. Following addition of DMSO or 500 nM rapamycin in complete medium for 10 min at 37°C in 
7.5% CO2, cells were washed with ice-cold PBS and then incubated in 1000 µL homogenization buffer (20 
mM HEPES pH 7.4, 10 mM KCl, 2 mM MgCl2, 1 mM EDTA, 1 mM EGTA) freshly supplemented with 1 
mM DTT, 2 mM PMSF, 1 x PIC either containing DMSO or rapamycin on a rocking platform at 4°C for 5 
min. After gentle scraping, the cell suspension was passed through a 27-gauge needle for 15 times. The 
homogenized suspension (Hom) was left on ice for 20 min before centrifugation at 700 x g for 5 min to 
pellet nuclei and unbroken cells. The supernatant was transferred into a new tube and spun at 10’000 x g 
for 5 min to pellet mitochondria from cytosol and membranes. The mitochondrial pellet was subsequently 
washed three times with supplemented homogenization buffer. The mitochondrial pellet was lysed in 200 
µL TBS containing 0.1% SDS, 2 mM PMSF and 1 x PIC to yield the mitochondrial fraction (Mito). 
The supernatant on top of the mitochondrial pellet was ultracentrifuged at 100’000 x g to separate 
membranes (Mem) from cytosol (Cyto). The membrane pellet was subsequently washed twice with 500 
µL homogenization buffer containing 1 mM DTT, 2 mM PMSF and 1 x PIC, and lysed in the same buffer as 
for mitochondria (in the same volume as the cytosol fraction).  
    
2.2.13 Biotin-Phenol Labeling  
To perform biotin-phenol labeling in mammalian cells, we used a modified protocol established by Ting 
and collaborators (Hung et al., 2017; Hung et al., 2016; Lam et al., 2015; Rhee et al., 2013). Briefly, cells 
stably expressing EGFP reporters were incubated with 5 µg/mL VHHGFP-APEX2 for 1 h to reach steady-
state. Following three washes with growth medium, biotin-phenol labeling was initiated by adding fresh 
complete medium containing 500 µM biotin-phenol for 30 min at 37°C in 7.5% CO2. Afterwards, H2O2 at 
a final concentration of 1 mM was added to the cells to start the reaction. After 3 minutes of labeling, the 
reaction was halted by washing three times with quencher solution (10 mM sodium azide, 10 mM sodium 
ascorbate, and 5 mM Trolox in PBS). Following lysis and centrifugation at 20’000 x g for 15 min to obtain 
the postnuclear supernatant, an aliquot of the cleared cell lysate was saved and the rest was used for 
precipitation using high-capacity streptavidin agarose resin. Cell lysates and pull-downs were mixed with 
SDS sample buffer containing reducing agents, and boiled at 95°C for 5 min for subsequent SDS-PAGE.  
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  3     Results 
 
 
3.1 Design and Expression of Functionalized Nanobodies 
 
To investigate retrograde transport biochemically, by live cell imaging, and by electron microscopy, we 
sought to establish a versatile approach where proteins of interest can be labeled at the cell surface with 
high specificity and affinity. We use protein binders as our basic tool to specifically label proteins of 
interest. A well-characterized protein binder in this regard is the anti-GFP nanobody (VHHGFP), a camelid 
single-chain domain antibody specifically recognizing folded GFP in a 1:1 stoichiometry with nanomolar 
affinity (Kubala et al., 2010; Rothbauer et al., 2008; Rothbauer et al., 2006). Using VHHGFP as basic binder 
module for cell surface labeling, there is the need of reporter proteins to contain an extracellular/lumenal 
GFP moiety. Accordingly, GFP fusion proteins that transiently appear at the cell surface will be specifically 
labeled with derivatized VHHGFP. Along with the need to modify fusion reporters with GFP, fluorescent 
tagging also has the benefit to simply visualize and monitor their subcellular localization in vivo. Moreover, 
since myriads of GFP-labeled reporter proteins already exist, our tool exploiting GFP binding might be 
widely applicable. To track GFP reporters of interest from the plasma membrane, VHHGFP domains need 
to be further modified in order to assess their itinerary through diverse compartments. We designed, 
bacterially expressed, and purified a number of functionalized VHHGFP nanobodies conferring all of our 
methodological needs (Fig. 3.1 A and B). 
All of these functionalized nanobodies share the VHHGFP domain (~ 12 kDa), an N-terminal T7 tag 
epitope, and a C-terminal cassette comprised of an HA tag, a biotin acceptor peptide (BAP), and a 
hexahistidine (His6) epitope for immunodetection and affinity purification. We refer to this basic 
arrangement as VHHGFP-control, while any further functionalization to this generic sequence is highlighted 
in the name (Fig 3.1 A). 
In order to biochemically assess PM-to-TGN transport, we took advantage of the exclusive 
localization of tyrosylprotein sulfotransferases in the trans-Golgi/TGN and thus modified VHHGFP-control 
with either one or two tyrosine sulfation (TS) consensus sequences derived from the rat cholecystokinin 
precursor to yield VHHGFP-1xTS and VHHGFP-2xTS (Fig 3.1 A). 
To monitor retrograde transport itineraries by live cell imaging, we engineered an anti-GFP 
nanobody derivative comprising a fluorescent mCherry moiety (~ 27 kDa). Addition of VHHGFP-mCherry 
to GFP reporter-expressing cell lines enables us to quantitate how long it takes for a given reporter to 
reach steady-state with its target compartments.  
For ultrastructural visualization of retrograde transport compartments by electron microscopy, we 
followed a cytochemical labeling strategy (Connolly et al., 1994; Futter et al., 1995) that makes use of 
internalized peroxidases catalyzing the H2O2-dependent polymerization of 3,3’-diaminobenzidine (DAB) 
into a local precipitate that gives EM contrast after treatment with osmium tetroxide (OsO4). However, 
instead of horseradish peroxidase (HRP), the most established peroxidase for such applications, we used 
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the recently described monomeric ascorbate peroxidase, APEX2 (Fig 3.1 A) (Hung et al., 2017; Hung et 
al., 2016; Lam et al., 2015; Martell et al., 2012). APEX2 is the improved version of APEX, a peroxidase 
derived from dimeric pea or soybean ascorbate peroxidases (Hung et al., 2014; Rhee et al., 2013). Unlike 
HRP, APEX2 is considerably smaller (28 kDa versus 44 kDa) and does not contain any disulfide bonds, 
thereby allowing the protein to be expressed in the reducing environment of bacteria. 
In addition to its application in electron microscopy, APEX2 can also be used for biochemical 
ablation of target compartments (Stoorvogel, 1998; Stoorvogel et al., 1989; Stoorvogel et al., 1988) or 
promiscuous proximity biotinylation (Hung et al., 2017; Hung et al., 2016; Lam et al., 2015). In the former 
approach, DAB polymerization is exploited to chemically crosslink or encapsulate lumenal and trans-
membrane proteins to yield an insoluble fraction that can be precipitated. Hence, to inactivate 
intracellular compartments of target proteins, we can feed VHHGFP-APEX2 into steady-state of EGFP-
labeled fusion reporters. Ablation, moreover, allows us to biochemically determine the localization of 
reporters within intracellular compartments. 
APEX2 can also be used to perform proximity labeling of proteins using biotin-phenol as substrate 
(Hung et al., 2017; Hung et al., 2016; Hwang and Espenshade, 2016; Lam et al., 2015). APEX2 generates 
biotin-phenoxyl radicals, highly reactive and short-lived species that conjugate to endogenous proteins 
(mainly tyrosine side chains) in close proximity. By enriching biotinylated proteins using streptavidin resins, 
proteins in close proximity to APEX2 can be detected (e.g. by mass spectrometry or Western blotting). 
Nanobody modified with APEX2 could therefore be used to qualitatively assess PM-to-TGN transport by 
immunodetection of endogenous TGN-resident proteins after streptavidin pull-down.     
The outlined functionalized VHHGFP (Fig. 3.1 A, see also Tab. S2 for protein sequences) were 
bacterially expressed in the presence of recombinant biotin ligase (BirA) and excess of D-biotin to modify 
the BAP site (also known as AviTag). Biotinylated nanobodies do not only facilitate their own biochemical 
detection by streptavidin-HRP, but also allow their high-affinity isolation by avidin-based purification resins. 
In addition, they can be further functionalized by coupling commercially available streptavidin conjugates 
(e.g. Alexa Fluor streptavidin conjugates, streptavidin-gold, etc.). We could for instance couple 
streptavidin-Alexa Fluor 647 or streptavidin gold to VHHGFP-control and others in vitro (Fig. S1). Such 
additionally functionalized nanobodies are very useful since our simplest nanobody fusion (VHHGFP-
control) could be taken as main building block to achieve biochemical or fluorescent derivatization. 
While VHHGFP-APEX2 requires additional 5-aminolevulinic acid as supplement for efficient heme 
incorporation, expression of all other VHHGFP derivatives was either induced for several hours at 30°C, 
or overnight at 16°C or 24°C, respectively, and then subsequently purified using Nickel columns. As seen 
in Figure 3.1 B (lanes 1-5), all nanobody-based retrograde transport trackers could be efficiently 
isolated from crude bacterial cell lysates to high purity and yield. Differences in their molecular weights 
are due to the specific functionalization with either peptide tags (TS-tags, Fig. 3.1 B, lanes 2 and 3) or 
entire protein domains (APEX2 and mCherry, Fig. 3.1 B, lanes 4 and 5). All bacterially expressed 
VHHGFP derivatives were free of visible degradation, with the exception of VHHGFP-mCherry that seems 
to be partially, but negligibly clipped after purification into two parts corresponding probably to a C-
terminal mCherry (~ 28 kDa) and an N-terminal VHHGFP (~ 22 kDa) fragment (see also Fig. 3.2 A). 
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Since detection and affinity purification of VHHGFP derivatives from mammalian cell lysates will be crucial 
for monitoring endocytosed anti-GFP nanobody derivatives by immunoblotting, we addressed the 
question whether we can detect them with antibodies targeting the various epitopes present in these 
fusions. To do so, we separated and transferred as little as 10 ng of purified VHHGFP derivatives using 
SDS-PAGE/immunoblotting and probed membranes with antibodies or streptavidin-HRP recognizing the 
HA, His6 and T7 epitope or biotin, respectively (Fig. 3.2 A). 
 
 
Figure 3.1: Design and bacterial expression of functionalized anti-GFP nanobodies. (A) Schematic cartoon of 
generated functionalized nanobodies. The basic arrangement of the GFP binder is composed of an N-terminal T7 epitope, followed 
by the VHHGFP nanobody domain and a cassette comprising an HA, BAP and hexahistidine epitope. To track PM-to-TGN transport, 
nanobodies with either one or two tyrosine sulfation (TS) consensus sequences were produced (VHHGFP-1/2xTS). To be able to 
follow EGFP-labeled reporters from the cell surface to any intracellular compartment by live cell imaging, functionalization was 
performed by recombinantly adding fluorescent mCherry (VHHGFP-mCherry). To ultrastructurally visualize retrograde transport by 
electron microscopy, the peroxidase reporter APEX2 was subcloned into VHHGFP to yield VHHGFP-APEX2. The peroxidase 
reporter can also be used to perform compartment ablation or proximity biotin labeling. Cartoon is not drawn to scale. (B) 
Bacterial expression of functionalized nanobodies. 30  µg of purified and desalted protein was loaded onto a SDS-PAGE gel and 
then subjected to Coomassie staining. Purified proteins were considerably pure and stable. Only a small fraction of VHHGFP-
mCherry seems to be unstable since two bands are visible at ~ 22 kDa and ~ 28 kDa. While the upper degradation fragment 
corresponds to clipped mCherry, the lower one represents clipped VHHGFP (see also Fig 3.2 A). Numbers along the markers 
correspond to molecular weight in kDa.       
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Figure 3.2: Detection and biotinylation efficiency of bacterially expressed anti-GFP nanobodies. (A) 10  ng 
of purified functionalized nanobody was loaded onto a SDS-PAGE gel, blotted and subjected to immunodetection using antibodies 
against the HA, hexahistidine and T7 epitope, as well as streptavidin-HRP. Functionalized nanobodies migrate to their expected 
molecular weights. As mentioned in Fig 3.1 B, VHHGFP-mCherry is to a subtle extent prone to degradation since two fragments can 
be observed. The upper degradation fragment corresponds to a product comprising mCherry, the lower to VHHGFP. (B) Bacterial 
expression of functionalized nanobody containing a myc epitope. 30  µg (lanes 1-2) or 10 ng (lanes 3-4) of purified and desalted 
protein was loaded onto a SDS-PAGE gel and then subjected to Coomassie staining (lanes 1-2) or Western blotting (lanes 3-4), 
respectively. As the other functionalized nanobodies, VHHGFP-myc could be expressed to high yields and to high purity. Cartoon is 
not drawn to scale. (C) Functionalized nanobodies are completely biotinylated by coexpressed BirA. To assess biotinylation 
efficiency of bacterially expressed nanobodies, ~ 100 µg of nanobody and bovine serum albumin (BSA) each were mixed in a total 
volume of 100 µL. To the nanobody-BSA mixture, 20 µL of high capacity streptavidin agarose were then added. After incubation 
for 1 h at 4°C, the supernatant (S) was removed and the beads (B) were extensively washed (7x) with PBS containing extra salts. 
Beads were finally resuspended in the same volume as the supernatant and boiled in SDS sample buffer. A volume of ~ 25 µL was 
loaded onto a SDS-PAGE followed by Coomassie staining. While BSA was excluded from the pull-downs (B, beads) and only 
present in the supernatant (S), the nanobody fusions were exclusively found on the beads indicating that BirA-mediated 
biotinylation with our conditions was very efficient, namely ~ 100%. Numbers along the markers correspond to molecular weight 
in kDa.       
 
Epitope tags of all VHHGFP trackers were efficiently detected with the respective antibodies (Fig. 
3.2 A, lanes 1-5). As reported previously in Fig. 3.1 B, only VHHGFP-mCherry showed degradation 
fragments (Fig 3.2 A, lane 5). Since the upper degradation fragment is detected with an anti-HA, anti-
His6 or streptavidin-HRP, it contains the C-terminal epitope cassette and most of mCherry to yield a 
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molecular weight above 25 kDa. The lower degradation fragment on the contrary was only positive for 
the T7 epitope, corresponding to an N-terminal portion containing VHHGFP to make it run at ~ 20 kDa.  
Studying retrograde protein transport by electron microscopy cannot only be accomplished by 
VHHGFP-APEX2 performing polymerization of DAB, but also by immunogold electron microscopy by 
simply staining for internalized functionalized VHHGFP. Since there is a good anti-myc antibody available 
that has been previously used in our hands with success (Beuret et al., 2017; Stettler et al., 2009), we 
generated an additional VHHGFP derivative containing a myc epitope (Fig 3.2 B, see also Tab. S2 for 
protein sequences). This nanobody fusion, termed VHHGFP-myc, was as well expressed as the other 
functionalized nanobodies (Fig 3.2 B, lanes 1-4). 
We also determined the biotinylation efficiency of our VHHGFP derivatives during bacterial 
induction and expression (Fig. 3.2 C). To do so, pure BSA was mixed with bacterially expressed 
nanobodies and incubated with streptavidin resin. After 1 h of incubation, the supernatant (S) was 
collected and saved. Beads (B) were extensively washed and prepared for analysis by SDS-PAGE and 
Coomassie staining. The nanobodies were found to be completely biotinylated by overexpressed BirA 
during induction (Fig. 3.2 C). A high biotinylation efficiency for downstream applications, such as pull-
downs or labeling with commercially available streptavidin conjugates, is of benefit. Otherwise, we would 
miss all non-biotinylated nanobodies in our experiments when we exploit streptavidin-based interactions.  
The so far outlined results demonstrate that functionalized anti-epitope (here anti-GFP) 
nanobodies can be efficiently expressed, detected and biotinylated. They thus fulfill all our needs to act as 
versatile tool to study retrograde transport itineraries of GFP-labeled proteins from the cell surface.  
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3.2 Design and Expression of EGFP-Labeled Reporter Proteins 
 
To establish a versatile nanobody-based approach to study retrograde traffic of GFP-labeled proteins from 
the cell surface to the endo-lysosomal system and to the TGN, there is the indispensable need of GFP 
reporter proteins traversing through these intracellular compartments. For our study, we decided to use 
bonafide retrograde transport transmembrane proteins to give basic proof-of-concept evidence. 
Among the best-characterized retrograde transport cargo proteins belong the two MPRs, CDMPR 
and CIMPR (Bonifacino and Rojas, 2006; Duncan and Kornfeld, 1988; Ghosh et al., 2003a; Griffiths et al., 
1988). As previously mentioned, their basic function is to deliver newly synthesized lysosomal acid 
hydrolases from the TGN to endosomes from where they are shuttled back to undergo additional cycles 
of cargo capturing and release. However, to a certain extent, they occasionally travel out to the plasma 
membrane from where they are rapidly retrieved by AP-2/clathrin-mediated endocytosis (Ghosh et al., 
2003a; Lobel et al., 1989; Prydz et al., 1990; Schweizer et al., 1997). 
Other transmembrane cargo proteins that are retrogradely transported from the plasma 
membrane to the TGN are the trans-Golgi network integral membrane proteins TGN38/46/51, which are 
all thought to behave identically. The best studied among these is TGN46. Though TGN46 is considered 
as TGN-resident protein, it is well established that a minor population of it is also present at the cell 
surface in steady-state (Banting et al., 1998; Banting and Ponnambalam, 1997; Ponnambalam et al., 1996; 
Rajasekaran et al., 1994; Saint-Pol et al., 2004). Even the molecular transport carriers that mediate TGN 
exit of TGN46, the CARTS (Pfeffer, 2012; Wakana et al., 2015; Wakana et al., 2012; Wakana et al., 2013), 
have been identified, highlighting that TGN46 and its isoforms constantly cycle at the TGN-to-PM 
interface. 
Even though we are aware of additional retrograde transport integral membrane proteins such as 
APP (Choy et al., 2012), WLS (Eaton, 2008; Harterink and Korswagen, 2012; Harterink et al., 2011; Yu et 
al., 2014), furin (Chia et al., 2011), ANK (Seifert et al., 2016), and more, we decided to follow our studies 
with the well-established acid hydrolase receptors (CD-/CIMPR) and TGN46. 
In order to have a negative control for TGN arrival, we sought to have a reporter that is only 
transported to the endocytic system (i.e. to endosomes). Prominent candidates for this are the recycling 
receptors, such as the transferrin receptor (TfR), the asialoglycoprotein receptor (ASGPR) and low-
density lipoprotein receptor (LDLR) that all deliver cell surface-bound ligands to early/recycling 
endosomes from where the ligand-free receptors are returned to the plasma membrane. Since TfR is 
ubiquitously expressed and a well-established recycling receptor, we have chosen this reporter to be our 
negative control for our approach. To be noted, however, there are also published reports, suggesting 
TfR to return to the TGN (Shi et al., 2012b; Snider and Rogers, 1985). With our nanobody-based tool 
exploiting tyrosine sulfation, we can basically directly assess whether TfR is facing the TGN lumen 
(compartment of sulfation) after internalization from the plasma membrane. 
The basic design of our GFP fusion reporters is outlined in Figure 3.3 A (see also Tab. S1 for 
protein sequences). Depending on the membrane protein topology (Goder and Spiess, 2001), GFP (more 
precisely EGFP; from now on, we will use the terminology EGFP) needs to be either N-terminally or C-
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terminally located. Since CIMPR, CDMPR and TGN46 are all type I transmembrane proteins, EGFP needs 
to be present at the N-terminus, directly preceded by a cleavable signal sequence for ER targeting. TfR, 
conversely, is a type II transmembrane protein and thus needs to have the EGFP domain at the C-
terminus so that it might be accessible by functionalized anti-GFP nanobodies at the cell surface. 
Apart from CIMPR, we only included full-length sequences in our studies. Due to the large protein 
size of ~ 300 kDa and thus ~ 7800 bp, we used instead a truncated and simplified version for CIMPR that 
is composed of its transmembrane and cytosolic domain, only. Such a truncated version has been 
previously published (Waguri et al., 2003), and since then successfully used in other studies (Amessou et 
al., 2007; Amessou et al., 2006; Anitei et al., 2014; Billcliff et al., 2016; Girard et al., 2014; Stahlschmidt et 
al., 2014), because it seems to behave as the full-length counterpart. To generate a truncated secretory 
EGFP-tagged CIMPR fusion reporter (EGFP-CIMPR), we made use of the well-characterized ER targeting 
sequence of hemagglutinin (SS-HA), followed by EGFP and the transmembrane and cytosolic domain of 
murine CIMPR. To establish EGFP-labeled CDMPR and TGN46, we took their respective human full-
length sequences, excluding wild-type ER targeting signal, and assembled them in the same signal 
sequence-EGFP cassette as EGFP-CIMPR to yield EGFP-CDMPR or EGFP-TGN46, respectively. TfR-EGFP 
was generated using the human TfR sequence followed by EGFP. To also have a second negative control 
in our assays, we used EGFP without signal sequence, a protein reporter that does not enter the 
secretory pathway and that stays exclusively cytosolic. 
Having these constructs in our inventory bag pack, we moved onwards and established HeLa cells 
stably expressing either EGFP, EGFP-CIMPR, EGFP-CDMPR, EGFP-TGN46 or TfR-EGFP. Stable reporter 
expression is important to avoid overexpression artifacts as they may occur during transient transfections. 
Stable cell lines were generated using retroviral transduction and further improved by fluorescent-
activated cell sorting (FACS) to achieve cell pools with homogeneous expression levels.  
Figure 3.3 B shows the expression levels of the stable HeLa cells. All EGFP-tagged reporters 
migrate to their expected molecular weight as monitored by SDS-PAGE and immunoblotting using an 
anti-GFP antibody (Fig. 3.3 B). EGFP-CDMPR runs as a double band, suggesting a high-mannose 
glycosylated ER form and a complex glycosylated mature form (Fig. 3.3 B, lane 4). The lower band that 
might most likely correspond to the ER form is more dominant, evoking the impression that the EGFP-
tagged reporter is inefficiently folded. However, when we expressed an EGFP-free version of CDMPR 
(SHMY-CDMPR), we also observed a dominant lower band, indicating that the EGFP does not impair 
reporter folding (Fig. S2 A). Since SHMY-CDMPR only contains an N-terminal cassette of short epitope 
tags (signal sequence, His6-, myc- and TS-tag), we can assume that it is not much different in protein 
structure and folding compared to overexpressed tag-free CDMPR. We thus think that the observed 
double band (Fig. 3.3 B, lane 4) represents the natural state of the protein in HeLa cells. Unfortunately, 
we were not able to confirm that since we did not come across antibodies detecting endogenous levels of 
CDMPR. As discussed later on, the lower band is in fact composed of two populations, one that is 
accessible to functionalized nanobody, the other not (Fig. S2 B). We only detected single bands for 
EGFP-tagged CIMPR, TGN46 and TfR at this percentage of the gel. For EGFP-CIMPR, at least, this is not 
surprising since it lacks any N-glycosylation attachment sites.  
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Figure 3.3: Design, expression and localization of EGFP-labeled reporter proteins. (A) Schematic outline of 
the EGFP reporter proteins. Selected type I transmembrane proteins (CIMPR, CDMPR and TGN46) all contain a well-established 
cleavable ER signal sequence derived from hemagglutinin (white), followed by EGFP (green) and the reporter sequence (black) 
without natural ER targeting signal. Apart from CIMPR, only full-length sequences were included in our studies. Since TfR has 
reverse topology (type II), the EGFP domain is following the reporter sequence. Cytosolic EGFP was used as control for a non-
secretory reporter protein. Cartoon is not drawn to scale. (B) HeLa cells stably expressing EGFP-tagged reporters. Lysates of the 
respective reporter cell lines were prepared and analyzed by SDS-PAGE/Western blotting. Fusions run at their expected molecular 
weights, with EGFP-CDMPR having a double band. (C) Intracellular localization of EGFP-tagged reporters. Reporter-expressing 
and parental HeLa cells were mixed and stained with antibodies targeting the endogenous counterparts. The distribution pattern of 
the EGFP reporter was similar to the endogenous version. Numbers along the markers correspond to molecular weight in kDa. 
Scale bar: 10 µm.               
 
To examine whether our EGFP-labeled reporter proteins have the same distribution pattern as 
their endogenous counterparts and are not too much overexpressed, we analyzed their intracellular 
localization by fluorescence confocal microscopy (Fig. 3.3 C). To do so, we mixed parental HeLa cells 
with cells stably expressing either EGFP-CIMPR, EGFP-CDMPR, EGFP-TGN46 or TfR-EGFP, seeded them 
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on the same coverslip and proceeded with immunofluorescence staining by labeling the endogenous 
counterparts of the EGFP-tagged reporters. Since we used full-length EGFP-tagged reporters (apart from 
CIMPR) all our antibodies do not only crossreact with the EGFP reporters, but also with the endo-
genously present counterparts. 
As seen in the first panel of Figure 3.3 C, EGFP-CIMPR is mainly clustered in small vesicular and 
tubular elements in the juxtanuclear region in addition to peripheral, endosomal structures overlapping 
with endogenous CIMPR, demonstrating proper localization of the reporter to its homing compartments 
in our cells. This is consistent with previous reports (Anitei et al., 2014; Waguri et al., 2003), and 
additionally shows that stable and modest protein expression does not alter compartment identity since 
we could not see any morphological changes between reporter-expressing and -lacking HeLa cells. 
Moreover, as mentioned above, the antibody targeting endogenous CIMPR reacts with the lumenal 
domain of the receptor, a domain that is completely absent in our EGFP-tagged reporter. This even more 
supports the notion that our reporter expression levels are in an acceptable range (with regard to 
unaltered compartment morphology). 
We can do a similar statement for the other EGFP-tagged reporters. EGFP-CDMPR, EGFP-TGN46 
and TfR-EGFP all colocalize with their endogenous counterparts (Fig. 3.3 C). For EGFP-CDMPR- and 
EGFP-TGN46-expressing cells, the signal obtained by staining with an anti-CDMPR or anti-TGN46 
antibody, respectively, did not produce an obvious increase of the signal compared to untransfected HeLa 
cells. This confirms that these two fusion proteins are not significantly overexpressed. Even though we 
anticipated having a considerable ER staining for EGFP-CDMPR based on our Western blot analysis (Fig. 
3.3 B), we predominantly detected a strong perinuclear labeling pattern (similar to EGFP-CIMPR). This 
confirms our suspicion that the faster migrating band of EGFP-CDMPR cannot exclusively represent high-
mannose glycosylated ER form (Fig. S2 B). 
When considering the mixed population of HeLa cells stably expressing TfR-EGFP with untransfect-
ed ones, stronger TfR staining was observed in stable transductants. As discussed and outlined later on 
(Fig. 3.10 A), we reported a three- to four-fold higher expression of TfR in our stable cells. This 
became also evident when fluorescently labeled transferrin (Tf) was administrated to a mixed population 
of HeLa and stable transductants. In such an experiment, more Tf endocytosed in the EGFP reporter cell 
line (Fig. S2 C). This experiment furthermore also revealed that our recombinant TfR is still functional 
to shuttle transferrin through the endocytic-recycling compartments. Since the distribution pattern of the 
fusion is similar to the wild-type TfR, we are not concerned about the expression levels of our 
recombinant TfR protein.  
The results above confirm that the used EGFP-modified reporters have similar intracellular locali-
zation pattern as their endogenous counterparts. By this, we have the methodological basis for studying 
retrograde transport and sorting itineraries of the selected reporters from the cell surface.  
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3.3 Analysis of Endocytic Uptake and Recycling Kinetics  
 
We next apply our nanobody-based toolkit to study endocytic uptake and recycling kinetics of EGFP-
labeled reporter proteins biochemically and by live cell imaging. To follow up on that, we first needed to 
address to most relevant and critical question to our approach, that it is whether bacterially expressed 
and functionalized nanobodies are at all taken up by reporter-expressing cells. 
 
3.3.1 Biochemical Uptake of VHHGFP-control and -mCherry 
To examine whether functionalized nanobodies are specifically taken up from the cell culture medium, we 
incubated cells with 2 µg/mL VHHGFP-control. After 1 h of incubation at 37°C, we prepared cell lysates 
and probed them for internalized and cell-associated nanobody. Cells stably expressing cytosolic EGFP did 
not show any uptake of VHHGFP-control (Fig 3.4 A, lane 1). This is very plausible, since EGFP was not 
accessible from the extracellular environment. The nanobody also did not significantly enter the cells by 
fluid phase uptake. In contrast, cells stably expressing any of the other reporter proteins show cell surface 
binding and uptake of VHHGFP-control (Fig 3.4 A, lane 3, 5, 7 and 9). To be mentioned is the fact that 
not all reporters take up nanobodies to the same extent. The amount of internalized nanobody is mainly 
dependent on two reporter characteristics, namely its cell surface fraction and how long it takes until the 
post-Golgi reporter fraction has faced the plasma membrane (i.e. when steady-state is reached). These 
characteristics are unique to every reporter, and hence, it is not surprising that we monitor differences in 
internalized nanobody between EGFP reporters after 1 h of uptake. Most crucially, our uptake 
experiment has revealed that the intended approach of using nanobodies and nanobody epitope-
containing reporters to study retrograde transport works and thus fulfills our major criterion.  
Since we also wanted to monitor uptake kinetics by live cell imaging, we also performed the 
internalization experiment with VHHGFP-mCherry. Similar to VHHGFP-control, VHHGFP-mCherry was only 
internalized by EGFP reporter cell lines (Fig 3.4 A, lane 4, 6, 8 and 10). It seems that relatively more 
VHHGFP-mCherry is internalized when comparing to the fluorophore-free version (Fig 3.4 A, lanes 1-10). 
The reason for this is unknown. The most plausible explanation is that these two proteins were not 
equally transferred or retained on the blotting membrane due to differences in molecular weight. 
Having VHHGFP-mCherry, not only we can monitor reporter-mediated nanobody uptake by 
immunoblotting, but also by fluorescence microscopy using fixed cells. VHHGFP-mCherry as such has the 
advantage that it is fluorescent by itself. To demonstrate uptake by fluorescence microscopy, cells on 
coverslips were fed with 5 µg/mL VHHGFP-mCherry for 1h at 37°C and subsequently processed for 
confocal microscopy. As seen in Figure 3.4 B, mCherry-labeled VHHGFP shows the identical labeling 
pattern as the corresponding EGFP reporters, indicating that the nanobody binds the reporter’s EGFP 
moiety at the cell surface and is trafficked piggyback to its homing compartments. There is also no uptake 
by cells stably expressing cytosolic EGFP (Fig S2 D). It appears that for most of the reporters, steady-
state has already been reached after 1 h of incubation. For our experiments, it is important to know how 
long it takes until a given reporter has reached its steady-state, the time after which no additional 
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nanobody uptake will occur anymore. This can be figured out by measuring endocytic uptake kinetics of 
the reporters, either biochemically or by live cell imaging. 
 
 
Figure 3.4: Biochemical uptake of VHHGFP-control and VHHGFP-mCherry by EGFP reporter cell lines.    
(A) Functionalized nanobodies are specifically taken up by reporters presenting an EGFP moiety to the extracellular environment. 
HeLa cells stably expressing EGFP reporters were incubated in the presence of either 2 µg/mL VHHGFP-control or 5 µg/mL 
VHHGFP-mCherry for 1 h at 37°C. Following uptake, cell lysates were prepared and probed with anti-His6, anti-GFP and anti-actin 
antibodies. (B) Similar procedure as in (A). Cells on coverslips were fed with 5 µg/mL VHHGFP-mCherry and processed for 
fluorescence confocal microscopy. Numbers along the markers correspond to molecular weight in kDa. Scale bar: 10 µm.               
     
3.3.2 Biochemical Uptake Kinetics with Functionalized Nanobodies 
To biochemically measure endocytic uptake kinetics, we administrated 2 µg/mL VHHGFP-control for up to 
120 min, extensively washed the cells to get rid of any cell-associated nanobody, and finally lysed the cells 
for immunoblot analysis (Fig. 3.5). As known from previous studies (Ciechanover et al., 1983; Grant and 
Donaldson, 2009; Hirschmann et al., 2015; Iacopetta and Morgan, 1983; Wauben-Penris et al., 1988), 
iodinated or fluorescently labeled Tf is rapidly endocytosed with a half time (τ1/2) of ~ 4-5 min, and 
reaching steady-state distribution at ~ 20 min. In our assay (Fig. 3.5 D and E), functionalized nanobody 
phenocopied transferrin as ligand during endocytosis. We determined identical rates and kinetics for 
nanobody riding along with TfR-EGFP, namely τ1/2 of ~ 5 min and steady-state at ~ 20 min. This means 
that after ~ 20 min, all TfR-EGFP in post-Golgi compartments are saturated by nanobody and no 
additional uptake can occur anymore. Our nanobody-based uptake approach is thus very close to the 
classical one where endogenous TfR is targeted with radiolabeled or fluorescently labeled Tf. Further-
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more, it confirms that recombinant and endogenous TfR behaves similarly. So there is rapid binding of 
nanobody to EGFP, at least as fast as Tf to TfR.  
In comparison to the use of labeled Tf as ligand to monitor retrograde transport of TfR to the 
endosomal system, our nanobody-based approach has even an advantage. While cells need to be serum-
starved to deplete intracellular Tf during a classical uptake assay, there is no requirement to do this with 
our tool. To be noted is that serum starvation affects signaling of kinases that sense the supply of 
nutrients, such as the mTOR kinase (Gonzalez and Hall, 2017; Shimobayashi and Hall, 2016). Indeed, a 
previous report has shown compelling evidence that the canonical TfR recycling pathway is under 
regulation of mTORC1 (Dauner et al., 2017). Serum starvation or rapamycin treatment led to the rapid 
degradation of TfR and other recycling receptors. To which extent mTORC1 signaling is affecting the 
kinetic readout during a classical, serum-starved Tf uptake assay is unknown. By using nanobodies that 
phenocopy Tf or other ligands, mTOR signaling can be cleverly circumvented since our assay is devoid of 
nutrient starvation. 
To the best of our knowledge, uptake kinetics of TGN46 or the MPRs have never been directly 
assessed and reported so far. This is probably mainly due to either lacking or not routinely established 
ligands. TGN46 for instance is even most likely not a cargo receptor at all. 
As true for TfR, which undergoes endocytosis with the same rate in the presence or absence of 
bound ligand (Hopkins et al., 1985), MPRs also traffic from the TGN or plasma membrane independently 
of mannose-6-phosphate (M6P)-tagged cargo load (van Meel and Klumperman, 2014). Using our reporter-
binding nanobody to determine endocytic uptake kinetics, we could show that both MPRs have half-lives 
(τ1/2) at ~ 8-10 min and reach their plateau at ~ 40-45 min (Fig. 3.5 A, B and E). Since both receptors 
have similar function and intracellular distribution, the observation of similar τ1/2 is not much of a surprise. 
The longer time to reach τ1/2 or steady-state compared to TfR are conceivable, too. While the main 
fraction of TfR is cycling between (sorting and recycling) endosomes (~ 85%) and the plasma membrane 
(~ 15%), MPRs have a more complex steady-state distribution, with pools present in the TGN, plasma 
membrane, early and late endosomes. Also the receptor’s itineraries along these compartments are not 
as clear as for TfR’s. It thus needs much more time for all post-Golgi MPR copies to come out from these 
individual pools to appear at the cell surface. Following this idea for TGN46, with predominant 
localization to the TGN, we would then even expect a longer time interval until steady-state is reached. 
Indeed, this is also what we observe. The half time of steady-state is reached at ~ 25-30 min and the 
process of nanobody uptake is completed > 60 min. 
Our nanobody-based approach to measure endocytic uptake kinetics has not only confirmed 
previously reported steady-state rates as exemplarily for TfR, but has also revealed rates of membrane 
proteins with more complex sorting routes (MPRs) or onesided intracellular distribution (TGN46). Our 
tool to assay uptake kinetics is basically applicable to any protein reporter that cycles via the cell surface 
and contains an EGFP at the extracellular/lumenal site. Furthermore, by introducing any perturbations to 
membrane-mediated traffic (e.g. small molecule inhibitors, RNAi, etc.), we can study how τ1/2 and steady-
state of reporters of interest will be affected.  
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Figure 3.5: Endocytic uptake kinetics of EGFP reporter cell lines. (A)-(D) To biochemically measure uptake 
kinetics of EGFP-CIMPR, EGFP-CDMPR, EGFP-TGN46 and TfR-EGFP, stable cells were incubated with 2 µg/mL VHHGFP-control 
for up to 120 min, followed by cell lysis to harvest total cell-associated nanobody (intracellular and plasma membrane). Cell-
associated nanobody was detected using an anti-His6 antibody, internal controls were made with anti-GFP or anti-actin antibodies. 
(E) Quantification of endocytic uptake kinetics. Quantification of three independent experiments is shown (average ± SD). Signal 
intensities of each time point is expressed as the percentage of the signal intensity after 120 min. 
 
3.3.3 Biochemical Recycling Kinetics with Functionalized Nanobodies 
Apart from measuring only uptake kinetics of reporters into steady-state, we also invested attempts in 
looking at both endocytosis and recycling of target proteins with one functionalized nanobody. To be able 
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to perform so, we modified our simplest nanobody, VHHGFP-control, with a TEV cleavage site (Fig. S3 
A-B). TEV cleavage site-modified nanobodies can be cleaved upon appearance at the cell surface with 
recombinant TEV protease, thereby causing removal of the C-terminal epitope cassette. 
 
 
Figure 3.6: Endocytosis and recycling kinetics of EGFP-CDMPR and TfR-EGFP. (A) and (C) To biochemically 
measure endocytic uptake and recycling of EGFP-CDMPR and TfR-EGFP, stable cells were first incubated with 2 µg/mL VHHGFP-
TEV-control for up to 60 min, followed by several washes, and then recombinant TEV protease was added for up to 60 min 
(starting from 2.5) to cleave nanobody arriving at the cell surface. Cells were lysed and the total cell-associated nanobody 
(intracellular and plasma membrane) was detected using an anti-His6 antibody, internal controls were made with anti-GFP or anti-
actin antibodies. (B) and (D) Plotting of endocytic uptake and recycling kinetics. Quantification of three independent experiments 
is shown (average ± SD). Signal intensities of each time point (endocytosis and recycling) is expressed as the percentage of the 
signal intensity after 60 min. 
 
To illustrate the use of our functionalized nanobody termed VHHGFP-TEV-control, we performed 
an endocytosis-recycling assay using EGFP-CDMPR and TfR-EGFP as receptor reporters. Similar to the 
experimental setup in Figure 3.5, we administrated 2 µg/mL VHHGFP-control for up to 60 min, washed 
the cells to get rid of any cell-associated nanobody, and then added purified TEV protease into the cell 
culture medium at 37°C for up to 60 min before cell lysis was performed.  
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In Figure 3.6, endocytic uptake/recycling kinetics of EGFP reporters are shown. As observed 
before (Fig. 3.5 B and D), we could report similar uptake kinetics for the receptors. The presence of 
TEV protease in the cell culture medium over the chase period caused a robust decrease of the nanobody 
signal, showing that the extracellular protease faces exocytosed nanobody and cleaves it. Strikingly, rates 
of recycling and uptake are similar for each individual EGFP reporter. While we observed steady-state to 
be reached after 20 min in an uptake experiment for TfR-EGFP, we reported < 7% of nanobody to be 
intracellularly present for the same period of time in the recycling assay (Fig 3.6 C and D). The minute 
difference is probably restricted to technical reasons. While the uptake assay relies on nanobody 
internalization only, the recycling assay is also dependent on the cleavage efficiency of TEV protease. It is 
likely that the used conditions (cell culture medium, temperature) do not mimic the most optimal 
working environment for the protease to confer complete TEV site removal, even though it has been 
added in 'excess' to compensate for this potential limitation. As for TfR-EGFP, we could see a similar 
trend for EGFP-CDMPR regarding endocytic uptake and recycling rates. After 60 min of recycling for 
instance, we could only detect minor traces (< 5%) of uncleaved VHHGFP-TEV-control (Fig. 3.6 A and 
B). We did not monitor significant levels of TEV protease to be unspecifically taken up during our assayed 
time. 
Even though rates of endocytosis and recycling are not completely identical, primarily because of 
technical caveats, our results demonstrate the potential use of TEV site-tagged nanobodies to monitor 
recycling from intracellular compartments to the plasma membrane. We can principally use such a setup 
to assay recycling of any cycling transmembrane cargo and perturb its traffic with any means.   
 
3.3.4 Live Cell Imaging Uptake Kinetics with Functionalized Nanobodies 
As previously mentioned, uptake kinetics so as recycling kinetics cannot only be measured biochemically 
by nanobody feeding and cell harvesting as performed in Fig. 3.5-3.6, but also by live cell imaging. Live 
cell imaging has the advantage that we can 'visualize' the process of endocytosis and quantitate the 
process of uptake more easily. In light of this notion, we established a semi-automated live cell imaging 
approach to quantitatively assess uptake using VHHGFP-mCherry.  
The live cell imaging approach is based on an inverted widefield microscope and a data analysis 
program correcting for any live cell perturbances. It also allows us to compute characteristic values 
describing the uptake process, among them the apparent rate constant kapp, half-life τ1/2 of the endocytic 
process, as well as the time T where uptake is completed (steady-state).  
To measure uptake kinetics of our two EGFP receptor reporters, EGFP-CDMPR and TfR-EGFP, 
we imaged cells in selected fields of view (FOV) before and after nanobody addition. Before adding 
nanobody, regions of interest (ROI) in the EGFP emission channel of selected FOV were marked in which 
nanobody (mCherry) increase over time was then quantitated. Since we considered endocytic uptake, 
whole cells were marked as ROI, but principally, we could mark any defined intracellular compartment. 
The frame rate was set to 1 frame per 30 seconds, meaning that a picture will be taken every 30 seconds 
after initial nanobody addition for up to 30 min or 50 min for TfR-EGFP or EGFP-CDMPR, respectively. 
Figure 3.7 A and C shows as selected series of silent pictures for the uptake of VHHGFP-mCherry by 
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cells stably expressing EGFP-CDMPR or TfR-EGFP. Selected insets are enlarged to qualitatively visualize 
the uptake process.  
As seen in both picture series (see also movies Mov. 3.1 for EGFP-CDMPR, and Mov. 3.2 for 
TfR-EGFP), retrograde transport compartments receive robust mCherry fluorescence over time, 
indicating that the process of endocytic uptake can be visualized with our nanobody tool. Image 
processing and data analysis of multiple recorded raw movies allowed us to plot endocytic uptake kinetics 
and to determine kapp, τ1/2 and T for EGFP-CDMPR or TfR-EGFP. The respective values as well as the 
uptake graphs are depicted in Figure 3.7 B and D. We calculated a rate constant of kapp = 1.33⋅10-3 s-1, a 
half-life of τ1/2 ∼ 9 min, and a steady-state time of T ∼ 43 min, with all having a relative error of 20%, for 
EGFP-CDMPR. For TfR-EGFP, we found a rate constant of kapp = 2.89⋅10
-3 s-1, a half-life of τ1/2 ∼ 4 min, 
and a steady-state time of T ∼ 20 min, with all having a relative error of 25%. The computed values for 
TfR-EGFP impressively demonstrate how well our live cell imaging approach is technically working. We 
obtained similar values for the endocytic uptake and recycling process, in particular with regard to the 
half-lives τ1/2.  
A similar statement can be made for EGFP-CDMPR. We for instance observed that no additional 
nanobody will be taken up after 45 min (Fig. 3.5 B). This is also reflected by our live cell imaging data 
that showed the process of uptake to be completed at ∼ 43 min (Fig. 3.7 B and D). Apart from selecting 
whole cells only, we could principally also mark defined subcellular compartments (ROIs), in particular, 
the prominent perinuclear region seen in cells stably expressing EGFP-CDMPR or TfR-EGFP. The 
perinuclear region of EGFP-CDMPR represents a cohort of distinct post-Golgi compartments, including 
the Golgi, early as well as late endosomes, while for TfR-EGFP, these perinuclear compartments mainly 
embody early endosomes. Our initial idea to track retrograde transport from the cell surface to the TGN 
using our EGFP-CDMPR reporter cell line in combination with VHHGFP-mCherry is, because of the 
ambiguous compartment representation, thus not directly measurable. Then, we do not know which parts 
of this perinuclear region actually correspond to the Golgi/TGN. We performed nevertheless such an 
uptake analysis by selecting the perinuclear compartments of EGFP-CDMPR-expressing cells in different 
FOVs, and found that it took about 60 minutes until nanobody has reached steady-state in these ROIs. 
The apparently longer time it took for EGFP-CDMPR to come to steady-state in the perinuclear region is 
obvious, then the receptor needs to pass a much longer route to come to this region. Though 'whole cell' 
uptake analysis also includes the perinuclear region, there is also the cell surface fraction and the 
peripheral endosome fraction that causes steady-state of total cell to be reached faster than in the 
perinuclear region. A strategy to specifically define compartments of interest to monitor retrograde 
transport is the coexpression of fluorophore-tagged organelle markers. We are currently implementing 
fluorophore-tagged TGN reporter proteins (TPST1, TPST2 and GalT) as reference markers to assess 
retrograde transport of EGFP-CDMPR. However, the results of these go beyond the scope of this study. 
Our established live cell imaging approach provided the basis to analyze endocytic uptake into cells, but 
also to address further experimental questions.   
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Figure 3.7: Live cell imaging kinetics of EGFP-CDMPR and TfR-EGFP, and immunoelectron microscopy. 
(A) and (C) To measure endocytic uptake of EGFP-CDMPR (A) and TfR-EGFP (C), the procedure as outlined in (E) was 
performed. Image processing was performed using Fiji, data analysis was done in phyton. (A) and (C) illustrate a series of silent 
pictures of a chosen recorded movie for either EGFP-CDMPR (A) or TfR-EGFP (C). Scale bar: 10 µm. (B) and (D) Plotting of 
endocytic uptake kinetics. Quantification of three independent experiments is shown (average ± SD). Characteristic values for each 
EGFP reporter are also depicted. See material and methods for data analysis. Curve starts delayed > 0 s, because of nanobody 
addition and curve fitting. (E) Typical workflow of live cell imaging acquisition. EGFP reporter cell lines were seeded into ibidi 
dishes (a). The following day, medium was exchanged to phenol red-free medium and prepared for acquisition. After having set the 
microscope (37°C, 5% CO2) and other parameters (b), FOVs were chosen in ibidi dishes (c). FOVs were imaged before (d) and 
after (e) addition of functionalized nanobody (fNb). Depending on the EGFP reporter, the number of recorded frames was changed. 
Following image recording, ROIs were selected and processed with ImageJ/Fiji. Analysis of uptake kinetics was performed in phyton 
(f). (F) Immunoelectron microscopy of endocytosed VHHGFP-myc by cells stably expressing TfR-EGFP. GFP was labeled with 20 
nm-, myc with 10 nm-collidoal gold particles. Legend: E, endosome; PM, plasma membrane. Scale bar: 500 nm.  
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Within the interest to visualize endocytic uptake by various methods, we also sought to use 
immunoelectron microscopy. Then, fluorescence microscopy cannot really resolve the identity of the 
perinuclear compartment that contains not only TGN, but also endosomes and lysosomes. As previously 
introduced, we established VHHGFP-myc for this purpose since there is a good anti-myc antibody for this 
application. For illustration purposes, we decided to use TfR-EGFP to visualize endocytic uptake 
ultrastructurally, mainly because TfR-EGFP has a relatively high cell surface population (15%), and because 
it reaches steady-state fast. Following internalization of VHHGFP-myc for 1 h, cells were fixed, processed 
for electron microscopy and double-labeled with an anti-myc and anti-GFP antibody that were detected 
with coupled collidoal gold particles. 
Figure 3.7 F visualizes uptake by cells expressing TfR-EGFP. We could predominantly observe 
small and big collidoal gold particles in early endosomes, at the plasma membrane or in transport carriers 
between these subcellular locations. In many labeled structures, small and big gold particles were seen to 
cluster together, in agreement with the notion that nanobody is captured at the cell surface and then 
transported piggyback to intracellular compartments. The observation of single labeled structures is due 
to the limited double labeling efficiency with colloidal gold particles. Then virtually 1 h of uptake is more 
than sufficient to label the entire TfR-EGFP population in post-Golgi compartments. We can also exclude 
unspecific labeling since the antibodies were initially titrated. We also tried to immunolabel EGFP-CDMPR 
for electron microscopy, however, but rarely detected substantial amounts of endocytosed VHHGFP-myc 
in these cells. It seems that the immunoelectron microscopy approach is not sensitive enough to detect 
endocytosed nanobodies by receptor reporters which only have a small cell surface fraction in steady-
state. Thus, a more sensitive approach is required to ultrastructurally visualize endocytic and retrograde 
transport compartments.        
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3.4 Analysis of Retrograde Transport by Peroxidase Labeling  
 
Ultrastructural investigation of retrograde transport itineraries by electron microcopy can be performed 
either by immunogold staining of cell surface-labeled and endocytosed reporters (as performed in Fig. 
3.7) or by peroxidase-mediated labeling. Stoorvogel and colleagues were one of the first who made use 
of the peroxidase HRP to label and study the endocytic pathway by electron microscopy and by 
biochemical approaches (Geuze et al., 1988; Stoorvogel, 1998; Stoorvogel, 2008; Stoorvogel et al., 1987; 
Stoorvogel et al., 1991). By coupling HRP to receptor ligands or to recombinant fusions, ultrastructural 
and biochemical insights of target compartments were possible. 
Since the heart of our approach relies on bacterial expression of nanobody fusion proteins, we 
could not use HRP due to its secretory properties (e.g. disulfide bonds). We instead used APEX2. By 
fusing the enzymatic domain of APEX2 to VHHGFP, we can basically label and track any EGFP fusions from 
the cell surface to finally study their ultrastructural localization, as well as to biochemically characterize 
the compartments in which they 'nest' by compartment ablation and proximity-dependent biotin labeling.  
 
3.4.1 Biochemical Uptake of VHHGFP-APEX2  
To see whether VHHGFP-APEX2 is internalized as the other functionalized nanobodies (Fig 3.4), medium 
of EGFP reporter cell lines was supplemented with 5 µg/mL VHHGFP-APEX2. After 1 h of uptake at 37°C, 
cell lysates were prepared and probed against cell-associated nanobody. VHHGFP-APEX2 is efficiently 
taken up by all via the cell surface cycling reporters (Fig 3.8 A), but not by cytosolic EGFP-expressing 
cells. To be noted is that despite the size of the enzyme (same for mCherry), it is taken up to the same 
extent as VHHGFP-control, if not even more. This means that functionalization even with bigger protein 
domains can be accomplished and internalized, provided that VHHGFP still acts as 'vector' for endocytic 
uptake by EGFP reporters. As expected because of previous observations, internalized VHHGFP-APEX2 
also follows its reporters into steady-state as revealed by immunofluorescence microscopy (Fig 3.8 B). 
We thus can feed VHHGFP-APEX2 to EGFP reporter cell lines and perform DAB cytochemistry.    
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Figure 3.8: Endocytic uptake of VHHGFP-control and VHHGFP-APEX2 by EGFP reporter cell lines. (A) Func-
tionalized nanobodies are specifically taken up by reporters presenting an EGFP moiety to the extracellular environment. HeLa 
cells stably expressing EGFP reporters were incubated in the presence of either 2 µg/mL VHHGFP-control or 5 µg/mL VHHGFP-
APEX2 for 1 h at 37°C. Following uptake, cell lysates were prepared and probed with anti-His6, anti-GFP and anti-actin antibodies. 
(B) Similar procedure as in (A). Cells on coverslips were fed with 5 µg/mL VHHGFP-APEX2 and processed for fluorescence 
confocal microscopy. APEX2 was detected using an anti-HA antibody. Numbers along the markers correspond to molecular 
weight in kDa. Scale bar: 10 µm.               
 
3.4.2 Electron Microscopy of Target Compartments with VHHGFP-APEX2  
A general and important note to be shared in advance is that Golgi appearance is strongly dependent on 
the applied EM method. It is thus crucial to be aware that a 'typical' Golgi is not always an array of nicely 
stacked cisternae. Depending on the sectioning and post-fixation procedures, Golgi architecture might 
look different from what we are familiar with from textbooks. 
To specifically peroxidase-label endocytic compartments, cell lines stably expressing EGFP 
reporters were incubated with 5 µg/mL VHHGFP-APEX2 for 1-2 h to reach steady-state. After fixation and 
DAB/H2O2 cytochemistry, cells were stained with osmium tetroxide for electron microscopy. Cells that 
do not possess any EGFP reporter, but have undergone cytochemistry, do not show any visible DAB 
precipitates due to missing APEX2 internalization (Fig 3.9 A). The only structures that are stained after 
osmium tetroxide in control cells are peroxidase-containing compartments, such as peroxisomes. The 
Golgi area was typically identified by the presence of a discernible cluster of elongated tubular/vacuolar-
shaped membranes in close proximity to the nucleus. To prove and compare that compartment labeling 
with our approach productively worked for EGFP-modified reporter proteins, we first used TfR-EGFP. As 
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established for TfR/Tf-HRP (Laulagnier et al., 2011; Stoorvogel et al., 1988; Theos et al., 2005), DAB 
precipitates are preferentially formed in compartments of the endosomal network. For TfR-EGFP (Fig. 
3.9 B), we observed DAB depositions outlining or filling endocytic compartments reminiscent of early 
and recycling endosomes. In addition, also stained vesicular structures (presumably endocytic CCV) and 
invaginated membranes (e.g. CCP) from the plasma membranes could be observed. Thus, APEX2 can very 
well substitute for HRP as peroxidase to label target compartments. Furthermore, the specific and local 
deposition of DAB also showed that APEX2, unlike HRP, can operate in both an oxidative and reductive 
cellular environment. So far, APEX2 has been only applied for cytosolic expression. We are not aware of 
studies using APEX2 in the secretory or endocytic pathway.  
 
 
Figure 3.9: DAB/H2O2 cytochemistry and electron microscopy of EGFP reporter cell lines. (A)-(E) Control 
and EGFP reporter cell lines were incubated with 5 µg/mL VHHGFP-APEX2 for 1-2 h at 37°C to reach steady-state. After fixation 
with 2% glutaraldehyde, cells were treated with DAB/H2O2 to yield a local and productive DAB polymerization reaction. The 
picture on the right of an alphabetic series refers to the enlargement of the respective selected area (dotted square). Straight lines 
correspond to 1000 nm (A-D or E), dotted lines to 380 nm (A-D or E). Legend: C, centrosome; E, endosome; G, Golgi; M, 
mitochondrium; MVB, multivesicular body; N, nucleus; Asterix (*), peroxidase-containing compartments (e.g. peroxisomes).   
 
In a next step, we wanted to see what kind of ultrastructural architecture compartments beyond 
endosomes, i.e. the TGN, have. Following this idea, we first considered to look at DAB-positive 
structures in cells expressing EGFP-CDMPR (Fig. 3.9 C). Apart from DAB-positive peripheral and 
perinuclear endosomes, we often found a concentrated pattern of small vesicular and tubular elements 
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adjacent to the Golgi cisternae. The labeled tubular elements varied in length and often had branched 
extensions (see also Fig. S4 A). In agreement with former reports that made use of wheat germ 
agglutinin (WGA)-HRP to label endocytic and Golgi compartments (Iida and Shibata, 1989; Klumperman, 
2011; Pavelka et al., 2008), our observed vesicular-tubular arrangement of membranes represents indeed 
TGN at ultrastructural resolution. Some of these tubular elements seem to be even interconnected with 
the trans-Golgi cisternae, thereby turning into integrated parts of the Golgi complex. The TGN varied in 
size, morphology, and also in the number of vesicular-tubular elements. It is therefore not a surprise that 
the TGN pattern of EGFP-CIMPR and EGFP-TGN46 (Fig. 3.9 D-E) does not look identical, but similar. 
Compared to WGA-HRP as retrograde tracer, our nanobody-based technique to label the retrograde 
route to the TGN is by far more specific. WGA is an N-acetyl-glucosamine- and sialic acid-binding lectin 
(Goldstein and Hayes, 1978) and thus labels and conveys a broad spectrum of glycosylated cargo proteins. 
As demonstrated by Iida and Shibata (Iida and Shibata, 1989) almost three decades ago, WGA-HRP can 
chart beyond the TGN and even label Golgi cisternae. The nanobody approach, in contrast, allows specific 
labeling of the steady-state ultrastructural distribution of a given EGFP reporter.  
 
3.4.3 Inactivation of Target Compartments with VHHGFP-APEX2  
Another application of peroxidases to study retrograde traffic is biochemical ablation (Stoorvogel, 1998; 
Stoorvogel et al., 1988). As mentioned previously, ablation describes the selective compartment 
inactivation by crosslinking and/or encapsulation of lumenal and integral membrane proteins using 
peroxidase-mediated DAB/H2O2 cytochemistry. Since polymerized DAB is water-insoluble and dense, the 
crosslinked proteins can be easily precipitated by centrifugation. Ablation is thus very much suitable to 
figure out to which intracellular compartments a reporter localizes and above all through which it traffics. 
By peroxidase labeling of endocytic compartments with HRP conjugated to Tf in combination with 
ablation, sorting itineraries of a number of proteins could be assessed through TfR-positive membranes 
(Hashiramoto and James, 2000; Livingstone et al., 1996; Mihov et al., 2015; Stoorvogel et al., 1989; 
Stoorvogel et al., 1988). The APEX2-labeled anti-GFP nanobody offers us a direct way to specifically 
ablate compartments, and to identify the subcellular localization of EGFP reporters.  
To assess the efficiency and specificity of the ablation reaction on living cells, we took advantage of 
the well-studied endocytic reporter TfR. Cells stably expressing TfR-EGFP were loaded with APEX2-
labeled VHHGFP for 1 h at 37°C, washed with ice-cold PBS to halt membrane transport and then incubated 
with a mixture of DAB/H2O2 to initiate crosslinking at 4°C for 90 min in the dark. Cells were harvested 
and the postnuclear supernatant was separated from the DAB crosslinking precipitate. Immunoblot 
analysis of cell lysates showed more than 90% elimination of recombinant TfR, demonstrating that not 
only intracellular levels (~ 85%), but presumably also cell surface fractions were affected (Fig. 3.10 A). 
The almost complete ablation of TfR-EGFP is in agreement with the observed auto-ablation of APEX2. 
APEX2 itself namely is completely ablated from the soluble fraction, highlighting that DAB precipitates can 
be potentially formed locally at distinct plasma membrane niches. Indeed, close to TfR-EGFP, we even 
often observed DAB precipitates along the extracellular rim of the plasma membrane by electron 
microscopy (Fig. S4 B-C), further confirming the existence of plasma membrane-associated 
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precipitations. As for the recombinant TfR with three to four fold higher protein expression, we reported 
productive elimination of the endogenous counterpart to the same extent (Fig. 3.10 A, blot lane with 
TfR). This result might suggest that some of the TfR are heterodimers, composed of an endogenous and 
recombinant subunit, otherwise we would not observe ablation of more than > 85% for endogenous TfR. 
The plasma membrane overall in general was not significantly affected by DAB crosslinking since we could 
monitor rather stable levels of the cell surface marker CD44. However, it has to be mentioned that 
CD44, a CIE cargo, probably populate plasma membrane domains where TfR, a CME cargo, might be 
absent. Missing ablation of overall cell surface proteins (including CD44) was probably mainly due to the 
high reaction volume provided by the extracellular space, thereby making DAB crosslinking considerably 
inefficient. While the concentration of APEX2 for a productive reaction in endocytic compartments is 
high, it is vanishingly small in the extracellular space despite constant amounts of DAB/H2O2. 
Other endogenous proteins that were affected by DAB polymerization were CIMPR and the 
endosomal SNARE proteins vti1a and vti1b (Fig. 3.10 A). All of these proteins are known to pass early 
endosomes to perform their individual functions as cargo receptor or membrane targeting, respectively. 
Even though reported to mainly localize to the TGN and to late endosomes in steady-state, we found a 
reproducible elimination of ~ 50% for CIMPR, revealing a rather dominant localization of the hydrolase 
receptor to TfR-positive endosomes and peripheral structures. Our results are supported by a previous 
study of Kornfeld and colleagues (Ghosh et al., 2003b) who showed the presence of ~ 60% CIMPR in 
endosomes and 'scattered elements' by quantitative immunogold labeling in HeLa cells. In agreement with 
endosomal localization of vti1a and vti1b (Hirst et al., 2004; Hirst et al., 2003), we consistently observed 
ablation of these proteins in TfR-positive compartments, even though these proteins have only an 
extremely short lumenal tail. Ablation from the soluble fraction is thus probably not only caused by 
covalent chemical protein crosslinking, but also contributed by encapsulation of soluble proteins into the 
DAB polymer meshwork (Stoorvogel et al., 1989; Stoorvogel et al., 1988; Stoorvogel et al., 1987). In a 
study of James and colleagues where recycling of the GLUT4 transporter from endosomal compartments 
in 3T3-L1 adipocytes was investigated using Tf-HRP, ablation of other post-Golgi SNAREs with short 
lumenal tails (syntaxin 6 and VAMP2) could be observed (Hashiramoto and James, 2000). 
In contrast to endosomal markers, proteins which predominantly localize to the TGN (TGN46, 
GalT, TPSTs), to the medial Golgi cisternae (ManII), or peripherally associate with endosomal membranes 
(Rab4, Rab5, Rab7 and Rab9) were not noticeably ablated. This is in line with the observation that TfR 
mainly cycles through endosomal compartments with only insignificant shortcuts to the TGN and beyond. 
LAMP1 was also not affected by APEX2-mediated compartment ablation, most likely because there is only 
a poor fraction in TfR-positive endosomes in steady-state. Other compartments of the secretory pathway 
(e.g. ER) or other organelles (e.g. mitochondria) were also not affected by endocytic DAB/H2O2 
cytochemistry, as demonstrated by immunoblotting against calnexin or Tom20 (Fig. 3.10 A). 
With proof in hand that APEX2-mediated ablation principally works in TfR-EGFP-expressing cells, 
we next investigated which retrograde transport compartments and intermediates are inactivated in cells 
expressing EGFP-CDMPR. Western blots probed against GFP showed mature recombinant CDMPR to be 
depleted from postnuclear supernatants (Fig. 3.10 B). As discussed previously, the lower band of EGFP-
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CDMPR does not exclusively represent high-mannose glycosylated ER form, but is rather composed of 
two bands that can be hardly separated by gel electrophoresis. Parts of the lower band of EGFP-CDMPR 
indeed were accessible by the nanobody that was provided in the cell culture medium, indicating an 
additional mature form of the receptor (Fig. S2 B). We therefore also observed a decline in protein 
levels of the lower band of EGFP-CDMPR. 
 
Figure 3.10: Biochemical compartment ablation analysis of TfR-EGFP and EGFP-CDMPR. (A)-(B) To 
inactivate endocytic or retrograde compartments of TfR-EGFP or EGFP-CDMPR, cells were prepared in 6-well clusters and 
incubated in complete DMEM containing 5 µg/mL of purified VHHGFP-APEX2 for 1 h at 37°C to reach steady-state. After three 
washes with ice-cold PBS, cells were incubated with either 1 mg/mL DAB or 0.03% H2O2 separately as control, or a combination 
thereof in PBS to yield a productive ablation reaction. After 90 min of incubation at 4°C in the dark, cells were washed twice with 
ice-cold PBS-5% BSA to stop the DAB crosslinking reaction, followed by three additional washes before lysis. Legend: GalT, β-1,4-
galactosyl-transferase; TPST, tyrosylprotein sulfotransferase; ManII, α-mannosidase II. Experiments have been repeated at least 
three times.  
   
As observed for TfR-EGFP as positive control, APEX2 was also ablated in cells expressing EGFP-
CDMPR to almost undetectable levels. Since both MPRs are implicated to have similar function and 
transport itineraries, we expected CIMPR to be ablated, too. Indeed, we noticed a concomitant 70-80% 
depletion of endogenous CIMPR after DAB/H2O2 cytochemistry. Similar to recombinant TfR, we also 
observed ablation of endogenous TfR and the endosomal SNARE proteins vti1a and vti1b in the EGFP-
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CDMPR reporter cell line. Because MPRs need to capture newly synthesized lysosomal hydrolases from 
the TGN, there is a requirement of continuous receptor retrieval from endosomes. It is thus obvious that 
the reporter must go back to the TGN where it will occasionally encounter and face more resident 
marker proteins. 
To examine whether our EGFP-CDMPR indeed undergoes the return route from the cell surface 
to the TGN via endosomes, we probed our lysates against TGN46, GalT and the two tyrosylprotein 
sulfotransferase isoforms (TPST1 and TPST2). We observed depletion of TGN46, GalT and TPST2 in the 
condition with productive DAB polymerization, consistent with the notion that EGFP-CDMPR undergoes 
retrograde transport to the TGN. TPST1 instead was maximally depleted by ~ 20%, thereby potentially 
suggesting that this isoform is not localized to the TGN to the same extent as TPST2. The literature is 
unclear regarding the precise localization of TPSTs, either in the trans-Golgi or TGN (Baeuerle and 
Huttner, 1987; Huttner, 1988; Stone et al., 2009). It thus might be that either TPST1 is preferentially 
localized to the trans-Golgi cisterna in steady-state and thus is less ablated, or it just resides in a 'TGN 
subdomain' where MPRs are not passing through. 
Although MPRs are reported to traverse late endosomes to reach the TGN (Barbero et al., 2002; 
Bonifacino and Rojas, 2006; Diaz and Pfeffer, 1998; Lombardi et al., 1993; Reddy et al., 2006), we did not 
find any ablation of the marker LAMP1 that is also present in late endosomes to a certain degree 
(Humphries et al., 2011; Saftig and Klumperman, 2009). However, we can also not exclude that APEX2 is 
rendered inactive in more acidic late endosomes. In agreement with the view that MPRs do not 
retrogradely traffic beyond the TGN, we did not observe any ablation of medial-Golgi compartments 
(ManII) or the ER (calnexin). Also Rab GTPases that are peripherally recruited to inactivatable 
compartments were not ablated. 
Our assay provides means to assess whether EGFP reporters undergo transport to the TGN just 
by assaying for ablation of TGN-resident markers. This approach can be expanded to other EGFP-
modified reporters.      
 
3.4.4 Proximity-Dependent Biotin Labeling of Target Compartments  
Instead of biochemically ablating the TGN, retrograde EGFP reporters can also be exploited to escort 
protein modifiers. Such a protein modifier will then have the task to substrate-label interactors or 
neighbors in close proximity. Valuable protein modifiers for proximity-dependent labeling in this regard 
are the promiscuous BirA mutant (BirA*) and peroxidases (Kim and Roux, 2016). The former has been 
developed and improved by Roux and colleagues (Kim et al., 2016a; Roux et al., 2012) and since then 
used in a wide number of applications ranging from immunoblot analysis to mass spectrometry (De 
Munter et al., 2017; Kim et al., 2016b; Le Sage et al., 2016; Li et al., 2017; Mehus et al., 2016; Roux, 2013; 
Roux et al., 2013). BirA* uses D-biotin as substrate and has a mutation within the biotin- and biotin-AMP-
binding domain that causes it to be released and reactive with primary amines within a diameter of 
approximately 10 nm. 
While the enzymatic activity of BirA*-mediated biotinylation is slow, peroxidase-driven labeling is 
more rapid. Peroxidases can generate short-lived free radicals from substrates such as phenolic aryl azide 
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derivatives or tyramide derivatives in combination with H2O2 (Gross and Sizer, 1959; Honke and Kotani, 
2011), and conjugate them to electron-dense side chains (e.g tyrosine and tryptophan) (Kim and Roux, 
2016). 
Based on the idea of Ting and colleagues who initially demonstrated proximity-dependent 
biotinylation using APEX2 (Hung et al., 2017; Hung et al., 2016; Hung et al., 2014; Lam et al., 2015; Rhee 
et al., 2013), we sought to send our nanobody fusion along with our EGFP reporters. A pulse with the 
peroxidase substrate biotin-phenol (biotin tyramide) would then lead to biotin transfer to APEX2-
proximal proteins. Biotinylation strictly depends on the steady-state distribution of the reporter, and thus 
reporter undergoing retrograde transport to the TGN might most likely biotinylate resident proteins in 
this compartment. Subsequently, biotinylated proteins from lysates can be enriched using streptavidin-
based purification and probed with antibodies recognizing TGN-specific markers. This approach is thus a 
simple way to assess retrograde traffic to the TGN or basically to any other target compartment. 
To detect APEX2-mediated biotinylation of TGN-resident proteins, we decided to use again TfR-
EGFP and EGFP-CDMPR as model proteins. Cells expressing these EGFP reporters were loaded with 5 
µg/mL VHHGFP-APEX2 for 1 h to reach steady-state. Following three washes, biotin-phenol labeling was 
initiated by adding fresh complete medium containing 500 µM biotin-phenol for 30 min at 37°C. 
Afterwards, H2O2 at a final concentration of 1 mM was added to the cells to start the reaction. After 3 
minutes of labeling, the reaction was halted and quenched. Cleared cell lysates were then incubated with 
streptavidin beads followed by immunoblot analysis. 
We first studied whether APEX2 can perform promiscuous biotinylation when present in the 
endocytic or retrograde pathway and, hence, checked our lysates with streptavidin-HRP. As seen in 
Figure 3.11, we observed a robust biotinylation in the condition where both biotin-phenol and H2O2 
were present. We even observed some discrete bands corresponding to biotinylated proteins in control 
cells lacking any EGFP reporter when biotin-phenol and H2O2 were both present. This most likely reflects 
the ability of endogenous peroxidases to transfer biotin onto neighboring proteins. We also observed 
bands at ~ 70 kDa and ~ 130 kDa (see black arrows in Fig. 3.11) in the condition where only one 
peroxidase substrate was present and thus no productive biotinylation reaction could occur. These bands 
correspond to endogenous biotinylated proteins, that are pyruvate carboxylase (~ 130 kDa) and propinyl-
CoA carboxylase (~ 70 kDa). In both lysates and pull-downs, we observed a visible biotinylation reaction 
by APEX2 that was transported piggyback by EGFP-CDMPR or TfR-EGFP to intracellular compartments, 
demonstrating that the peroxidase can be exploited to label proteins in close proximity. 
To see whether we could use proximity-dependent biotinylation as qualitative readout to assess 
TGN arrival of proteins of interest, we probed our streptavidin pull-downs from cells expressing EGFP-
CDMPR with antibodies targeting TPST2, TGN46 and GalT. If these resident markers are in close 
proximity to the EGFP reporter, that cycles through the TGN, then they should be modified with biotin. 
For unknown reasons, we could not detect any biotinylated TPST2 or TGN46, suggesting that these 
proteins are either not in close proximity, sterically not well positioned for biotin modification or the 
amount of these proteins is just too scarce for detection. GalT, in contrast, was found in our streptavidin 
pull-downs, implicating that EGFP-CDMPR must have passed a GalT-positive compartment. In steady-
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state, GalT is mainly localized to the trans-Golgi/TGN. However, it has to be noted that the signal derived 
from GalT in the streptavidin pull-downs was quite weak. We did not report any GalT to be present in 
streptavidin pull-downs derived from TfR-EGFP, in agreement with the notion that TfR and GalT only 
have poor colocalization in steady-state. As reported previously (Fig. 3.10), other endomembranes 
beyond the TGN (ER, calnexin) are not affected by biotinylation. Surprisingly, we could not recover the 
same relative amounts of EGFP-CDMPR/APEX2 in our pull-downs when compared to TfR-EGFP/APEX2. 
The reason for this is unknown. 
 
 
Figure 3.11: Proximity-dependent biotinylation analysis of EGFP-CDMPR and TfR-EGFP. Cells stably 
expressing either EGFP-CDMPR or TfR-EGFP were loaded with 5 µg/mL VHHGFP-APEX2 for 1 h to reach steady-state. Following 
three washes, biotin-phenol labeling was initiated by adding fresh complete medium containing 500 µM biotin-phenol for 30 min at 
37°C. Afterwards, H2O2 at a final concentration of 1 mM was added to the cells to start the reaction. After 3 minutes of labeling, 
the reaction was halted and quenched. Cleared cell lysates were then incubated with streptavidin beads followed by immunoblot 
analysis. Left panel with blots correspond to total cell lysate, right panel with blots correspond to streptavidin pull-downs. Black 
arrows indicate endogenous biotinylated proteins, the white arrow corresponds to APEX2 whose BAP epitope has been modified 
(even though no biotin was added during bacterial expression here). The faint smear (in SA-HRP) running in lane 3 (control cells) 
at nanobody migration speed does not correspond to VHHGFP-APEX2. Legend: SA-HRP, streptavidin conjugated to HRP; GalT, β-
1,4-galactosyltransferase. Numbers along the blots correspond to molecular weight in kDa. Experiments have been repeated at 
least three times.  
 
An other perplexing finding we have made was that when we incubated with H2O2 too long (> 10 
min), our antibody signal strongly declined in our cell lysates and pull-downs (even those from VHHGFP-
APEX2 and the EGFP reporters). It thus seems that extended biotinylation destroys epitopes for antibody 
recognition. While promiscuous BirA* can only modify lysine residues, peroxidases can modify much 
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more amino acids (tyrosines, tryptophans, and even histidines and cysteines). The risk of destroying 
epitopes for antibody recognition is thus considerably higher.  
We have exemplified that APEX2-driven reactions can also be exploited to test whether a given 
protein of interest faces TGN-resident markers. We thus could use an improved system to test other 
reporters for appearance in the TGN using this proximity-dependent labeling approach. An alternative 
strategy to look more globally at biotinylated proteins by EGFP reporter/APEX2 complexes is by mass 
spectrometry. Indeed, Ting and colleagues have established and used this biotinylation-based setup to 
detect interaction partners of their proteins of interest by the means of proteomics (Branon et al., 2017; 
Hung et al., 2017; Hung et al., 2016; Hung et al., 2014; Lam et al., 2015; Rhee et al., 2013). Whenever 
there is a need to test weak or transient interactions, we can call in mind that APEX2 is suitable for this 
experimental endeavor.     
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3.5 Analysis of Retrograde Transport to the TGN  
 
Although the previously described functionalized nanobodies could be used for studying cell surface-to-
TGN transport, they have the disadvantage that retrograde transport kinetics cannot be directly 
measured. For VHHGFP-mCherry, there is the indispensable requirement of stable overexpression of a 
fluorescent TGN-resident marker to perform live cell imaging, while for VHHGFP-APEX2, only qualitative 
and no quantitative conclusions can be drawn concerning TGN arrival and localization. To overcome the 
drawbacks of each of these with regard to TGN arrival, we established nanobodies that can be modified 
by sulfation. Sulfation of tyrosines is a posttranslational modification that is exclusively restricted to the 
trans-Golgi/TGN (Baeuerle and Huttner, 1987; Huttner, 1988) where TPSTs reside and PAPS supply is 
high. Hence, by using tyrosine-sulfatable nanobodies that ride piggyback with EGFP reporters, we cannot 
only monitor arrival, but also determine retrograde transport kinetics to the TGN.   
 
3.5.1 Biochemical Uptake of VHHGFP-1xTS and -2xTS 
To increase the efficiency of tyrosine sulfation, we preventively constructed nanobodies not only with one, 
but also with two tyrosine sulfation (TS) consensus sequences derived from of the rat cholecystokinin 
precursor (Fig. 3.1 A and B). To verify that VHHGFP-1xTS and VHHGFP-2xTS are efficiently internalized 
by EGFP reporter cell lines as previously monitored for VHHGFP-control, VHHGFP-mCherry and VHHGFP-
APEX2 (Fig. 3.4 and 3.8), nanobodies were applied for immunoblot and immunofluorescence analysis 
(Fig. 3.12 A-C). 
As reported for the other functionalized nanobodies (Fig. 3.4 and 3.8), TS-tagged derivatives are 
also internalized and distribute themselves along the same compartments as the reporters. Knowing that 
EGFP-CDMPR rides to the TGN as revealed by our APEX2 studies, we can biochemically test our 
nanobodies for TGN return using sulfate-radiolabeled nanobody as readout.   
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Figure 3.12: Endocytic uptake of VHHGFP-1xTS and VHHGFP-2xTS by EGFP reporter cell lines. (A) Func-
tionalized nanobodies are specifically taken up by reporters presenting an EGFP moiety to the extracellular environment. HeLa 
cells stably expressing EGFP reporters were incubated in the presence of either 2 µg/mL VHHGFP-control, VHHGFP-1xTS or 
VHHGFP-2xTS for 1 h at 37°C. Following uptake, cell lysates were prepared and probed with anti-His6, anti-GFP and anti-actin 
antibodies. (B)-(C) Similar procedure as in (A). Cells on coverslips were fed with 2 µg/mL VHHGFP-1xTS (B) or VHHGFP-2xTS (C) 
and processed for fluorescence confocal microscopy. TS-tagged nanobodies were detected using an anti-HA antibody. Numbers 
along the markers correspond to molecular weight in kDa. Scale bar: 10 µm.               
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3.5.2 TGN Arrival Sulfation Analysis with VHHGFP-1xTS and -2xTS    
To analyze sulfation, cells expressing cytosolic EGFP or secretory reporters were incubated with 
functionalized nanobodies in the presence of radiolabeled [35S]sulfate at 37°C for 1 h. The postnuclear 
supernatant was harvested and incubated with Nickel sepharose beads to affinity-isolate potentially 
sulfated VHHGFP derivatives. In parallel, a fraction of the postnuclear supernatant was saved as reference 
for the total amount of cell-associated VHHGFP-1xTS/2xTS or as loading reference. Radioactive signals 
were assessed by SDS gel electrophoresis and autoradiography, while uptake and the loading reference 
was evaluated by immunoblot analysis (Fig. 3.13). 
 
 
Figure 3.13: TGN arrival sulfation analysis in EGFP reporter cell lines. Cells stably expressing cytosolic EGFP or 
secretory reporter proteins were starved in sulfate-free medium for 1 h at 37°C and 7.5% CO2, and then pulse-labeled with 
sulfate-free medium reconstituted with 0.5 mCi/mL [35S]sulfate supplemented with 2 µg/mL of either VHHGFP-control, VHHGFP-
1xTS or VHHGFP-2xTS for up to 75 min. Postnuclear supernatants were collected and incubated with Nickel beads to affinity-
isolate nanobodies. A fraction of the postnuclear supernatant was saved as reference for the total amount of cell-associated 
nanobody or as loading control. Proteins were separated using gel electrophoresis and prepared for autoradiography. Cell-
associated nanobody was detected using an anti-His6 antibody. Numbers along the markers correspond to molecular weight in kDa.  
 
As expected from previous results, there is no visible nanobody uptake by cells expressing 
cytosolic EGFP (Fig. 3.13, lanes 1-3). Conversely, cells expressing recombinant MPRs show a specific 
sulfation signal at the molecular weight of the respective TS-modified nanobody (Fig. 3.13, lanes 5-6 and 
8-9), while there is no signal from the nanobody lacking a TS motif in these reporters (Fig. 3.13, lanes 4 
and 7). In addition, the degree of sulfation between the MPR reporters is similar, but in general with more 
incorporation of radiolabeled sulfate into VHHGFP-2xTS. Even though we monitored sparse uptake of 
nanobodies into cells expressing EGFP-TGN46 relative to the other reporters throughout this study, we 
observed a higher degree of sulfation for TGN46 (Fig. 3.13, lanes 11 and 12), and this even under 
conditions where TGN46 is not yet in steady-state (see also Fig. 3.5 C and E). The higher degree of 
sulfation is most likely explained by the longer residence time of the reporter in the compartment of 
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labeling. MPRs, on the contrary, dynamically move in and out from the TGN, thus having a much shorter 
time to face the sulfation machinery.  
To complete our uptake experiments and demonstrate the overall specificity of nanobody uptake 
by confocal immunofluorescence microscopy, we fed VHHGFP-2xTS (any other derivatives are possible, 
too) to cells expressing either cytosolic EGFP or fusions residing in the early secretory pathway (Fig. S5). 
Popular markers for the early secretory pathway are the quality control chaperone calnexin (ER) and the 
lectin ERGIC53 (ERGIC). We did not see any nanobody uptake by cells expressing either cytosolic EGFP, 
EGFP-calnexin or EGFP-ERGIC53, indicating that a reporter presenting an EGFP moiety to the 
extracellular environment is a prerequisite for VHHGFP internalization (see also Fig. S3 D).    
Since there was stronger sulfate incorporation into VHHGFP-2xTS (Fig. 3.13), we continued to use 
this version for our future studies. Apart from VHHGFP-1xTS and VHHGFP-2xTS, we also generated and 
bacterially expressed a TS-tagged version (TS-VHHGFP-TS), where the sulfation consensus was present 
both at the N- and C-terminus. However, this nanobody was much worse than VHHGFP-2xTS, but 
comparable if not even worse to VHHGFP-1xTS (Fig. S6).        
Our nanobody-based approach offers us a direct way to biochemically study cell surface-to-TGN 
transport of EGFP fusion proteins using sulfation. Our attempts are not only restricted to do qualitative 
statements based on simple pulse experiments, but also can be expanded to quantitative analysis of kinetic 
transport to the TGN.        
 
3.5.3 TGN Arrival Kinetics of MPRs with VHHGFP-2xTS 
As proof-of-concept to study retrograde transport kinetics to the TGN, we chose MPRs as reporters. 
After AP-2/clathrin-mediated endocytosis, endosome-to-TGN transport of MPRs has been reported to be 
mediated by different sorting machineries, including retromer (Arighi et al., 2004; Seaman, 2004), epsinR- 
(Saint-Pol et al., 2004) and AP-1/clathrin-coated carriers (Meyer et al., 2000; Robinson et al., 2010) from 
early endosomes, as well as Rab9/TIP47-dependent transport (Diaz and Pfeffer, 1998; Lombardi et al., 
1993) from late endosomes (discussed in the introduction). It is suggested that the overlapping or 
orchestrated action of these pathways might mediate retrieval of the hydrolase cargo receptor to the 
TGN. It remains elusive and to be determined what the individual contribution of each of these pathways 
is to ensure proper TGN relocalization of MPRs. 
To generally interfere with retrograde transport, we decided to use the fungal metabolite Brefeldin 
A (BFA) that inhibits guanine exchange factors (GEFs) of the ARF protein family. ARF proteins, mainly 
ARF1, have been shown to recruit adaptors, such as AP-1 and epsinR, to endosomal membranes, but not 
retromer complex and Rab9/TIP47 which membrane-associate in an ARF-independent manner. To follow 
transport kinetics to the compartment of labeling using VHHGFP-2xTS, we pulsed cells stably expressing 
EGFP-CIMPR and EGFP-CDMPR for up to 75 min with [35S]sulfate in the presence or absence of BFA 
(Fig. 3.14 A-D). Cells were harvested after each time point, incubated with nickel beads and analyzed 
by autoradiography. As before, nanobody uptake by the MPRs reached steady-state after 45 min. In 
contrast, sulfation started only after a lag time of > 15 min and did not yet reach maximum after 75 min. 
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Figure 3.14: Cell surface-to-TGN transport kinetics of MPRs. (A) and (C) Cells stably expressing either EGFP-
CIMPR or EGFP-CDMPR were starved in sulfate-free medium for 1 h at 37°C and 7.5% CO2, and then pulse-labeled with sulfate-
free medium reconstituted with 0.5 mCi/mL [35S]sulfate supplemented with 2 µg/mL of VHHGFP-2xTS for up to 75 min. BFA was 
used at 2 µg/mL during the pulse. Postnuclear supernatants were collected and incubated with Nickel beads to affinity-isolate 
sulfated nanobody. A fraction of the postnuclear supernatant was saved as reference for the total amount of cell-associated 
VHHGFP-2xTS or as loading control. Proteins were separated using gel electrophoresis and prepared for autoradiography. Cell-
associated VHHGFP-2xTS nanobody was detected using an anti-His6 antibody. (B) and (D) Quantification of retrograde transport 
kinetics. Quantification of three independent experiments is shown (average ± SD). Signal intensities of each time point is 
expressed as the percentage of the signal intensity after 75 min. Black and white squares belong to kinetics of sulfation, grey 
triangles correspond to kinetics of cellular uptake. Data points of sulfation kinetics between DMSO and BFA were at least p < 0.05 
statistical significant.        
 
The observed difference between maximal uptake and sulfation of nanobody can have diverse 
reasons. First, and most relevantly, MPRs have a complex retrograde transport itinerary, with trajectories 
through early endosomes, late endosomes, and possibly even with multiple round trips in these compart-
ments before reaching the TGN. Additionally, MPR-captured nanobody could also reencounter the cell 
surface for other rounds before migrating to the TGN for being sulfated. Second, sulfation of the 
nanobody likely depends on the residence time and one transit through the TGN will only cause partial 
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sulfation of the four tyrosines present that might be completed only after multiple cycling rounds. 
Another point in light of dwelling time in the TGN is the inherent feature of the receptor to dynamically 
cycle at the endosome-to-TGN interface. Consequently, the delayed increase in sulfation might be a 
consequence of all these parameters. 
Consistent with the notion of BFA to inhibit retrograde transport (Amessou et al., 2007; Mallard et 
al., 1998), we observed a robust, if not complete block in retrograde transport to the compartment of 
labeling (Fig. 3.14 A-D). We even reported inhibition of retrograde transport at concentrations lower 
than 2 µg/mL of BFA, indicating that the observed effect is due to inhibition of ARF-dependent processes, 
rather than of reported secondary effects of the fungal metabolite (Fjeldstad et al., 2002). Interestingly and 
surprisingly, while retrograde transport was blocked by BFA, uptake of nanobody into cells and above all 
steady-state levels were not significantly affected. This suggests that the pool of MPRs residing in the TGN 
is not trapped and still able to traffic out to the cell surface. Otherwise similar levels of internalized 
nanobody in the presence or absence of BFA would not have been detected. It has been previously shown 
that BFA in general does not impair cellular uptake into cultured cells (Damke et al., 1991; Hunziker et al., 
1992; Lippincott-Schwartz et al., 1991; Prydz et al., 1992). 
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3.6 Knocksideways of AP-1-Dependent Retrograde Transport  
 
As discussed in the introduction, the precise contribution of AP-1 in retrograde transport is still unclear. 
Most of the conclusions regarding directionality were based on mislocalization of AP-1-dependent cargo 
deduced from altered steady-state distribution. Furthermore, most of these studies were conducted with 
indirect approaches or such with possible secondary effects. Our tyrosine-sulfatable nanobody (VHHGFP-
2xTS) offers us the opportunity of studying kinetics. To selectively and rapidly interfere with the AP-1 
transport machinery, we used the recently described knocksideways technique (Robinson and Hirst, 
2013; Robinson et al., 2010).  
 
3.6.1 Rapid Inactivation of AP-1 by Knocksideways 
The knocksideways (KS) approach, pioneered by Margaret Robinson (Robinson et al., 2010), describes the 
rapid sequestration and thus inactivation of FKBP-modified target proteins onto mitochondria by 
rapamycin-induced heterodimerization with a FRB-tagged mitochondrial bait protein called Mitotrap (see 
also introduction 1.4). Compared to a conventional knockdown or knockout, the knocksideways 
technique has the advantage of eliminating the problem of gradual or long-term protein loss during which 
the cell might switch on compensatory pathways, or accumulate indirect effects of protein depletion over 
time. Since protein traffic in the retrograde pathway and, hence, at the endosome-to-TGN interface, is a 
concerted action of a vast number of cytosolic factors (i.e. ARF and Rab GTPases, coat adaptors, 
tethering factors, lipid kinases and phosphatases, etc.) in a complex network, rapid inactivation rather than 
siRNA-mediated gradual depletion of proteins is strongly favored in order to look at immediate con-
sequences of impaired traffic. 
We established the AP-1 knocksideways system (with minor modifications) in our HeLa cells. To 
mitochondrially trap FKBP-tagged AP-1, we generated a Mitotrap composed of the targeting sequence of 
the yeast mitochondrial outer membrane protein Tom70p, followed by a mutant FRB domain, and a 
3xFLAG epitope. The mutant FRB domain has a threonine to leucine point mutation that enables it to 
bind not only rapamycin, but also the rapalog AP21967. The latter, however, can no longer bind to the 
full-length wild-type FRB-containing domain of mTOR. As AP-1 prey, we used the same protein sequence 
as previously described (Robinson et al., 2010). Using these constructs, we first retrovirally transduced 
our parental HeLa to generate a Mitotrap cell line, and then with the AP-1 prey to obtain the AP-1 
knocksideways cells line. Single clones were picked and analyzed.  
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Figure 3.15: Characterization of the AP-1 knocksideways cell line. (A) Lysates from AP-1 KS cells were prepared 
and probed against AP-1 (γ-adaptin), Mitotrap (anti-FLAG), AP-2 (α-adaptin) and clathrin (CHC17). Equal amounts of proteins 
were loaded. (B) siRNA-treated AP-1 KS cells were seeded on coverslips, treated with 500 nM rapamycin and processed for 
fluorescence confocal microscopy. Mitochondria were detected with an antibody targeting MTCO2, Mitotrap was labeled with an 
anti-FLAG antibody. (C) siRNA-treated AP-1 KS cells were seeded on coverslips, treated with 500 nM rapamycin for 10 min and 
processed for fluorescence confocal microscopy. Recombinant γ-FKBP was specifically detected using an antibody targeting a 
recombinant epitope present in the neuronal splice variant of α-adaptin, Mitotrap was labeled with an anti-FLAG antibody. (D) 
Crude isolation of mitochondria from AP-1 KS cells. Confluent 100 mm dishes containing AP-1 KS cells were treated with DMSO 
or 500 nM rapamycin for 10 min, homogenized, and fractions of mitochondria, cytosol and membranes were collected. Fractions 
were probed with antibodies targeting membranes (vti1a, LAMP1), cytosol (GAPDH and PGK-1/2), mitochondria (Mitotrap, 
MTCO2, COX IV) and CCV machinery components (γ-FKBP of AP-1, α-adaptin of AP-2, CHC17). Scale bar: 10 µm.                  
 
Figure 3.15 A shows a typical lysate harvested from clone 9 of our generated AP-1 KS HeLa cell 
line. As shown by immunoblotting using an anti-FLAG antibody, only AP-1 knocksideways cells showed 
expression of recombinant Mitotrap (Figure 3.15 A, lanes 3-4). Since only the recombinant, functional 
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and siRNA-resistant AP-1 subunit (γ-adaptin) should take over, knocksideways requires the preceding 
depletion of the endogenous counterpart of the prey. In parental HeLa cells, we typically observed KD 
efficiencies of > 85% for endogenous γ (Figure 3.15 A, lanes 1-2). AP-1 KS cells, which show a higher 
recombinant γ-FKBP expression, are, as expected, not affected by RNAi with regard to the recombinant 
construct. Surprisingly, AP-1 KS cells showed a considerably lower expression of endogenous γ-adaptin 
than their parental cell line. This observation is most likely explained by the competition between 
endogenous and the recombinant subunit. Unbound free γ-adaptin is rapidly degraded, and hence, since 
there is excess of the recombinant subunit, it is preferentially assembled into the functional 
heterotetrameric adaptor complex compared to the endogenous one (Figure 3.15 A, lanes 1 and 3). In 
both the parental and stable cell line, there is no change in the expression of other trafficking components, 
such as of clathrin (CHC17) or α-adaptin (AP-2), due to silencing of AP-1. 
Since we decided to use rapamycin rather than the rapalog AP21967 to heterodimerize FKBP- and 
FRB-fusion proteins, we first checked whether addition of rapamycin influences overall mitochondrial 
morphology. The reason for applying rapamycin rather than the synthetic heterodimerizer was that the 
latter needs to be applied at much higher concentrations to get comparable heterodimerization 
phenotypes, as previously already reported for getting a robust knocksideways of prey proteins (Robinson 
and Hirst, 2013). In general, we did not see striking differences between DMSO and rapamycin-treated 
cells, as judged by stainings of the mitochondrial marker MTCO2 and Mitotrap (Figure 3.15 B). In 
contrast, recombinant FKBP-tagged AP-1 was almost completely rerouted to mitochondria after 10 min 
of rapamycin addition (Fig. 3.15 C), consistent with previous reports illustrating the principle of AP-1 KS 
(Hirst et al., 2012a; Robinson et al., 2010). 
Since rapamycin interferes with mTOR signaling, we were wondering to which magnitude the 
mTOR pathway is affected in our KS system. It would be a drawback of the KS technique if an observed 
phenotype would be a result of both mitochondrial prey sequestration and impaired mTOR downstream 
pathways. To check the extent of mTOR inhibition in our AP-1 KS cell line, we treated parental HeLa and 
AP-1 KS cells with rapamycin for up to 75 min, harvested the cells and immunoblotted against the 
mTORC1 downstream target ribosomal protein S6 (Fig. S7 A). As expected from previous studies, 
parental HeLa cells quickly responded to rapamycin treatment after 30 min of incubation and had almost 
undetectable levels of Phospho-S6 (Ser235/236) at 75 min. Surprisingly, our AP-1 KS cells did not show 
that a significant reduction in Phospho-S6 (Ser235/236) levels after 75 min. This thus suggests that the AP-
1 KS cell line is partially resistant to rapamycin administration, as judged by reduced mTOR inhibition. The 
reason for the decreased susceptibility might be explained by the fact that apart from γ-FKBP also 
endogenous FKBP12 is trapped on mitochondria, thereby not only knocking sideways AP-1, but also 'the 
mTORC1 pathway' to a certain extent. The same statement might be the case for a Mitotrap-only-
expressing cell line. Unfortunately, due to the lack of working antibodies (Fig. S7 B-D), we could not 
prove our hypothesis of mitochondrial FKBP12 sequestration. There was no specific signal present for any 
antibodies. Additionally, we also do not know whether the FKBP subunit present in γ-FKBP can 
heterodimerize with the FRB domain of mTOR1 to inhibit downstream effectors. However, our data 
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suggest that the mTOR pathway is only partially affected upon rapamycin administration within the 
assessed time of 75 min.  
To biochemically demonstrate rapamycin-triggered mitochondrial relocalization of FKBP-modified 
AP-1, subcellular fractionation was performed to enrich mitochondria, cytosol and membranes. While 
recombinant AP-1 was substantially rerouted to the mitochondrial fraction with concomitant loss from 
the cytosolic and membrane fraction in rapamycin-treated cells (Fig. 3.15 D), other coats or coat 
components (AP-2, CHC17) did not follow AP-1 onto mitochondria. The residual and minor levels of γ-
FKBP in the cytosol or on membranes indicate that either mitochondrial trapping was not as complete as 
the immunofluorescence suggested, preparation by homogenization might have caused AP-1 to be 
disconnected from membranes, or that a subpopulation of AP-1 has a longer residence time (longer koff) 
on membranes, respectively. However, the biochemical readout obtained by mitochondria isolation 
reflects what we have observed by immunofluorescence, i.e. sequestration of AP-1 onto mitochondria 
upon rapamycin addition.  
 
3.6.2 Retrograde Transport of MPRs Is Impaired by AP-1 Knocksideways 
Having established the basis for rapid AP-1 inactivation, we now combined it with our nanobody assay to 
study its involvement in retrograde transport. To this end, we set out to establish a triple stable cell line 
expressing the knocksideways components (γ-FKBP and Mitotrap) and either EGFP-CIMPR or EGFP-
CDMPR, respectively. Cell lines were generated by retroviral transduction of the described AP-1 KS cell 
line (Fig. 3.15) with the corresponding MPR reporters, followed by blasticidin selection and FACS. Since 
reporter-transduced AP-1 KS cell lines were derived from our characterized clone 9, we did not see any 
changes in fusion protein expression (γ-FKBP, Mitotrap) or endogenous markers (CHC17, AP-2), apart 
from that we have additional expression of either EGFP-CIMPR or EGFP-CDMPR (Fig. 3.16 A and C). 
To confirm the functionality of our AP-1 KS cell lines, we looked at the steady-state distribution of 
the recombinant MPR reporters after AP-1 inactivation. To do so, we silenced endogenous γ-adaptin, 
treated cells for 1 h with rapamycin, and proceeded with immunofluorescence. We detected a higher 
ratio of peripheral to juxtanuclear steady-state localization of both EGFP-modified reporters (Fig. 3.16 
B and D). This observation is in agreement with previous reports after knockouts (Medigeshi and Schu, 
2003; Meyer et al., 2000), after knockdowns (Robinson et al., 2010), after drug-mediated inhibition 
(Stahlschmidt et al., 2014), or after knocksideways (Robinson et al., 2010). Since we considered here total 
protein (Fig. 3.16 B and D), the mislocalization phenotype is less pronounced than in the anti-CIMPR 
antibody uptake experiment (Robinson et al., 2010), though. 
Rather than doing antibody uptake experiments to look at peripherally clustered and accumulated 
CIMPR in AP-1-inactivated cells by immunofluorescence, we sought to use VHHGFP-2xTS in combination 
with a sulfation assay to look at the contribution of AP-1 in retrograde transport. For this purpose, AP-1 
KS cells stably expressing EGFP reporters were pulsed with radiolabeled sulfate in the presence of 
VHHGFP-2xTS and rapamycin for up to 75 min, harvested and analyzed by autoradiography (Fig 3.17 A-
D).  
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Figure 3.16: AP-1 knocksideways cells stably expressing EGFP-tagged MPR reporters. (A) and (C) Lysates 
from AP-1 KS cells stably expressing EGFP-CIMPR or EGFP-CDMPR were prepared and probed against AP-1 (γ-adaptin), Mitotrap 
(anti-FLAG), EGFP-CIMPR or EGFP-CDMPR (anti-GFP), AP-2 (α-adaptin) and clathrin (CHC17). Equal amounts of proteins were 
loaded. (B) and (D) siRNA-treated AP-1 KS cells stably expressing EGFP-CIMPR or EGFP-CDMPR were seeded on coverslips, 
treated with 500 nM rapamycin for 1 h and processed for fluorescence confocal microscopy. Recombinant γ-FKBP was specifically 
detected using an antibody targeting a recombinant epitope present in the neuronal splice variant of α-adaptin, Mitotrap was 
labeled with an anti-FLAG antibody. Scale bar: 10  µm.                  
 
For both MPRs, we observed a delay in sulfation in rapamycin-treated (AP-1-inactivated) cells. At 
75 min, for instance, the level of sulfation is reduced by a third when compared to control cells. While the 
degree of sulfation between rapamycin-treated and -untreated cells differed, we did not see apparent 
alterations in nanobody uptake over the measured time (Fig 3.17 A-D). These results suggest AP-1 to 
be partially involved in retrograde transport from endosomes to the TGN.  
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Figure 3.17: Cell surface-to-TGN transport kinetics of MPRs in AP-1 knocksideways cells. (A) and (C) AP-1 
KS cells stably expressing either EGFP-CIMPR (A) or EGFP-CDMPR (C) were starved in sulfate-free medium for 1 h at 37°C and 
7.5% CO2, and then pulse-labeled with sulfate-free medium reconstituted with 0.5 mCi/mL [35S]sulfate supplemented with 2 µg/mL 
of VHHGFP-2xTS for up to 75 min. Rapamycin was used at a concentration of 500 nM during the pulse. Postnuclear supernatants 
were collected and incubated with Nickel beads to affinity-isolate sulfated nanobody. A fraction of the postnuclear supernatant was 
saved as reference for the total amount of cell-associated VHHGFP-2xTS or as loading control. Proteins were separated using gel 
electrophoresis and prepared for autoradiography. Cell-associated VHHGFP-2xTS nanobody was detected using an anti-His6 
antibody. (B) and (D) Quantification of retrograde transport kinetics. Quantification of three independent experiments is shown 
(average ± SD). Signal intensities of each time point is expressed as the percentage of the signal intensity after 75 min. Black and 
white squares belong to kinetics of sulfation, grey triangles correspond to kinetics of cellular uptake. Data points of sulfation 
kinetics between DMSO and rapamycin were at least p < 0.05 statistical significant.      
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3.7 Alternative Retrograde Transport Pathways to the TGN  
 
The only partial reduction of sulfated VHHGFP-2xTS nanobody in knocksideways cells suggests that AP-1-
independent retrograde transport routes for MPRs from endosomes coexist. Indeed, evidence for 
alternative sorting machineries operating from early, recycling or late endosomes to deliver cargo back to 
the TGN have been reported (see also introduction), among them retromer (Arighi et al., 2004; 
Bonifacino and Hurley, 2008; Carlton et al., 2004; Carlton et al., 2005; Hierro et al., 2007; Seaman, 2004), 
epsinR/clathrin (Saint-Pol et al., 2004) and Rab9/TIP47 (Carroll et al., 2001; Diaz and Pfeffer, 1998; Diaz et 
al., 1997; Riederer et al., 1994). It is thus likely that the concerted action of these trafficking machineries, 
and not of AP-1 alone only, facilitates retrograde transport to the TGN. This hypothesis is supported by 
the notion of MPRs to have a multitude of diverse cytosolic sorting determinants that might permit TGN 
retrieval from any level of the endocytic pathway by diverse machineries. 
To examine to which extent transport of MPRs is dependent on such alternative pathways, we 
sought to individually interfere with them. Ideally, knocksideways of these machinery components would 
be the best choice for specific and rapid interference. Since establishing a knocksideways system for every 
machinery component is a cumbersome procedure and would go beyond the scope of our topic, we 
decided to target individual machinery coat components by RNAi-mediated knockdown. 
To this end, we set out to assay retrograde transport of MPRs in Vps26 (retromer)-, TIP47-, and 
Rab9-depleted HeLa cells using VHHGFP-2xTS. We did not consider to include epsinR in our studies since 
Ludger Johannes and colleagues (Saint-Pol et al., 2004) have previously demonstrated that this monomeric 
adaptor is not only involved in retrograde transport of Shiga toxin and TGN46, but also of CIMPR. 
 
3.7.1 Interference with Alternative Retrograde Transport Pathways 
 
RNAi-Mediated Depletion of Alternative Retrograde Transport Components 
To assess the knockdown efficiencies of Vps26-, Rab9- and TIP47-depleted cells, we transiently reverse-
transfected HeLa cells with specific and well-described siRNA duplexes (Bulankina et al., 2009; Ganley et 
al., 2004; Hirst et al., 2005; Hirst et al., 2003; Popoff et al., 2009; Popoff et al., 2007a; Reddy et al., 2006). 
After a period of 96 h, cells were harvested and immunoprobed against various markers. Since we were 
also curious about readouts of an AP-1 knockdown, we also included AP-1-depleted cells in our studies. 
Apart from TIP47, we reached robust depletion of Vps26, Rab9 and AP-1 with knockdown efficiencies 
greater than 90% (Fig. 3.18 A and B). 
As expected for a multimeric protein coat such as AP-1 and retromer complex, we observed 
concomitant depletion of other coat complex subunits. While siRNA-mediated depletion of  µ1A-adaptin 
resulted in the concomitant and partial loss of γ-adaptin, Vps26-depleted cells showed a slight reduction in 
Vps35 levels. The sorting nexins 1 and 2 (SNX1 and SNX2), conversely, were not significantly affected. 
This is in agreement with previous reports suggesting the pentameric retromer complex to be composed 
of an independent dimeric (with SNX1 or SNX2) and trimeric (Vps26-Vps29-Vps35) subcomplex (Fuse et 
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al., 2015; Rojas et al., 2007a; Rojas et al., 2008). As expected, depletion of neither Rab9 nor TIP47 
affected the stability of the other markers (Fig. 3.18 A and B). 
 
 
Figure 3.18: Knockdown of alternative transport pathways. (A) HeLa cells were reverse-transfected with the 
indicated siRNAs and harvested after 96 h. Immunoblots were probed with markers against µ1A-adaptin, γ-adaptin (both AP-1), 
Vps26, Vps35, SNX1, SNX2 (all retromer complex), TIP47, Rab9 and clathrin. Actin was used as reference. (B) Quantification of 
knockdown efficiencies. Quantification of three independent experiments is shown (average ± SD). Signal intensities of each 
knockdown is expressed as the percentage of the control.  
     
RNAi-Mediated Inhibition of the Retromer Complex Pathway 
We next wanted to see how retrograde transport of MPRs is affected in cells depleted of Vps26, TIP47, 
Rab9 and µ1A. We decided to use EGFP-CDMPR as our reporter in this part of the study since it 
represents, unlike EGFP-CIMPR, the full-length receptor version. In order to study retrograde cell 
surface-to-TGN transport of EGFP-CDMPR, we reverse-transfected stable cells with siRNAs for 96 h and 
performed a sulfation assay as described beforehand. 
We observed a significant reduction of sulfation of VHHGFP-2xTS riding piggyback with the 
recombinant receptor to the TGN in Vps26-depleted cells (Fig. 3.19 A and B). After 75 min of labeling, 
we could observe a ~ 50% reduction in sulfation, while nanobody uptake into cells was not altered 
significantly. It has been previously reported that retromer is acting as one of the prime machineries in 
delivering the empty hydrolase receptor from an endosomal compartment to the TGN. However, all 
what we know about its function in CIMPR retrieval is based on protein-protein interaction studies and 
immunofluorescence data. Our nanobody-based approach allowed us to investigate retrograde traffic 
from endosomes in a different manner. Instead of looking at steady-state reporter redistribution in fixed 
cells, we could measure transport kinetics to the compartment of labeling. However, as a drawback, the 
endosomal transit stations en route to the TGN cannot be deciphered directly with any previous 
knowledge. 
Concerning the retromer complex, literature is inconsistent on which endosomal compartment 
(early or late) it assembles. Electron microscopy studies have demonstrated the retromer complex to 
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assemble on tubular elements of tubular-vacuolar structures reminiscent of early endosomes. In addition 
to that, retromer complex colocalizes with EEA1 and Tf, markers characteristic to early endosomes. 
Moreover, there are also a vast number of reports showing the complex to functionally cooperate with 
clathrin in sequential staging during carrier formation (Johannes and Wunder, 2011; Popoff et al., 2009; 
Popoff et al., 2007a). Clathrin, so far, has been shown to localize only to early, but not late endosomes. 
Conversely, retromer complex is membrane-recruited by Rab7, a GTPase typically found on late 
endosomes (Rojas et al., 2008; Seaman, 2004; Seaman et al., 2009). Although still elusive, it might be that 
this controversy is due to the generally accepted notion that retrograde sorting is a progressive process 
that is part of endosomal maturation.  
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Figure 3.19: Cell surface-to-TGN transport kinetics of EGFP-CDMPR in retromer complex-, TIP47-, 
Rab9- and AP-1-depleted HeLa cells. (A, C, E, G) HeLa cells stably expressing EGFP-CDMPR were RNAi-mediated 
silenced with specific duplexes against Vps26 (A), TIP47 (C), Rab9 (E) or µ1A-adaptin (G). After 96 h of knockdown, cells were 
starved in sulfate-free medium for 1 h at 37°C and 7.5% CO2, and then pulse-labeled with sulfate-free medium reconstituted with 
0.5 mCi/mL [35S]sulfate supplemented with 2 µg/mL of VHHGFP-2xTS for up to 75 min. Postnuclear supernatants were collected 
and incubated with Nickel beads to affinity-isolate sulfated nanobody. A fraction of the postnuclear supernatant was saved as 
reference for the total amount of cell-associated VHHGFP-2xTS or as loading control. Proteins were separated using gel 
electrophoresis and prepared for autoradiography. Cell-associated VHHGFP-2xTS nanobody was detected using an anti-His6 
antibody. (B, D, F, H) Quantification of retrograde transport kinetics. Quantification of three independent experiments is shown 
(average ± SD). Signal intensities of each time point is expressed as the percentage of the signal intensity after 75 min. Black and 
white squares belong to kinetics of sulfation, grey triangles correspond to kinetics of cellular uptake. Data points of sulfation 
kinetics between control and target KD were at least p < 0.05 statistical significant.      
     
RNAi-Mediated Inhibition of the Rab9/TIP47 Pathway 
While the localization of retromer complex based on previous reports is not fully conclusive, TIP47, on 
the contrary, has been described to operate from late endosomes, exclusively (Diaz and Pfeffer, 1998; 
Diaz et al., 1997; Lombardi et al., 1993). To examine the role of TIP47 in MPR sorting from late 
endosomes, we performed a sulfation assay in TIP47-depleted cells. To our surprise, we did not see any 
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difference in the rate of sulfation or nanobody uptake over 75 min between control- and TIP47-depleted 
cells (Fig. 3.19 C and D). The reason for the absence of an effect on transport could be either due to 
the incomplete knockdown (Fig. 3.18 A and B) where a small pool of the cargo adaptor (~ 35%) is still 
able to perform its job, or because TIP47 is not involved in MPR retrieval from late endosomes. Given the 
fact that the applied siRNA has been described previously with similar depletion efficiencies, but observed 
an effect on TIP47-mediated processes, we can conclude that the residual levels of TIP47 at least are not 
sufficient to perform their normal task. 
In addition, we initially also performed experiments with siRNAs as suggested by Pfeffer and 
colleagues (Ganley et al., 2004). However, knockdown efficiency was not strikingly better using their 
described duplexes. Albeit unsuccessful, we even tried to improve our results with anti-TIP47 antibodies 
raised and kindly provided by Susan Pfeffer, but with no success. Another explanation for the missing 
effect on MPR sorting might be EGFP-CDMPR. Though functionally identical to CIMPR, CDMPR has been 
previously shown to have subtle differences during segregation into endosomal sorting elements for TGN 
delivery (Klumperman et al., 1993), with CDMPR to segregate earlier and more rapidly. This would 
propose that CDMPR would escape more preferentially from early rather than from late endosomes 
during maturation. However, this is rather unlikely since TIP47 has been shown to interact with both 
hydrolase receptors with high-fidelity in vitro and in vivo (Diaz and Pfeffer, 1998). As mentioned in the 
introduction, TIP47 has been recently described more prominently as a lipid droplet protein that is 
required for lipid droplet biosynthesis (Bulankina et al., 2009; Wolins et al., 2001). Further investigations 
from our side are required to figure out whether TIP47 acts as MPR-specific cargo adaptor. 
Depletion of Rab9, that is acting upstream of TIP47, showed a partial reduction of ~ 30% in 
retrograde transport of EGFP-CDMPR to the compartment of labeling (Fig. 3.19 E and F). This 
observation is in agreement with former studies indicating CIMPR to redistribute to peripheral 
compartments like for AP-1 and retromer complex depletion (Barbero et al., 2002; Ganley et al., 2004; 
Kucera et al., 2016b; Progida et al., 2010; Progida et al., 2012). However, it has to be mentioned that Rab9 
acts as platform for many downstream effectors (Kucera et al., 2016a; Stenmark and Olkkonen, 2001; 
Zhen and Stenmark, 2015). It is thus very plausible that MPR traffic is likely affected not as a direct 
consequence of Rab9 depletion, but rather due to a misbalance of endosome homeostasis and 
dysregualtion of endosome maturation.    
 
RNAi-Mediated Inhibition of the AP-1 Pathway 
For the sake of completeness, we also performed the sulfation assay experiment in cells silenced for AP-1. 
Surprisingly and unexpectedly, the levels of sulfated VHHGFP-2xTS did not decline over 75 min in AP-1-
depleted cells, but were strongly elevated on the contrary (Fig. 3.19 G and H). This readout suggested 
AP-1 not to be not involved in retrograde transport to the TGN and is in disagreement with reported 
immunofluorescence stainings showing MPRs to accumulate in peripheral compartments in antibody 
uptake experiments (Meyer et al., 2000; Robinson et al., 2010). The experiment (Fig. 3.19 G and H) not 
only shows that sulfation starts earlier in AP-1-depleted cells, but also that it seems to head towards 
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steady-state soon after 75 min. The observation and phenotype of 'hypersulfation' under certain 
experimental conditions is not a new discovery and will be addressed in detail in the discussion. 
Concerning our AP-1 KD phenotype, explanations for the observed hypersulfation of VHHGFP-2xTS 
in AP-1 KD cells may be due to either more MPR being faster transported to the TGN, more efficient 
sulfation in the TGN, accumulation in the TGN or mislocalization of the sulfation machinery to post-Golgi 
compartments. 
Faster kinetic transport to the TGN is rather unlikely since AP-1 is thought to mediate retrograde 
transport and not prevent receptor recycling to the cell surface. Moreover, imaging data suggest trapping 
of MPRs in peripheral EEA1-positive endosomes (Meyer et al., 2000; Robinson et al., 2010), not 
accelerated transport to the TGN. We also did not report striking differences in nanobody uptake 
between control and AP-1-depleted cells. In general, we do not think that activity of TPST1 and TPST2 is 
increased by knocking down AP-1. Actually, it would be rather plausible when AP-1 depletion would 
cause reduced TPST activity since a knockdown would rather induce a misbalance than a balance in 
conferring efficient tyrosine sulfation. 
Another possibility responsible for hypersulfation is the missorting of TPSTs and PAPS transporters 
to peripheral compartments, thereby making sulfation possible earlier and multicompartmentalized than 
only TGN-specific. We indeed reported that sulfation occurred already after 15 min in AP-1-depleted 
cells, while their control counterparts showed initial sulfation at similar levels after 30 min. The leakage of 
the sulfation machinery to post-Golgi membranes rather than only localization to the TGN would be in 
line with more efficient sulfation of cycling MPRs due to higher dwelling times in compartments. It would 
also explain why steady-state kinetics of sulfation are reached faster. To test this hypothesis, we 
generated HeLa cell lines stably expressing TPST1-EGFP or TPST2-EGFP and checked for their post-Golgi 
localization after knocking down AP-1 by RNAi (Fig. S8 A-B). We did not see any difference between 
control and AP-1-silenced cells when we costained with the endosomal marker EEA1, suggesting no effect 
on TPST localization upon AP-1 knockdown. We did not invest any attempts in quantifying colocalization 
between EEA1 and TPSTs since no difference could be detected by eye. 
We also transiently overexpressed TPST1-EGFP or TPST2-EGFP in an AP-1 KO HeLa cell line, 
however, we did not observe any effect here either (Fig. S8 C-D). Which extent of sulfation machinery 
mislocalization would be required to cause the observed hypersulfation is not known. It could be just a 
little fraction that cannot be detected by optical means. 
Furthermore, what is the exact nature and identity of the perinuclear compartment? Our opinion is 
that it primarily reflects Golgi/TGN, however, at the same time it is also of our awareness that a number 
of overexpressed Rab proteins (Rab5, Rab6, Rab7, Rab9, etc.) localize to the same perinuclear region. It 
thus might be that some of the perinuclear structures represent post-Golgi compartments with 
endosomal identity. Ultrastructural resolution could give us more precise localizations of TPSTs in 
control- and AP-1-depleted cells in this regard. These are experimental attempts we might be addressing 
in the near future to nail down TPST localization in AP-1-depleted cells more precisely. 
Testing whether increased sulfation is a consequence of MPR-nanobody accumulation in the TGN 
would make sense. Apart from AP-1 to operate in the retrograde route, there is also a considerable body 
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of evidence for its involvement in anterograde TGN-to-endosome transport in polarized and non-
polarized cells (Deborde et al., 2008; Doray et al., 2002; Folsch et al., 1999; Gonzalez and Rodriguez-
Boulan, 2009; Gravotta et al., 2012b; Mardones et al., 2007; Robinson, 2004). We did not find a suitable 
way how to convincingly show that MPR-nanobody complexes are stuck in the TGN.  
But, why is the knocksideways readout different to the knockdown phenotype? Schu and colleagues 
(Meyer et al., 2000) have previously shown biochemical proof for AP-1-mediated retrograde transport 
apart from anti-CIMPR antibody uptake experiments. They have demonstrated that cell surface-
desialylated MPR got resialylated in control-, but to a lesser extent in µ1A-deficient fibroblast cells, 
indicating that retrograde transport to the TGN is severely impaired in these cells. Using an in vitro 
approach, Medigeshi and Schu (Medigeshi and Schu, 2003) also demonstrated that the competence of 
membranes from AP-1-deficient cells for endosome-to-TGN transport was strongly compromised. 
 
3.7.2 AP-1 Knockout Does Not Phenocopy AP-1 Knocksideways 
The controversial readout of nanobody hypersulfation in AP-1 knockdown cells made us curious to see 
whether our phenotype is a result of gradual rather than rapid protein loss. During the gradual elimination 
of a protein, it might be possible that cells adapt or accumulate the indirect consequences of 4 days (96 h) 
of protein loss. The observed readout and interpretation of the former would be compensation, of the 
latter secondary effects. 
To see whether also long-term depletion of AP-1 resulted in increased sulfation of VHHGFP-2xTS 
imported by MPR reporters, we set out to establish a HeLa cell line with a genetic deletion of AP-1 using 
the CRISPR/Cas9 technology. We decided to induce double-strand breaks in loci encoding the γ-adaptin 
subunit of AP-1. Genetic deletion of the γ-adaptin subunit also allows us to exclude potential siRNA off-
target effects originating from the µ1A duplexes. Then, we targeted µ1A for knockdowns, while γ-adaptin 
was inactivated in KS and KO experiments. To achieve genetic elimination of γ-adaptin, we transiently 
transfected our parental HeLa cell line with a commercial pool of three plasmids containing specific 
sgRNAs and NLS-tagged Cas9-2A-GFP. A pool of or single GFP-positive cells were collected using FACS 
and cultured to confluency. We continued with a pool of cells to avoid clonal variations. 
To verify the genetic deletion of γ-adaptin, we harvested HeLa and HeLa AP-1 KO cells and 
subjected cell lysates for immunoblot analysis (Fig. 3.20 B). We could report absence of γ-adaptin 
protein expression in HeLa AP-1 KO cells, confirming its genetic deletion. To prove that loss of γ-adaptin 
expression resulted in overall AP-1 complex instability, we probed our cell lysates also against β1-, µ1A- 
and σ1A-adaptin. We observed a strong reduction of µ1A and σ1A protein levels, β-adaptin was only 
partially affected. The reason for this is that the antibody targeting β-adaptin crossreacts with both β1 
(from AP-1) and β2 (from AP-2). Since there are estimated higher intracellular protein levels of β2 than 
for β1 (Hirst et al., 2012b), most of the β-adaptin is represented by the version from AP-2. Cellular levels 
of AP-2 and clathrin were not affected in the KO cell line. 
To examine whether loss of γ-adaptin did not only affect adaptor complex stability, but also AP-1-
mediated traffic, we transiently transfected γ-FKBP into AP-1 KO HeLa cells, followed by an anti-CIMPR 
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antibody uptake assay for 45 min (Fig. 3.20 C). As reported previously (Meyer et al., 2000), we found 
that the antibody failed to reach the perinuclear region over 45 min and that it clustered in peripheral 
endosomal spots. This observation is in agreement with the common consensus about the involvement of 
AP-1 in retrograde transport of CIMPR. Expression of recombinant γ-adaptin in the AP-1 KO cells could 
partially rescue the phenotype of CIMPR mislocalization (Fig. 3.20 C, see also Fig. S9 A-C). We could 
also show that two AP-1-dependent SNARE proteins vti1a and vti1b (Hirst et al., 2004; Hirst et al., 2003) 
were also affected in their steady-state localization in AP-1-deficient HeLa cells (Fig. S9 D-E). TGN46, 
on the contrary, was not affected in its steady-state localization in AP-1 KO cells (Fig. S9 F), in 
agreement with previously reported AP-1 KD readouts (Ishizaki et al., 2008). 
Having the proof for genetic and functional absence of AP-1 in HeLa cells, we can now test 
whether MPR-nanobody complexes are sulfated preferentially more in these AP-1 KO cells. To do so, 
EGFP-CDMPR was transiently transfected into HeLa and HeLa AP-1 KO cells, followed by a sulfation 
assay using VHHGFP-2xTS. After 60 min of labeling, we observed increased sulfation of VHHGFP-2xTS in 
cells lacking AP-1 (Fig. 3.20 D, lane 2). This phenotype is in agreement with our observations from AP-1 
KD cells (Fig. 3.19 G and H), showing that the lack of AP-1 expression causes increased levels of 
sulfated VHHGFP-2xTS.  
Since immunofluorescence readouts of CIMPR mislocalization were not phenocopied by our 
sulfation analysis experiments, we started to consider both of them critically. Could it be that the 
peripheral compartments in which internalized anti-CIMPR antibody accumulates does not solely 
represent early endosomes? The report by Schu and colleagues (Meyer et al., 2000) at least suggested a 
redistribution of MPRs to EEA1-positive compartments. However, not all of the MPR-positive peripheral 
and juxtanuclear punctates were also EEA1-positive. A considerable number of the observed peripheral 
structures were EEA1-negative (Meyer et al., 2000). They could represent TGN-derived or -scattered 
membranes as result of AP-1 deficiency. We can also express our uncertainty concerning AP-1 readouts 
by asking the other way around. Why do we observe increased sulfation at all when we can see 
internalized CIMPR to have severe problems to shuttle to the perinuclear region from EEA1-positive 
compartments? Why do we not monitor increased accumulation of internalized CIMPR in the perinuclear 
region by immunofluorescence when believing the kinetic sulfation readouts? We can only speculate why 
the readouts are inconclusive and look like this. An interesting observation we have made, however, was 
that we could detect sulfation of MPR-nanobody complexes to start earlier in AP-1 KD cells (Fig. 3.19 
G and H). Earlier onset could mean that sulfation might occur to some extent also in post-Golgi 
compartments like early endosomes. Following this notion, this would implicate that also proteins that 
usually do not cycle back to the TGN could be sulfated to a certain extent. 
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Figure 3.20: AP-1 knockdowns and knockouts can cause indirect effects. (A) HeLa cells stably expressing TfR-
EGFP were RNAi-mediated silenced with specific duplexes against µ1A-adaptin, Vps26, TIP47 and Rab9. After 96 h of knockdown, 
cells were starved in sulfate-free medium for 1 h at 37°C and 7.5% CO2, and then pulse-labeled with sulfate-free medium 
reconstituted with 0.5 mCi/mL [35S]sulfate supplemented with 2 µg/mL of VHHGFP-2xTS for 1 h. Postnuclear supernatants were 
collected and incubated with Nickel beads to affinity-isolate sulfated nanobody. A fraction of the postnuclear supernatant was 
saved as reference for the total amount of cell-associated VHHGFP-2xTS or as loading control. Proteins were separated using gel 
electrophoresis and prepared for autoradiography. Cell-associated VHHGFP-2xTS nanobody was detected using an anti-His6 
antibody. (B) Parental and AP-1 KO HeLa cells were lysed and probed against γ-, µ1A-, σ1A-, β1/2-adaptin, α-adaptin (AP-2) and 
CHC17. (C) AP-1 rescue with anti-CIMPR antibody uptake assay. AP-1 KO HeLa cells were transiently transfected with 
recombinant γ-FKBP for 24 h and incubated with a 1:5000 dilution of anti-CIMPR antibody for 45 min. Cells were then processed 
for fluorescence confocal microscopy. Recombinant γ-FKBP was specifically detected using an antibody targeting a recombinant 
epitope present in the neuronal splice variant of α-adaptin, internalized mouse anti-CIMPR was directly detected with a 
fluorochrome-tagged secondary antibody. (D-E) AP-1 KO HeLa cells were transiently transfected with either EGFP-CDMPR (D) 
or TfR-EGFP (E). After 24 h of overexpression, cells were starved in sulfate-free medium for 1 h at 37°C and 7.5% CO2, and then 
pulse-labeled with sulfate-free medium reconstituted with 0.5 mCi/mL [35S]sulfate supplemented with 2 µg/mL of VHHGFP-2xTS for 
1 h. Postnuclear supernatants were collected and incubated with Nickel beads to affinity-isolate sulfated nanobody. A fraction of 
the postnuclear supernatant was saved as reference for the total amount of cell-associated VHHGFP-2xTS or as loading control. 
Proteins were separated using gel electrophoresis and prepared for autoradiography. Cell-associated VHHGFP-2xTS nanobody was 
detected using an anti-His6 antibody. Scale bar: 10 µm.                  
 
Since TfR does not undergo retrograde transport to the TGN at substantial levels, we took 
advantage of cells stably expressing TfR-EGFP in combination with RNAi-mediated AP-1 knockdown. 
Indeed, recombinant TfR-nanobody complexes were moderately sulfated in AP-1-silenced cells (Fig. 
3.20 A), while under the same conditions they were not with the other knockdowns. We performed the 
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same experiment with transiently transfected AP-1 KO HeLa cells (Fig 3.20 E). Also here, we could 
observe sulfation of recombinant TfR-nanobody complexes. Although these results point towards 
sulfation to occur also in post-Golgi compartments, we do not know which fraction of nanobody-bound 
TfR reporter is sulfated. It might be a very tiny and negligible amount, only. As a matter of fact, we had to 
expose cassettes containing these samples much longer. We do not think that AP-1 depletion favors TfR 
to recycle to the TGN. But, previous reports have shown that depletion of AP-1 from endosomes can 
affect Tf recycling indirectly (Chamberland et al., 2016; D'Souza et al., 2014; Perrin et al., 2013). However, 
the main finding out of this experiment was that we observed a potentially dysregulated system upon AP-
1 depletion. Otherwise nanobody riding with TfR-EGFP would not have been sulfated. It thus might be 
that AP-1 sorting not only contributes to the correct targeting of a number of membrane proteins to 
their acceptor compartments, but perhaps also contributes to TGN/endosome homeostasis to certain 
degree. We will follow up on this topic in more detail in the discussion. 
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  4     Discussion 
 
 
4.1 A Versatile Nanobody-Based Toolkit 
 
In the present study, we have established the basis for a methodological approach to investigate 
retrograde transport of reporter proteins from the cell surface. The approach to track proteins from the 
cell surface to any intracellular compartment relies on binding of functionalized VHHGFP to recombinant 
EGFP-modified reporter proteins. Depending on the functionalization, we can use specific cell surface 
labeling to biochemically determine retrograde transport kinetics, to monitor endocytic uptake by 
fluorescence live cell imaging, or to ultrastructurally visualize retrograde transport compartments by 
electron microscopy. In particular, a nanobody featuring a consensus motif for tyrosine sulfation (e.g. 
VHHGFP-2xTS) allows us to assay whether a reporter reaches the TGN or not. We cannot only 
qualitatively examine whether a reporter is shuttled to the TGN by simply detecting sulfated nanobody, 
but we can also determine transport kinetics.  
Below, we would like to compare previously described strategies for TGN arrival, thereby 
highlighting the advantages and disadvantages of our approach to others. In addition to that, we will also 
discuss the other 'cargo trackers' (TEV-based VHHGFP, VHHGFP-mCherry, VHHGFP-APEX2), thereby also 
emphasizing how they can be powerfully used in a wide number of other applications.        
 
 
4.1.1 Sulfatable Nanobodies Are Superior to Other Approaches 
 
Radiolabel and Radiolabel-Free Sulfation-Based Approaches to Study TGN Arrival 
We are not the first to develop an experimental toolkit to biochemically study retrograde transport to 
the TGN. Over the last decades, approaches have been established that rely on in vitro or in vivo 
sulfation, reglycosylation or artificially introduced modifications at the cell surface to assess TGN arrival. 
Previously, Ludger Johannes, Sjur Olsnes, Kirsten Sandvig, Bo van Deurs and colleagues have 
independently developed sulfation site sequences that can be expressed in the context of recombinant 
cargo proteins or can be chemically coupled to them (Amessou et al., 2006; Johannes et al., 1997; Mallard 
et al., 1998; Rapak et al., 1997; Sandvig and van Deurs, 1994). In brief, they constructed recombinant 
fragments of ricin and Shiga toxin subunits that were modified with a sulfation site (Johannes et al., 1997; 
Mallard and Johannes, 2003; Rapak et al., 1997; Shiba et al., 2010; Utskarpen et al., 2006). Using these 
recombinant toxin subunits, they could show that the fragments were sulfated, revealing that they must 
have passed the TGN en route to the ER from where they reached the host cytoplasm. These studies 
paved the way for exploiting sulfation as PTM, not only to study TGN exit as part of the secretory 
pathway, but also to assess TGN arrival from the retrograde route. 
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Ludger Johannes and colleagues pioneered sulfation peptide chemistry approaches to cell surface-
label proteins or antibodies (Amessou et al., 2007; Amessou et al., 2006; Christiano et al., 2010; Saint-Pol 
et al., 2004). Concerning the latter, they coupled sulfation site-containing peptides to anti-GFP or anti-
TGN46 antibodies in order to study retrograde transport of recombinant GFP-CI-MPR or endogenous 
TGN46. In the study of Ludger Johannes and collaborators (Saint-Pol et al., 2004), such an approach 
showed epsinR to be partly involved in endosome-to-TGN transport of the above proteins. The anti-GFP 
antibody chemically modified with a sulfation site resembles our functionalized TS-tagged nanobodies. 
Using such an antibody-based approach to monitor retrograde traffic brings along many technical and 
experimental caveats.  
First, while our VHHGFP domain is only capable of binding GFP in a 1:1-stoichiometry, an anti-GFP 
antibody has the potential of binding more than one GFP epitope with its two paratopes. Such a setup is 
likely prone to cause crosslinking of GFP-CI-MPR reporters at the cell surface. Crosslinking of reporters 
might result in local aggregates, reduced mobility and altered endocytosis rates. The possibility and risk of 
cell surface crosslinking by antibodies is higher when the antibody is of polyclonal nature. Although 
Johannes and colleagues (Amessou et al., 2007; Amessou et al., 2006; Saint-Pol et al., 2004) used a 
commercial 'monoclonal' anti-GFP antibody to couple sulfation site-containing peptides, the antibody is 
actually a pool of two monoclonal antibodies (clone 7.1 and 13.1), thereby making it biclonal at the end. 
Second, modification of antibodies with sulfation peptides occurs in a random fashion. Crosslinking 
can occur in the variable regions that can cause the antibody to fail binding the GFP epitopes. Additionally, 
the random and uncontrolled modifications of the antibody might cause disruption of important 
intramolecular interactions, resulting in structural changes and increased instability. Also, the modified 
anti-GFP antibodies are quite heterogeneous, some might have none, one, two or more chemically 
crosslinked sulfation peptide tags (batch-to-batch variation). Whether all of these sulfation tags are 
functional and efficiently modified by endogenous TPSTs due to sterical hindrance remain in question. 
Third, detection of sulfated antibody proves difficult in autoradiography-based readouts since 
peptide modifications occur in both heavy and light chains. Separation via a reducing SDS-PAGE does not 
then result in a single sharp band, but rather in two dissimilarly strong sulfation signals corresponding to 
light or heavy chain, respectively (Amessou et al., 2007). Our functionalized nanobody in contrast is 
monovalent, has a specific tyrosine sulfation consensus sequence close to the C-terminus and can be 
separated as a single band. Since we bacterially express our nanobody fusions, we can achieve high 
amounts and yields in one single step. 
The other approach, conversely, requires commercially available antibody that has to be first 
chemically crosslinked with sulfation peptide sequences prior to use. Overall, both antibody- and 
nanobody-based approaches are powerful tools to study transport to the TGN, with a plus to the 
nanobody-based technique, however.  
A drawback, admittedly, which both approaches presumably have, is the low efficiency of tyrosine 
sulfation. We were surprised to realize that the steady-state of nanobody uptake and sulfation were not 
similar after 75 min of labeling (see for instance Fig. 3.14 or 3.17). Steady-state of sulfation was in most 
cases not yet reached after this time interval. The best explanation for this observation is that not every 
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nanobody passing through the TGN is completely sulfated during the first transit. Incorporating more 
than two sequences cannot avoid this phenomenon. Even though more tandem TS sequences would 
permit a stronger sulfation signal, it would also increase the risk that more retrieval rounds at the 
endosome-to-TGN interface are required to complete sulfation. Sulfation signal strength and reaching of 
steady-state of sulfation are thus standing in conflict with each other. We can circumvent or partially 
abolish this problem when we can identify a sulfation consensus sequence that is modified with a higher 
efficiency during the first transit than ours. One of our future attempts to improve the sulfation assay will 
thus include to screen and test additional tyrosine sulfation consensus sequences, this either by testing 
already described sequences or by simulating and finding the most suitable ones with the help of 
bioinformatics (Bundgaard et al., 1997; Kehoe and Bertozzi, 2000; Nedumpully-Govindan et al., 2014; 
Rosenquist and Nicholas, 1993). Incomplete sulfation, however, might be an inherent feature of 
endogenous secretory proteins (Bundgaard et al., 1997; Nedumpully-Govindan et al., 2014). This raises 
the issue that completed sulfation after one transit through the TGN lumen might be unlikely at all.   
 
A less elegant, but acceptable approach, also based on sulfation, to study retrograde transport of 
receptor proteins from the cell surface to the TGN has been described in the study of Pfeffer and 
colleagues (Sincock et al., 2003), and Kutsche and collaborators (van Rahden et al., 2012). Instead of using 
a cell surface label, the protein of interest can be directly tagged with a site conferring tyrosine sulfation. 
To study endosome-to-TGN transport in this manner, cells expressing TS-tagged reporters are first 
incubated in sulfate-free medium containing excess of chlorate to prevent sulfation of newly synthesized 
proteins. Chlorate is a reversible inhibitor of sulfation (Humphries and Silbert, 1988; Safaiyan et al., 1999) 
and competitively interferes with the formation of PAPS. The reporter is then chased to its steady-state 
localization, while new synthesis is blocked with the addition of cycloheximide. Reporter transport from 
endosomes to the TGN is then measured by incubating cells in the presence of radiolabeled sulfate and 
cycloheximide, after removal of chlorate. An approach in this setup has been used to monitor retrograde 
transport of a modified version of CDMPR (HMY-MPR46) containing an N-terminal cassette with a His6-, 
myc-, and TS-tag. Using this reporter, the authors proposed that the endosomal OCRL phosphatase (van 
Rahden et al., 2012) and TIP47 (Sincock et al., 2003) are involved in retrograde transport of MPRs. The 
disadvantage of their strategy is that one has to chemically block sulfation over several days by adding 
excess of chlorate. Blocking sulfation over a long time range causes natural proteoglycans and other 
proteins not to be sulfated anymore and might render them unfunctional as a consequence. Since the 
assay also makes use of cycloheximide to block de novo reporter synthesis, we probably also have to 
cope with indirect effects (cell stress, ribosome pausing, etc.) that might be finally reflected in the results. 
Another drawback of this assay is that we can hardly measure cell surface-to-TGN kinetics. After 
having substituted chlorate for radiolabeled sulfate, reporters momentarily residing in the Golgi lumen will 
be sulfated. Also reporter on the way to the TGN or prior to exit from endosomes will have earlier 
access to the sulfation machinery. In particular, when the assay is performed in combination with a 
knockdown with additional possible indirect and/or compensatory effects, the assay is stretched to its 
limits and solid interpretations of the obtained results are hard to be made. The advantage of this assay is 
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that TGN exit and arrival of a reporter-expressing cell line can be monitored without the need of any cell 
surface modifications (e.g. nanobodies). However, our nanobody approach is much more suitable to 
determine retrograde transport kinetics. It is not only free of any inhibitors like chlorate and cyclo-
heximide, but also circumvents adverse experimental setups. 
 
An alternative, radiolabel-free approach to study TGN arrival is by using anti-sulfotyrosine 
antibodies. The only existing antibody detecting sulfotyrosine as epitope independently of sequence 
context has been described in the publication of Moore and colleagues (Hoffhines et al., 2006). Protein 
arrival in the TGN could then by easily measured by detecting 'cold'-sulfated nanobody from a pull-down. 
Even though we tried to apply the anti-sulfotyrosine antibody (sulfo-1C-A2) on precipitates containing 
sulfated VHHGFP-2xTS nanobody, no antigen cross-reactivity could be monitored. Antibody detection of 
nanobodies would simplify all of our radioactive assays. We also plan to test natural and artificial peptide 
sequences that have previously been shown to crossreact with sulfo-1C-A2 antibody (Cha et al., 2009; 
Cimbro et al., 2014; Friedman et al., 2012; Hoffhines et al., 2006; Seko et al., 2015; Yang, 2009). The 
reason why the sulfotyrosines within our SAEDYEYPS-based peptide from the cholecystokinin precursor 
are not recognized is unknown.    
 
In addition to conventional biochemical approaches relying on radiolabeling, assays have been 
developed to monitor kinetics of sulfation using a fluorescence-based probe readout (Chen et al., 2013a; 
Zhou et al., 2014). Such probes are converted to fluorescence once they have become substrates for 
TPSTs. Fluorescence detection could then be taken as readout for TGN arrival. However, both of the 
cited publications have the huge drawback that probes are not yet directly applicable for the use in a cell 
culture system. Convertible probes attached to VHHGFP that turn fluorescent after reaction with TPSTs 
would manifest as ideal tool for radiolabel-free detection other than biochemical ones. 
 
A Desialylation-Resialylation-Based Approach to Study TGN Arrival 
An other approach to assess PM-to-TGN transport has been initially described by Duncan and Kornfeld 
(Duncan and Kornfeld, 1988). Instead of making use of the endogenous sulfation machinery, their assay 
relies on oligosaccharide processing of retrogradely transported cargo proteins. To do so, mature 
oligosaccharides units of cell surface receptors are desialylated so that they become substrates for 
sialyltransferase, a marker of the trans-Golgi/TGN. If the deglycosylated receptor then returns to this 
compartment, the oligosaccharides regain sialic acid. This approach and variants thereof have been widely 
used in the past (Draper et al., 1990; Goda and Pfeffer, 1988; Goda and Pfeffer, 1989; Jin et al., 1989; 
Prydz et al., 1990; Riederer et al., 1994), above all to study retrograde transport of MPRs. Indeed, this 
kind of assay has been used to test whether AP-1 is involved in MPR receptor return to the TGN by Schu 
and colleagues (Meyer et al., 2000). Our AP-1 KD phenotype based on a sulfation assay did not support 
the observations made by Schu and coworkers using a resialylation assay.  
As reported previously, since our AP-1 KD and KO readouts of increased sulfation might be 
indirect consequences specifically of sulfation machinery mislocalization, a sulfation-independent approach 
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would have been very useful, too. In order to quantitatively measure return to the TGN by still using our 
tools, one could try to apply a modified protocol derived from the study of Duncan and Kornfeld 
(Duncan and Kornfeld, 1988). Cells expressing EGFP reporters could be specifically cell surface-labeled 
with VHHGFP derivatives at 4°C or 37°C, and digested with neuraminidase to remove terminal sialic acid 
residues from mature glycans. Internalized desialylated EGFP reporters carrying VHHGFP derivatives in a 
piggyback mode can then be terminally resialylated when facing the lumen of trans-Golgi/TGN. To easily 
analyze compartment arrival from the retrograde route, the assay could make use of radiolabeled sialic 
acid. The total fraction of cell surface-to-TGN transported cargo can then be collected by affinity 
precipitation of the bound VHHGFP derivatives and analyzed by autoradiography. 
Even though Golgi PTM machineries are considered to 'remain' static and unaffected upon inter-
ferences (RNAi, knockout, inhibitors), what they probably will not do, it is of a big advantage to have 
more than just one detection strategy. If, for instance, readouts of two or even more approaches 
(sulfation and resialylation) are consistent with each other, then final conclusions of an experiment can be 
drawn more convincingly. If, however, they do not balance each other, then one or more PTM 
machineries are affected by the applied interferences, directly or indirectly. We are currently part of such 
an experimental readout discrepancy. On the one hand, we know from literature that in AP-1-deficient 
mouse fibroblasts retrograde transport of MPR is severely impaired, as judged by a resialylation approach 
(Meyer et al., 2000). On the other hand, conversely, we reported increased sulfation of recombinant 
CDMPR in AP-1-depleted (KD and KO) HeLa cells using sulfation as PTM. The biochemical readout based 
on sulfation would then rather favor AP-1 not be involved in retrograde transport. However, when we 
rapidly inactivate AP-1 using the knocksideways approach, we could not see any increase, but a partial 
decrease in sulfation, thus favoring AP-1 to be involved in endosome-to-TGN retrieval. 
The suggested resialylation approach in combination with nanobody as described above might be an 
alternative strategy to reconcile the observed AP-1 phenomenon.   
 
A Proteomics-Based Approach to Study TGN Arrival 
Proteomics has gained fundamental importance over the last decade, and therefore it is not surprising 
that attempts have been undertaken to analyze retrograde transport using the power of mass 
spectrometry. Ludger Johannes and collaborators (Shi et al., 2012a) have previously presented a SNAP-
tag-based proteomics approach to study cell surface-to-TGN transport of endogenous proteins. They 
created a TGN-localized trap composed of truncated GalT fused to GFP and a SNAP-tag. Cargo that has 
been chemically cell surface-labeled with benzylguanine (BG) can react and be covalently bonded to the 
recombinant resident trap (GalT-GFP-SNAP) if retrograde transport to the TGN has occurred. 
Applying this approach, the authors (Shi et al., 2012a) could present a list of 20 proteins, including 
GPCRs, transporters, kinases and more, that undergo retrograde traffic to the TGN. Among the hits, TfR, 
the first proposed endogenous retrograde cargo protein (Snider and Rogers, 1985), was detected, too. 
This observation is in contrast to the general notion that recycling receptors, such as TfR or ASGPR, only 
pass early endosomes before being recycled to the cell surface. 
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By using our versatile nanobody approach, we could not detect significant amounts of sulfated 
nanobody riding along with recombinant TfR-EGFP, or at least vanishingly minute traces relative to other 
retrograde transport cargoes. In contrast to the publication of Johannes and collaborators (Shi et al., 
2012a) whose results are based on the overexpression of a recombinant TGN trap, we made use of the 
endogenous sulfation machinery to detect retrograde cargo. Overexpression systems might have the risk 
that they are not as tight as their endogenous counterparts. Although GalT is generally considered a 
bonafide TGN-resident protein because of its function, GalT is naturally also moving out to the cell 
surface (Hathaway et al., 2003). Johannes and collaborators (Shi et al., 2012a) used a well-established 
truncated version of GalT, composed of its cytosolic tail, transmembrane domain and stem region, an 
arrangement that is mimicking full-length GalT regarding traffic. The recombinant GalT-GFP-SNAP thus 
likely contains the trafficking determinants to distribute to the post-Golgi environment. Thus, there is a 
high risk that the covalent reaction between the BG-modified cell surface cargo and SNAP-tag-based trap 
may also occur somewhere at the TGN-to-PM interface, and not exclusively in the TGN. Using HeLa cells 
stably expressing GalT-EGFP, we could detect significant uptake of VHHGFP derivatives, indicating that this 
protein transiently appears at the cell surface (Fig. S10). Even more, we could reveal that nanobody 
bound to GalT-EGFP is sulfated, suggesting that GalT might be actively cycling for- and backwards at the 
TGN-to-PM interface. Since mass spectrometry is one of the most sensitive approaches, it is likely that 
SNAP-tagged crosslinked TfR is mainly reflected by peripheral non-Golgi GalT distribution. 
Surprisingly and interestingly, the SNAP-tag-based proteomics approach (Shi et al., 2012a) failed to 
detect MPRs and TGN46, thereby indicating that the mass spectrometry methodology can also pass over 
relevant candidates that are amenable with classical biochemical approaches. Moreover, there was no 
follow-up publication so far for the other detected retrograde cargo proteins (Shi et al., 2012a).  
Nonetheless, the idea of specific cell surface labeling (or modification) and trapping represents a 
strategy to identify novel cargo proteins traversing respective compartments of interest. A similar SNAP-
tag-based approach to investigate retrograde transport to the ER has been presented by the group of Ari 
Helenius (Geiger et al., 2012).       
 
Towards a Novel Approach to Study TGN Arrival 
Inspired by ideas derived from publications originating from the lab of Ludger Johannes and Ari Helenius 
(Geiger et al., 2012; Shi et al., 2012a), we thought that we could establish an approach ourselves for 
measuring PM-to-TGN transport based on an artificial TGN-restricted modification that is free of any 
radiolabel. To this end, we designed a fusion construct composed of shortened GalT (shGalT) fused to 
mCherry and wild-type BirA, referred to as shGalT-mCherry-BirA-3xFLAG. As reported previously in 
the lab of Barry Shur (Hathaway et al., 2003), two alternate forms of GalT exist that only differ in the 
length of their cytoplasmic domains. They demonstrated that the long cytoplasmic and transmembrane 
domains of GalT is capable of targeting a reporter protein to the cell surface, whereas the short 
cytoplasmic and transmembrane domains (shGalT) do not have this property, but remain stuck in the 
Golgi instead. This is the reason why we introduced shGalT in our TGN-localized modifier, and not GalT 
that contains sorting determinants for exocytic traffic. While mCherry was incorporated for fluorescence 
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visualization and cell sorting, BirA confers the specific transfer of activated D-biotin onto a BAP (AviTag) 
epitope. Reporters that bring along a BAP motif will then be specifically modified by TGN-hooked BirA. 
To channel BAP-containing proteins into the retrograde pathway, we followed the versatility in domain 
organization of our nanobody fusions. Instead of bacterially modifying them with D-biotin during induction, 
we grew bacteria under biotin-reduced conditions to avoid functionalization of the BAP epitope. Purified 
nanobody under these conditions is then mainly biotin-free and can be used for piggyback transport 
conveyed by EGFP reporters. Kinetics of de novo biotinylation of internalized nanobody into BirA-
containing compartments can be taken as readout for TGN arrival. Since radiolabeling with sulfate takes 
advantage of the endogenous sulfation apparatus rather than of a recombinant artificial machinery, we 
gave the sulfation approach priority. However, the basis for such a biotinylation approach exists, including 
the above-mentioned BirA-modifier HeLa cell line and several nanobodies devoid of biotinylation. 
Using non-biotinylated VHHGFP-2xTS and EGFP reporters in combination with a BirA-modifier 
HeLa cell line, we will be able to directly and simultaneously compare the increase in sulfation and 
biotinylation over time. Biotinylation might also overcome the problem of inefficient sulfation that we 
have observed, so that in best case, steady-state of nanobody uptake and biotinylation are not so strongly 
shifted from each other as it is the case for sulfation. 
Taken together, the described approach would offer us an alternative, radiolabel-free method to 
study retrograde transport from the cell surface to the TGN. Other TGN-hooked BirA fusions need to 
be established in case of leakiness of shGalT-based fusions. 
 
4.1.2 TEV Site-Modified Nanobodies to Study Endocytosis and Recycling 
We have not only established an approach to monitor uptake kinetics into steady-state, but also to 
simultaneously investigate recycling of receptor proteins to the plasma membrane. To do so, we have 
generated nanobodies with a TEV cleavage site after the VHHGFP domain. Once internalized TEV site-
modified functionalized nanobodies have appeared at the cell surface, they can be specifically shaved using 
TEV protease. By using such a TEV site-modified nanobody (e.g. VHHGFP-TEV-control), we could confirm 
the rates of endocytosis and recycling of the well-studied TfR. In addition to that, we could study 
endocytosis and recycling of CDMPR. 
To be mentioned is that TEV cleavage site-containing nanobodies allow us to investigate uptake and 
recycling kinetics of 'difficult-to-study' receptor proteins, assuming that nanobody binding does not affect 
receptor properties. They include proteins that either have no ligands, less well-established ligands or 
antibodies failing to detect their extracellular domain for uptake assays. Among these are for instance 
recycling receptors such as LDLR or H1 with no suitable ligands (for recycling), stimuli-triggered 
internalized cargo proteins such as GPCRs or GLUT4, or other proteins with no detailed information 
about their final fate after endocytosis from the cell surface. In all such cases, a nanobody with a TEV site 
can help us to narrow down the endocytic and recycling fate of EGFP-modified receptor proteins. A 
physiological relevant process in whole-body glucose homeostasis is the translocation of the GLUT4 to 
cell surface upon insulin signaling in cells. Insulin initiates GLUT4-mediated uptake of glucose into the cell, 
however, once glucose and hence insulin levels decrease, the transporter is endocytosed and kept in 
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storage endosomes (Bryant et al., 2002; Rea and James, 1997; Stockli et al., 2011). Using our TEV site-
containing nanobody, we can basically follow the transporter’s endocytic route after decreasing levels of 
insulin, and follow again how GLUT4 is retranslocated to the cell surface when insulin levels increase again. 
For other approaches of interest, we can even apply expressed VHHGFP-TEV-2xTS for studying 
exocytosis rates of sulfated proteins, or VHHGFP-TEV-mCherry for monitoring how long it takes until a 
certain compartment is depleted of nanobody after having reached steady-state by live cell imaging. 
Ongoing attempts in investigating retrograde traffic of a number of EGFP-tagged proteins will include the 
use of these TEV site-containing nanobodies.   
 
4.1.3 APEX2-Modified Nanobody for Electron Microscopy and Ablation  
We demonstrated that VHHGFP-APEX2 could label retrograde transport compartments as analyzed by 
electron microscopy using DAB cytochemistry. To label TfR-positive compartments, Tf coupled to HRP 
has previously served as tool to dissect which other receptors travel through these endocytic organelles. 
Using our nanobody approach, we could not only follow receptor proteins where a known ligand (e.g. Tf), 
that channels the peroxidase moiety for DAB cytochemistry into the cell, but could look more generally 
at reporters of interest. Based on the knowledge that MPRs and TGN46 cycle back to the TGN, and also 
that internalized nanobody strongly overlapped with TGN-resident markers by immunofluorescence, we 
could ultrastructurally visualize membranes of TGN identity in the perinuclear region by DAB/H2O2-
cytochemistry. Unlike to the clearly identifiable trans-Golgi compartment, a distal cisterna in the 
perinuclear region, the TGN is structurally less well defined. It often appears as a scattered network of 
tubular, but mostly vesicular membrane elements. Our observed vesicular and tubular elements look like 
the membrane structures previously labeled by bacterial toxins or WGA coupled to HRP that traffic to 
the TGN (Iida and Shibata, 1989; Llorente et al., 1998; Sandvig et al., 1989; van Deurs et al., 1986). These 
observations from almost more than 30 years ago already gave evidence that the detected vesicular-
tubular structures of different sizes are indeed representing TGN. We are curious to know and elucidate 
what kind of retrograde DAB labeling patterns, we are obtaining from other EGFP-labeled cargo proteins 
we are investigating in the future. 
Even though APEX2-mediated DAB cytochemistry has worked to our satisfaction, we would have 
appreciated having more pronounced DAB precipitation for detection by electron microscopy. 
Comparing our results using APEX2 with results published on HRP conjugates, it is clear that HRP 
generates more pronounced DAB precipitates than APEX2 does. This is also reflected by the finding of 
Ting and colleagues who have recently outlined that APEX2 turns over ~ 3000-4000 times before 
becoming permanently inactivated in the presence of 1 mM H2O2 and peroxidase substrate, while HRP 
survives > 130’000 turnovers under these conditions (Lam et al., 2015). Due to the higher turnover rates 
and thus labeling effectivity of HRP, we started to generate HRP-coupled nanobody probes. We are 
currently testing whether VHHGFP-APEX2 or VHHGFP coupled to HRP is as better retrograde transport 
tracker for electron microscopy.  
Peroxidase-mediated compartment ablation is also strongly depended on the enzyme being used. 
HRP conjugates might be much more effective in generating DAB polymers than APEX2. This is above all 
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then of crucial importance when only a very small amount of EGFP fusions is present at the cell surface 
that might only generate a decent signal with APEX2-driven polymerization. Thus, HRP conjugates might 
not only be beneficial for electron microscopy, but also for our biochemical approaches including ablation 
and peroxidase-mediated biotinylation. It has to be mentioned that the strength of our APEX2-mediated 
DAB labeling reaction was in the range as previously reported by Parton and colleagues (Ariotti et al., 
2015a; Follett et al., 2016). The great advantage of APEX2 is that we can simply express it in the reducing 
environment of bacteria, while HRP derivatives are obtained the easiest way by coupling peroxidase to 
our nanobody.   
 
4.1.4 mCherry-Modified Nanobody for Live Cell Imaging  
Apart from considering retrograde transport by immunofluorescence on fixed cells, we also had VHHGFP-
mCherry in our toolbox to study uptake by live cell imaging microscopy. Using a semi-automated 
widefield microscope in combination with quantitative image analysis, we could determine uptake kinetics 
of EGFP reporter cell lines. While the biochemical approach only allows to measure uptake into steady-
state of total cell, the live cell imaging approach would have additionally enabled us to selectively mark 
regions of interest, such as perinuclear compartments, peripherally associated endosomes, or other 
fluorescently marked compartments. We used EGFP-CDMPR and TfR-EGFP as cargo proteins to 
illustrate our live cell imaging approach, mainly to study uptake kinetics into steady-state. Although not 
studied in depth because of experimental and technical constraints, we could test that kinetics of 
nanobody uptake into steady-state in the perinuclear region and into total cell differed. This is in line with 
the biochemical observation that it takes longer to reach compartments beyond early endosomes. Longer 
nanobody internalization rates for EGFP-CDMPR into steady-state in the perinuclear region is obvious 
since the nanobody is passing late endosomes and the TGN. Surprisingly, although TfR is being 
transported through the endosomal network only, we also observed for this receptor a difference 
between reaching steady-state in the perinuclear compartment and total cell in preliminary experiments. 
It thus seems that the observed perinuclear compartment in cells expressing TfR-EGFP does not solely 
represent sorting endosomes. Since TfR recycles to the cell surface in different modes, Rab4-dependent 
'fast recycling' from sorting endosomes and Rab11-dependent 'slow recycling' from recycling endosomes 
(Maxfield and McGraw, 2004), differences in the observed kinetics could be explained by different 
recycling pathways. However, we need to investigate this more carefully, above all by coexpression with 
fluorophore-tagged Rabs to specifically mark compartments. 
The approach based on a nanobody suitable for live cell imaging has the advantage that we can also 
determine kinetics of uptake in transiently transfected cells with good expression levels. This is 
particularly important when stable cells lines are difficult to be obtained, or when many EGFP-labeled 
cargo proteins are to be studied and compared. Since apparent rates (kapp) of uptake are specific for every 
receptor protein, it might be interesting to determine many of these rates from receptors of interest and 
compare them with those from proteins with well-established sorting itineraries.  
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Future experimental attempts using VHHGFP-mCherry will not only include to determine half-lives 
of other receptors, but also to combine the assay with additionally expressed fluorophore-tagged markers 
to reveal the identity of the receptor-passing retrograde transport compartments.  
 
4.1.5 Functionalized Nanobodies as Ideal Biochemical Tool 
In the present study, we have introduced a number of functionalized nanobodies that can be used to study 
retrograde traffic by various methods. Because of their advantageous features (size, high stability, affinity, 
binding to folded epitopes, etc.), nanobodies have been used in a wide number of applications in 
multicellular organisms or in cell culture systems. In particular, VHHGFP has been used in a number of 
recent studies. 
Using a strategy based on VHHGFP, a novel method to induce protein degradation called deGradFP 
(degrade Green Fluorescent Protein) was recently introduced (Caussinus et al., 2011). The idea behind 
this turnover tool is to exploit the ubiquitin pathway by supplying a new substrate recognition domain 
interacting with GFP. This is accomplished by functionally tagging a component of the E3 ubiquitin ligase 
complex with VHHGFP to send GFP-labeled proteins for rapid proteasomal destruction. This method is 
not only applicable to induce turnover of cytosolic, but also of transmembrane proteins (Caussinus et al., 
2011). 
Another powerful strategy based on VHHGFP is morphotrap (Rothbauer et al., 2006). Morphotrap 
was developed in Drosophila as a tool to modify the extracellular distribution of secreted GFP-modified 
proteins, either by retaining them on the cell surface of producing cells or by sequestering them on target 
cells in the surrounding environment. The rationale for morphotrap is similar as for deGradFP. For 
morphotrap, VHHGFP is incorporated into the extracellular portion of mouse CD8 transmembrane 
protein where receptor expression mediates trapping of secreted GFP-tagged proteins. Morphotrap has 
been used among others to address the importance of morphogen spreading in Drosophila wing disc 
development (Harmansa et al., 2015). Very recently, the idea of synthetic traps has been expanded to 
capture GFP-tagged proteins along the apical-basal axis of polarized cells (Harmansa et al., 2017).   
While the studies above were mainly performed in multicellular organisms, functionalized 
nanobodies as tool have also been used in unicellular eukaryotes and prokaryotes. An interesting 
application is the fluorescent-three-hybrid (F3H) system, a method to visualize protein-protein 
interactions in vivo (Herce et al., 2013). In this system, a GFP binder module is anchored to a specific 
subcellular compartment. To probe putative interaction between two proteins, one is labeled with GFP, 
the other with RFP. As a result, the GFP-tagged protein will be recruited by the nanobody to the 
subcellular compartment. If the RFP-labeled protein interacts with the GFP-labeled protein, a 
colocalization of the green and red fluorescent signal will be observed. 
 
Another application of nanobodies is their use as inhibitors or activity modulators. Previously, it 
was shown that enzymes, such as lysozyme, could be inhibited by nanobodies that bind to the enzyme’s 
active site (De Genst et al., 2006). In another study, diverse nanobodies against human FIC domain-
containing proteins, proteins that can AMPylate target substrates, were demonstrated to not only inhibit, 
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but instead overactivate target AMPylation (Truttmann et al., 2015). Modulating a protein with 
nanobodies does not only apply for altering enzymatic activity, but also for inducing conformational 
changes of proteins to have different fluorescent properties (Kirchhofer et al., 2010). Nanobodies were 
also used to drug influenza nucleoprotein to disrupt the replication of virus particles (Ashour et al., 2015). 
As outlined with only a few examples, nanobodies represent a versatile device to study protein-
protein interactions, properties and functions. Their broad range applicability in basic science makes them 
a powerful tool. Being aware of the nanobodies’ versatility, we established a tool to track proteins from 
the cell surface to intracellular compartments. To our knowledge, we are the first who made use of 
bacterially expressed functionalized nanobodies to follow the retrograde sorting itineraries of EGFP-
modified cargo. The increasing number of nanobodies against different proteins and domains will make it 
possible to monitor retrograde transport of endogenous, untagged cargo. Our nanobody approach can 
then be used by replacing VHHGFP by a receptor-specific nanobody to yield functionalized transport 
trackers.       
 
  
136 Discussion 	  
4.2 Role and Function of AP-1 in Endosome-to-TGN Transport 
 
As mentioned throughout this study, AP-1/clathrin carriers are involved in protein sorting at the TGN-to-
endosome interface. Over the last decades, evidence has accumulated that AP-1 does not just simply 
mediate anterograde transport of proteins from the TGN, but also retrograde transport to the TGN. 
Therefore, the consensus has arisen that the AP-1 cargo adaptor is involved in bidirectional traffic 
between the TGN and early endosomes. 
We have investigated the question of the involvement of AP-1 in retrograde transport from 
endosomes using a direct assay with our functionalized, tyrosine sulfatable nanobody (VHHGFP-2xTS). For 
this, we combined our retrograde nanobody-based 'transport tracker' with protein interference to look 
at transport to the TGN. We used four different interference approaches, BFA treatment, RNAi, 
CRISPR/Cas9 and knocksideways, to inactivate AP-1 function. Apart from providing evidence for AP-1 to 
be involved in retrograde transport to the TGN, some of our results, partially contradict previous findings. 
In the following, we will briefly discuss the results from the different protein interference approaches and 
relate them to each other to corroborate the role of AP-1 in retrograde endosome-to-TGN traffic.  
 
4.2.1 BFA-Mediated Interference Blocks Retrograde Transport of MPRs  
We used the fungal metabolite BFA to generally interfere with retrograde transport. As mentioned 
before, BFA inhibits sensitive ARFGEFs, resulting in missing recruitment of ARF GTPases to early 
endosomes and the Golgi. As a consequence of this, ARF GTPase-recruited adaptor proteins will not 
assemble anymore on these membranes and will rather remain cytosolic, thereby precluding productive 
ARF1-dependent carrier formation from endosomes. We observed a complete block in retrograde 
transport of recombinant CIMPR and CDMPR to the TGN in the presence of BFA, as assessed by 
sulfation analysis of bound nanobody. These results are in agreement with previous studies on retrograde 
transport using BFA (Amessou et al., 2007; Mallard et al., 1998). BFA does not only result in the 
immediate dissociation of several adaptors from the membranes, but also in Golgi complex disassembly 
and redistribution of Golgi enzymes into the ER (Klausner et al., 1992; Lippincott-Schwartz et al., 1991). 
Recently, there was also a report that high BFA concentrations can indirectly affect sulfation in the 
TGN (Fjeldstad et al., 2002). Proteins from the biosynthetic pathway were sulfated at reduced levels due 
to impaired uptake of PAPS into the lumen of the Golgi apparatus after BFA administration. However, we 
used concentrations at 2 µg/mL of BFA where sulfation was not significantly affected. We thus can 
conclude that the lack of signal in BFA-treated cells is not due to inhibition of sulfation by TPSTs, but 
rather a consequence of impaired transport to the TGN or Golgi dysfunction. We also do not think that 
the lack of sulfation is a result of complete relocalization of the sulfation machinery to ER upon BFA 
treatment. In such a case, the sulfation assay would measure transport to the dispersed Golgi/ER rather 
than the TGN. 
To our surprise, steady-state nanobody uptake levels of BFA-treated cells reached the same 
plateau as control cells after 75 min. Even though AP-1 is dissociating from TGN membranes by acute 
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BFA treatment, the fungal metabolite also induces highly dynamic tubular extensions from the TGN that 
fuse with endosomes to yield a tubular network with endosomal characteristics (Waguri et al., 2003). This 
finding may explain why also the TGN-resident recombinant MPR pool reaches the cell surface in BFA-
treated cells. 
Furthermore, as previously shown in our lab, there was no effect on in vitro TGN carrier 
formation of MPR-containing transport intermediates in the presence of BFA (Kobialka, unpublished). 
Although BFA causes a block in retrograde transport of MPRs, we cannot specifically reduce this 
phenotype to AP-1 inactivation only. 
 
4.2.2 AP-1 Knocksideways Partially Blocks Retrograde Transport of MPRs  
Unlike BFA that has a broader spectrum of action than only affecting AP-1, the knocksideways approach 
was established to specifically and acutely inactivate the AP-1 pathway. Fast approaches to rapidly block 
and thus to look at immediate consequences of AP-1 depletion became necessary since knockout and 
knockdown studies have produced misleading results regarding directionality of transport and function. In 
some studies, cargo proteins were found to accumulate in peripheral endosomal (Meyer et al., 2000) or 
postendosomal (Foote and Nothwehr, 2006) compartments, whereas, in others, they accumulated in the 
perinuclear Golgi region (Canuel et al., 2008) or even at the cell surface (Lubben et al., 2007). From these 
phenotypes, it was concluded that AP-1 is involved in anterograde and retrograde carrier transport, 
thereby not considering the possibility of indirect effects or cell adaptation. In case of indirect effects, a 
possible scenario might be that during gradual depletion, the sorting of cargo proteins is likely to become 
less and less efficient as the levels of AP-1 decrease. Some of the transported cargo proteins may be 
themselves components of the trafficking machinery, including SNAREs or tethers. Thus, by the time the 
cells are ready for an experiment, other proteins may have been missorted, not as a consequence of AP-1 
depletion, but as secondary effect, due to the mislocalization of machinery components (Robinson et al., 
2010). On the other hand, it might also be possible, that the cell compensates for the loss of AP-1 by 
upregulating other sorting pathways. Indeed, a cellular adaptation in such regard has been previously 
described. It was reported that when the formation of clathrin-coated vesicles was inhibited by 
knockdown of either CHC17 or auxilin, AP-4 vesicle formation was stimulated without affecting protein 
levels (Hirst et al., 2012b). Also, as shown for instance in a different study, specific depletion of any GGA 
adaptor resulted in a partial decrease of the others (Ghosh et al., 2003b), pointing out that a 'specific' 
knockdown might affect more components than just the protein of interest. Another study also showed 
that levels of active ARF-GTP are drastically increased in cells depleted of either CHC17 or AP-1 by 
RNAi (Matsudaira et al., 2015). Thus, gradual depletion can indeed lead to biochemical changes.    
In the present study, we thus applied the currently most reliable way of inactivating a protein, 
knocksideways. By using the AP-1 knocksideways system, we were revisiting the role of AP-1 in 
retrograde transport and thereby found that endosome-to-TGN transport of recombinant MPRs was 
partially, by far not completely blocked. This observation is in line with other studies supporting AP-1 to 
operate in retrograde transport (Meyer et al., 2000; Robinson et al., 2010) on top of its undisputed role in 
anterograde traffic. Given the fact that retrograde transport of CIMPR to the TGN was strongly impaired 
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as judged by immunofluorescence (Robinson et al., 2010), we were a little bit disappointed to only see a 
mild reduction of about a third. We thus speculate that the other two thirds are transported by 
alternative, AP-1-independent sorting machineries, including retromer complex, epsinR and Rab9/TIP47. 
Although knocksideways is more specific than BFA and less indirect than a knockdown, it has to be 
mentioned that rapamycin-induced AP-1 rerouting also relocalizes AP-1 binding partners, including epsinR, 
aftiphilin and γ-synergin, to mitochondria (Hirst et al., 2012a; Robinson et al., 2010). One can thus not 
formally rule out the possibility that the observed reduction in sulfation of piggyback-transported 
nanobody is caused or contributed by relocalization of these factors, in particular that of epsinR. EpsinR 
has been suggested to traffic MPRs from early endosomes to the TGN (Saint-Pol et al., 2004), and the 
respective study reported a reduction of ~ 30% in MPR transport to the TGN in epsinR-depleted cells. 
The extent of epsinR relocalization by mitochondrially sequestered AP-1 is unknown (Hirst et al., 2012a; 
Robinson et al., 2010), however, it has to be mentioned that ~ 50% reduction of epsinR levels was 
sufficient to cause an inhibition of ~ 30% in retrograde MPR transport (Saint-Pol et al., 2004). When 
knocking down AP-1 by RNAi, epsinR still normally localizes to its target membranes. Thus, in the case of 
a knockdown, epsinR distribution does not depend on AP-1 (Hirst et al., 2004; Hirst et al., 2003). 
However, since knockdown readouts might bring along the risk of indirect or compensatory effects, we 
should also skeptically regard gradual epsinR depletion phenotypes. It thus remains to be figured out what 
the precise contribution of epsinR in our rapid inactivation approaches is. Robinson and colleagues 
established an epsinR KS cell line and could show that this adaptor seems to have a more global role than 
just acting as SNARE-specific cargo adaptor. It would thus be very interesting to test to which extent 
retrograde traffic of recombinant MPR is affected in cells with rapidly sequestered epsinR.  
In general, we think that the contribution of epsinR to retrograde transport during AP-1 
knocksideways is neglectable. Even though there is an interdependent action of epsinR and AP-1 in 
intracellular CCV formation as suggested by Robinson and colleagues (Hirst et al., 2012a; Hirst et al., 
2015), epsinR alone nucleates a separate population of transport carriers. Given the fact that cytosolic 
levels of epsinR are unchanged during an AP-1 knocksideways (Robinson et al., 2010), we believe that 
there is still enough of the adaptor available to confer epsinR-mediated membrane traffic from early 
endosomes. We thus think that the partial block in retrograde transport observed for MPRs is mainly due 
to the inactivation of AP-1. 
 
4.2.3 AP-1 Knockdown/out and Alternative Pathways  
To figure out the involvement of other, alternative sorting machineries in retrograde transport of MPRs, 
we followed an RNAi-based approach by simply monitoring sulfation upon compartment arrival. As 
reported previously (Arighi et al., 2004; Popoff et al., 2009; Popoff et al., 2007b; Seaman, 2004), depletion 
of retromer subunits caused an accumulation of MPRs in peripheral compartments. We were thus not 
much surprised when retromer depletion by targeting Vps26 resulted in decreased nanobody sulfation. 
The TIP47 adaptor, conversely, did not alter retrograde transport kinetics of CDMPR. TIP47 was initially 
described as MPR-specific adaptor operating in late endosome-to-TGN transport (Diaz and Pfeffer, 1998; 
Diaz et al., 1997). Over the years, however, findings have accumulated contradicting TIP47 to be involved 
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in retrograde MPR transport (Bulankina et al., 2009; Medigeshi and Schu, 2003), but rather in lipid droplet 
biogenesis. Our results suggest that TIP47 is likely not taking part in retrograde transport of MPRs. 
Depletion of Rab9, the upstream regulator of TIP47, in contrast caused a slight reduction in nanobody 
sulfation, indicating the GTPase to be operating in retrograde transport. This was somehow expected 
since Rab9 acts as a hub for many downstream trafficking events on endosomes (Kucera et al., 2016a; 
Kucera et al., 2016b). Impaired MPR transport is thus likely not a direct consequence of Rab9 depletion, 
but rather an indirect effect, including dysregulation of endosome maturation and endosome misbalance. 
For completeness sake, we then also performed an AP-1 knockdown, with the idea to confirm our 
knocksideways readouts. Surprisingly, retrograde transport of CDMPR was affected differently, sulfation 
of transported nanobody was strongly increased. Also, AP-1 KO HeLa cells showed stronger sulfation of 
MPR-transported nanobody compared to their parental cells. Both these results suggested AP-1 to not 
function in retrograde transport, but rather to prevent MPR traffic to the compartment of labeling. In this 
regard, our results are in disagreement with our and previous reported immunostainings showing MPRs 
to accumulate in peripheral compartments in antibody uptake experiments (Meyer et al., 2000; Robinson 
et al., 2010) or in resialylation experiments of cell surface-desialylated MPRs (Meyer et al., 2000). Sulfation 
analysis of EGFP-CDMPR not only showed sulfation to start earlier in AP-1 KD cells, but also to head 
towards steady-state of sulfation close after 75 min. As a consequence, nanobody sulfation was higher at 
every measured time point within 75 min.  
How can the AP-1 KD sulfation phenotype be explained? There are many not mutually exclusive 
explanations for this observation. One idea might be that retrograde transport of MPRs is not dependent 
on AP-1/clathrin carriers at all, but only on anterograde transport. Following this view, this would explain 
the enhanced sulfation phenotype where MPR cargo might enter the TGN, but accumulate there since 
exit is impaired. Impaired exit is in line with prolonged residence time in the TGN, and thus potentially 
higher sulfation efficiency. Indeed, a previous publication favored an unidirectional rather than a 
bidirectional role of AP-1 traffic (Canuel et al., 2008). This report suggested AP-1 and retromer to play 
opposite roles in hydrolase receptor traffic.  
Another reason to explain the increased sulfation phenotype is that sulfation machinery localization 
might be affected by AP-1 perturbances. 'Generally', it is assumed that when perturbances are introduced 
into a system, the machinery giving rise to the experimental readout, in our case the endogenous sulfation 
apparatus, remains static. However, this should be rarely the case. We thus thought that parts of the 
sulfation machinery, among them TPSTs or PAPS transporters, might have shifted their steady-state 
localizations to post-TGN compartments. In such a model, nanobody sulfation would not only occur 
earlier after endocytosis, but would also be increased due to higher residence time of MPRs in sulfation-
competent compartments. We checked the steady-state distribution of fluorescently tagged TPSTs, but 
did not see any striking difference by optical means between control and AP-1 KD or KO cells, 
respectively. Ultrastructural resolution of the perinuclear region by electron microscopy might have 
allowed determining membrane subcompartments, thus more convincingly providing evidence whether 
there is a shift in steady-state after interference. But, the current data suggest that there is no significant 
TPST relocalization to post-TGN membranes in AP-1 KD and KO cells.  
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We also tried to check other sulfation machinery components such as one member of the PAPS 
transporters (PAPST2, systematic name: SLC35B3). In our hands, the commercial antibody recognizing 
this transporter did not work, leaving the question open whether other sulfation machinery components 
rather than TPSTs are missegregated to endosomal membranes. Recently, however, we have had a closer 
look at affected cargo proteins from AP-1/CCVs (Hirst et al., 2012a). Robinson and lab listed cargo 
proteins that were depleted more than two fold from intracellular CCVs after rapid inactivation of AP-1. 
Interestingly, SLC35B2 (PAPST1), the other out of two PAPS transporters was found among robustly 
depleted cargo proteins from AP-1/CCVs. This finding is very stimulating since it suggests that AP-1 is 
either involved in retention or retrieval of this transporter. SLC35B2 had a fold depletion of 2.26, 
cathepsin Z, a bonafide MPR cargo, had a fold depletion of 2.35 in comparison, showing that SLC35B2 is 
strongly affected from AP-1/CCVs. In the study of Robinson (Hirst et al., 2012a), SLC35B2 was not 
further validated, however. While SLC35B2 was depleted from AP-1/CCVs, it was neither from 
epsinR/CCVs nor GGA2/CCVs, suggesting that the protein is specifically affected by AP-1 inactivation, 
only. Proteomics profiling of AP-1 KS gives a snapshot which proteins are immediately affected after 
adaptor sequestration without indirect effects to emerge. As a KD lasts for several days, it might be that 
SLC35B2 is gradually missorted to peripheral compartments upon RNAi-mediated depletion of AP-1. 
Other transmembrane proteins found in the list (Hirst et al., 2012a) with more than two fold depletion 
from AP-1/CCVs include for instance CDMPR (2.68), STX10 (3.04), furin (3.05), STX16 (3.06) or CIMPR 
(3.12). All these proteins have been previously reported to shift their steady-state distribution to early 
endosomes upon AP-1 KD. It thus might be that SLC35B2 is also misdistributed using RNAi, making our 
AP-1 KD readout in general hard to interpret for sulfation experiments. Since AP-1 KS experiments 
lasted for 75 min at maximum, such changes in steady-state distribution of transmembrane proteins might 
be unlikely to occur rapidly.   
Even though EGFP-tagged TPSTs show an exclusive perinuclear labeling pattern, we could also 
report TPST1-EGFP and TPST2-EGFP to migrate to the cell surface, since they were both accessible to 
externally added nanobody to a certain degree (not shown). It thus might be that TPSTs cycle also, but 
that sulfation nevertheless can only occur in the TGN where PAPS transporters and additional factors 
coincide to enable sulfation locally. If PAPS transporters really had an altered steady-state distribution 
towards early endosomes in AP-1 KD and KO cells, then it might be that sulfation could even occur in 
these compartments due to cycling TPSTs.                 
Another explanation for the enhanced sulfation phenotype is the possible discrepancy between 
acute and gradual or long-term protein depletion readouts. This is also the reason why we were favoring 
knocksideways-based inactivation strategies, since they hardly allow cellular adaption or indirect effects to 
dominate given the short time of inactivation. In particular for AP-1, a number of striking differences 
between RNAi- and knocksideways-based experimental readout have been already reported by the group 
of Robinson (Hirst et al., 2012a; Robinson et al., 2010). While we exploit sulfation to look at immediate 
consequences of perturbed traffic, Robinson and colleagues performed biochemical and proteomic 
characterization of isolated CCVs. Western blot analysis of isolated CCVs from AP-1 KS cells and AP-1 
KD cells has for instance shown that there was a strong depletion of CIMPR from the former cell line 
Discussion 141 	  
only (Robinson et al., 2010). This result suggested that during the period of gradual depletion, CIMPR was 
given a 'lift' by other transport intermediates to find its way to its target organelle. The same CCV 
isolation experiment also showed that there was more α-adaptin associated with vesicles prepared from 
AP-1 KD cells, whereas levels from AP-1 KS cells were unaltered. This observation probably reflected 
compensation for the loss of AP-1 (Robinson et al., 2010). In a follow-up study (Hirst et al., 2012a), 
Robinson and colleagues even showed a more dramatic difference in loss of AP-1’s binding partners on 
isolated CCVs. Apart from epsinR and other previously known proteins, GGA2 was strongly depleted 
from AP-1 CCVs, even though not co-rerouted with AP-1 to mitochondria, while the amount of GGA2 in 
the vesicle fraction of a conventional knockdown was not affected (Hirst et al., 2012a). This result clearly 
demonstrated that the time from depleting a protein up to phenotype assessment can matter with regard 
to the readout. Additionally, in the latest study of Robinson (Navarro Negredo et al., 2017), the 
difference between long-term depletion (KD and/or KO) and knocksideways became apparent once again. 
While ARF1 was barely affected in CCVs isolated from AP-1 KO cells, it was strongly depleted from 
CCVs derived from AP-1 KS cells. Based on such previous findings derived from AP-1 KD or KO cells, 
we were already a little bit 'sensibilized' with possible cellular adaption or indirect effects which might 
misdirect us. Is thus the increased sulfation of nanobody with recombinant CDMPR a compensatory or 
indirect effect of gradual AP-1 depletion? We cannot give a definite answer. However, in our studies, we 
have made an observation that tends towards post-Golgi compartment dysregulation. We observed that 
in AP-1-depleted cells, nanobody-recombinant TfR complexes became sulfated, while this was not the 
case in control cells. The amount of nanobody that is sulfated in AP-1-depleted cells is unknown. We 
think that the sulfated fraction only represents a minor part of total bound nanobody to TfR-EGFP.  
We were also wondering whether the phenotype of hypersulfation has been previously already 
reported for retrograde transport cargo proteins. Indeed, Ludger Johannes and collaborators have 
demonstrated that HeLa cells depleted of Hsc70, RME-8, or Vps35 have considerably elevated levels (300-
400%) of sulfated Shiga toxin B-subunit (STxB), even though the bacterial cargo accumulated in 'peri-Golgi 
structures' (Popoff et al., 2009). This result was very much surprising since peripheral non-Golgi 
compartment accumulation of STxB was paralleled by increased sulfation. It has been previously observed 
that clathrin is involved in retrograde transport of STxB (Saint-Pol et al., 2004) as assessed by sulfation 
analysis using CHC17 KD. The clathrin uncoating ATPase Hsc70, conversely, which is part of the clathrin 
interactome and should essentially impair clathrin-dependent transport, played an opposite role. It is very 
hard to rationalize this finding, since removal of Hsc70 facilitated sulfation rather than preventing it. 
RNAi-based depletion did not only retain STxB in peri-Golgi tubular structures, but also fluorescently 
tagged CIMPR, highlighting a similar failure in retrograde delivery to the Golgi. RME-8, which is a 'bridging 
adaptor' between Hsc70 and the retromer complex via the Hrs protein, produced a similar hypersulfation 
phenotype. Also here, RME-8 depletion resulted in accumulation of STxB and recombinant MPR in 
peripheral compartments. Interestingly, Vps35 depletion, but not depletion of Vps26, caused hyper-
sulfation of STxB. Even though they are both components of the same retromer subcomplex, and 
targeting either of them is commonly used to eliminate retromer complex function, interference with one 
of the subunits produced distinct biochemical phenotypes. While depletion of Vps26 caused an 
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accumulation in TfR-containing early endosomal tubules and concomitant reduction in sulfation of STxB, 
decrease in Vps35 expression prevented exit from endosomes, but resulted in increased sulfation. This 
result is misleading with regard to retromer complex function. Since Vps35 KD caused a stronger 
concomitant depletion of Vps26 than vice versa, the authors speculated that in Vps35-depleted cells, 
fusion with TGN/Golgi membranes is uncoupled from retrograde tubules detachment from early 
endosomes. The authors reasoned that STxB and other cargo might be in contact with sulfotransferases 
for extended periods of time in tubules in a dynamic manner. However, Ludger Johannes and colleagues 
could not detect TPSTs in the tubules by fluorescence microscopy. The puzzling observation of 
hypersulfation might be a result based on indirect effects of RNAi-mediated Hsc70-, RME8-, and Vps35-
depletion.   
A number of studies from the lab of Kirsten Sandvig have also recently reported unexpected 
hypersulfation, the cause of which remains unresolved in her studies, too (Dyve Lingelem et al., 2015; 
Klokk et al., 2011; Tcatchoff et al., 2012). It was shown that either addition of ONO, an inhibitor of 
cytoplasmic phospholipase A2, or geldanamycin, an inhibitor of Hsp90, caused increased sulfation of STxB 
and ricin. In both studies, it was speculated why inhibition culminated in increased cargo sulfation. Also 
here, it remained to be determined whether increased sulfation had an indirect or direct cause.   
 
In the present study, we have established a toolset of functionalized nanobodies to study 
retrograde traffic of EGFP-labeled proteins. By combining our nanobody-based tool with protein 
interference approaches, we readdressed the involvement of AP-1 in endosome-to-TGN transport of 
MPRs. So far, most of conclusions drawn on traffic at the TGN-to-endosome interface were based on 
gradual or long-term AP-1 depletion experiments. However, these studies had the caveat that they had 
neglected possible secondary or cellular adaptation effects. In particular, in the case of a trafficking 
adaptor like AP-1 that permanently traffics proteins between two intracellular compartments, the 
question about directionality is more complicated to be addressed in potentially dysregulated cells. On 
the one hand, RNAi-based or genetic depletion of AP-1 causes accumulation of MPRs in endosomes and 
depletion from the TGN (i.e. shift of steady-state towards endosomes). This idea supports AP-1 to be 
involved in retrograde transport. On the other hand, such AP-1-depleted cells have deficits in lysosomal 
targeting of cathepsin D, a readout that is often used to illustrate AP-1 dysfunction at the TGN. However, 
it can also be that the lack of efficient lysosomal targeting might be just the result of peripherally 
redistributed MPRs over the period of a knockdown or knockout, and not a consequence of AP-1 
function at the TGN. 
To thus investigate the immediate consequences of AP-1 inactivation, the knocksideways approach 
is preferable, since we have wild-type and unaltered steady-state distribution of trafficking components. 
We could report a partial reduction in retrograde transport of MPRs to the TGN upon AP-1 KS. Given 
the fact that nanobody might be trapped in the TGN due to a block in anterograde transport, our AP-1 
KS readout might represent even an underestimate because of hypersulfation. In summary, our nanobody 
toolset in combination with knocksideways allowed us to reinvestigate the contribution of AP-1/clathrin 
carriers in retrograde transport from early endosomes to the TGN. 
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  5     Perspectives  
 
 
In this thesis, we have presented proof-of-concept of our nanobody-based tool to study retrograde 
transport from the cell surface to intracellular compartments. In the remainder of this work, we would 
like to give some perspectives to point out our future research interests and to stress additional 
experimental endeavors. Already during our pilot studies, we have rationalized the versatility of our 
nanobody-based toolkit to study intracellular protein traffic. One the way, we were inspired for other 
derivatized nanobodies with new functions and features to monitor or manipulate intracellular transport. 
Simultaneous to the expansion of nanobody fusions, we also started to widen the number of EGFP-tagged 
receptor proteins. In the following, we would like to outline the use of other established EGFP-modified 
reporter cell lines, functionalized nanobodies and other applications. 
 
With the attempt to establish retrograde transport protein fusions as well as suitable controls, we 
came up with a list comprising a variety of different cargo proteins. So far, we have made use of MPRs and 
TGN46 as bonafide PM-to-TGN retrograde cargo proteins for proof-of-concept studies. In addition, we 
were also aware of APP, WLS, furin, and ANK that have been reported to return to the TGN. Because of 
the considerable number of reports manifesting their retrograde transport routes and underlying sorting 
machineries, we decided that time to go for MPRs and TGN46, only. Apart from these two proteins, the 
most well-described retrograde transport cargo is APP. Schekman and colleagues (Choy et al., 2012) 
provided some data for APP to undergo retrograde transport from early endosomes to the TGN for 
efficient amyloid β peptide production, a process that is involved in the development of Alzheimer’s 
disease. The site of APP processing after internalization, however, is actually still debated. While the TGN 
is considered one of the main APP processing compartments in the study of Schekman (Choy et al., 2012), 
some others propose the endo-lysosomal system (Tam and Pasternak, 2015; Tam et al., 2014). We also 
established a stable HeLa cell line expressing EGFP-tagged APP695 (splice variant 695). We found the 
protein to reach the cell surface, as shown by nanobody internalization in these cells. Using VHHGFP-2xTS 
in a sulfation assay, we could not detect any sulfated nanobody bound to EGFP-APP695, indicating that 
there was no substantial delivery of nanobody from the PM/EE pool of APP to the TGN (Fig. S10). 
These preliminary results indicate that APP is probably not a real bonafide retrograde transport cargo. 
Using our VHHGFP-APEX2 and VHHGFP-mCherry nanobodies, we plan to analyze APP’s retrograde 
journey into the endocytic system in more detail in the future.  
While APP was initially considered a bonafide retrograde transport protein, we started with similar 
premises for the 'Golgi-resident' proteins β-1,4-galactosyltransferase, α-2,6-sialyltransferase and α-
mannosidase II, namely that they represent Golgi-resident proteins. However, we noticed that HeLa cells 
stably expressing GalT-EGFP or SiaT-EGFP could capture nanobody and bring it to the TGN for sulfation 
(Fig. S10). So far, it has never been reported that these glycosyltransferases cycle to the cell surface and 
come back again. For GalT, it has been shown that a fraction is detectable at the cell surface, potentially 
146 Perspectives 	  
with a function in cell adhesion (Hathaway et al., 2003). For Man II, in contrast, there is so far no evidence 
for a similar cell surface pool. When we looked at internalized nanobody in fixed HeLa cells stably 
expressing GalT-EGFP or SiaT-EGFP, we indeed could monitor transport back to the TGN, however, in 
addition, we also noticed that a considerable fraction of EGFP fusions did not overlap with TGN. 
To concretize, it will be our interest to show that putative bonafide retrograde transport cargo 
proteins (i.e. APP) are not that bonafide as literally documented, and that Golgi marker proteins (i.e. GalT 
and SiaT), which are considered compartment-resident, are cycling at the TGN-to-cell surface interface. 
Using our functionalized nanobodies, we can start to look at these cargo proteins in more detail.  
In our collection of cell lines, we also established HeLa stably expressing EGFP-LAMP1 and H1-
EGFP. While the former can be used to study transport to lysosomes, the latter can be used as an 
additional recycling receptor reporter. As for recombinant TfR, we could not see any sulfation of 
nanobody riding along with H1-EGFP. H1 is a little bit more attractive than TfR for use. Then H1 has 50% 
of its mature protein at the cell surface while TfR only 15%. The versatility of our nanobody-based toolkit 
makes it possible to simply generate any EGFP fusion of interest and to study its retrograde transport.       
 
Apart from looking at other EGFP cargo proteins with our functionalized nanobodies, we also 
generated some that could not be discussed within the scope this thesis. With the future attempts to 
investigate also PM-to-ER traffic, we generated and expressed a nanobody conferring N-glycosylation 
(VHHGFP-Nglyco). It has been previously shown that N-glycosylation on proteins cannot only occur 
cotranslationally, but also posttranslationally (Plaut and Carbonetti, 2008). We also expressed a derivative 
comprising a tyrosine sulfation and N-glycosylation site to be able to measure TGN-to-ER transport 
(VHHGFP-Nglyco-1xTS). In particular, in order to look at retrograde intra-Golgi transport of proteins, 
such a nanobody derivative is especially useful. Such a N-glycosylatable and sulfatable nanobody can also 
be used to determine TGN-to-ER-to-Golgi round trip kinetics by monitoring first sulfation (TGN arrival), 
detection of a shift because of the addition of an oligosaccharide chain (ER arrival) and by following its 
maturation to a mature glycan (second Golgi passage). Since a shift from an immature to mature glycan is 
not always very easy to separate and detect on a SDS-PAGE, we have developed another round trip 
tracker that is VHHGFP-GAG-TS. It contains a site for glycosaminoglycanation that starts in the ER by the 
additon of xylose, followed by the attachment of long unbranched polysaccharides and subsequent 
sulfation during passage through the Golgi. 
Even though we have these functionalized nanobodies already for use, we are still lacking an 
appropriate retrograde cargo protein to the ER. The probably best-established cargo proteins migrating 
from the cell surface to the ER are bacterial and plant toxins. The only known endogenous membrane 
protein which travels from the cell surface to the ER is the Wnt ligand receptor, WLS (Yu et al., 2014). 
WLS encodes a multipass transmembrane protein and has its N- and C-termini both in the cytosol. We 
have inserted an EGFP moiety into lumenal loops, but so far we did not obtain a functional protein. It is 
our aim to generate a WLS fusion, which is functional and can be used in our PM-to-ER retrograde and 
round trip approaches. 
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Another functionalized nanobody that awaits its further use is VHHGFP-KDEL. KDEL mediates ER 
retrieval from KDEL receptor (KDELR)-positive compartments. Using such a functionalized nanobody, we 
might be able to test which EGFP-labeled cargo proteins are passing KDELR-positive compartments, and 
as second application, to potentially reroute reporters to the ER. Is KDELR also localized to the TGN? 
We can test this by administrating VHHGFP-KDEL to cells expressing EGFP-tagged MPRs, for instance. In 
case the KDEL signal overrides the sorting determinants present in the EGFP fusions, then it might be 
shuttled to ER. The initial goal that we were following with the VHHGFP-KDEL was to perform 
'transmembrane protein knocksideways'. This nanobody might relocalize EGFP reporters of interest to 
the ER and traps them there.   
Other functionalized nanobodies that are currently in planning are such which 'force' EGFP-
modified cargo to continuously cycle at the endosome-to-PM interface rather than undergoing retrograde 
transport to the TGN, and such which target proteins for lysosome-mediated degradation. We think to 
achieve that by fusing either Tf (for 'forced' recycling) or EGF (for lysosomal targeting) to VHHGFP. 
Unfortunately, there are no established lumenal signals for lysosomal degradation that might facilitate 
targeting. They typically all reside in the cytosolic tail of proteins. 
 
As already briefly mentioned in the discussion, we are improving our sulfatable nanobodies by 
introducing other tyrosine sulfation consensus sequences than reported here. Then assessing transport to 
the TGN remains part of our core interest. New sequences should confer higher sulfation efficiency on 
the one hand, and guarantee detection by an anti-sulfotyrosine antibody (Sulfo-1C-A2) on the other hand. 
Using 'cold' rather than 'hot' sulfation would simplify all our future experimental endeavors concerning 
determination of cell surface-to-TGN transport kinetics. 
We do not only want to examine new cargo proteins for retrograde transport to the TGN, but 
also to test a number of tail mutants of a given protein to elucidate the precise sorting determinants for 
endosome-to-TGN transport. Some of the motifs required for endosome-to-TGN in the cytosolic tail of 
CDMPR have been already described (Nair et al., 2003). It would be thus of interest to screen tail 
mutants of selected EGFP-tagged reporter proteins by feeding a TS-tagged nanobody that is detectable by 
an anti-sulfotyrosine antibody. By this, we can analyze and screen much faster for signals required for 
retrograde transport to the TGN. The assay would also enable us to screen whether the same patches of 
sorting signals are required for endocytosis and endosome-to-TGN transport, or whether they are 
present on different stretches of the cytoplasmic tail. 
 
The number of available nanobodies is increasing and combining two or more of these in a system 
brings along many advantages. We have recently produced functionalized anti-mCherry nanobodies 
(VHHmCh) and reporter cell lines stably expressing both an EGFP- and a mCherry-modified cargo protein. 
This allows us to study two recombinant fusion proteins at the same time in the same cell line. 
Accordingly, we have replaced VHHGFP by VHHmCh in some of our existing nanobodies and even prepared 
new ones (see also Fig. S11 A-B). By applying for instance VHHGFP-2xTS and VHHmCh-3xTS (to 
distinguish MW) to HeLa cells stably expressing EGFP-TGN46 and mCherry-CDMPR, we can follow 
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sulfation kinetics to the TGN of both these receptors. Simultaneously, we generated also an additional 
number of fluorophore-tagged VHHGFP and VHHmCh so that we can perform live cell imaging using a four 
color approach with no overlapping emission spectra (see also Fig. S11 A). 
As mentioned previously, we are also preparing double stable cell lines expressing both an EGFP- 
and an mCherry-modified protein for other reasons. To be able to measure cell surface-to-TGN 
transport by live cell imaging in the future, we need a fluorophore-tagged TGN marker. We already 
established a repertoire of cell lines expressing for instance GalT-, TPST1-, or TPST2-EGFP with 
mCherry-CDMPR or TfR-mCherry. In this case, we can use VHHmCh-mTagBFP2 or VHHmCh-iRFP670 to 
follow mCherry-tagged receptors to endocytic compartments or to the TGN. Another attempt for live 
cell imaging with our generated nanobodies is to measure vectorial transport from a donor to an 
acceptor compartment. We can for instance express mTagBFP2-Rab5 (early endosomes) and mCherry-
Rab9 (late endosomes) to study transport of EGFP-labeled cargo proteins between these two labeled 
endocytic compartments using VHHmCh-iRPF670. Other fluorescent compartment markers can be used to 
label other organelles of interest (i.e. recycling endosomes, TGN, etc.). In light of other nanobody 
functionalization to monitor traffic of proteins of interest through the endo-lysosomal system, it would be 
also interesting to chemically couple commercially available pH sensors, like pHrodo, to our nanobodies. 
 
We do not only follow the idea of using nanobodies as transport trackers, but also want to apply 
them as a tool to inactivate proteins similar to the knocksideways approach. We would like to attempt 
making use of the type III secretion-based protein delivery tool of Yersinia enterocolitica (Ittig et al., 
2015). As presented in the study of Ittig, this bacterial injectosome device can be exploited to deliver 
proteins into target cells with a high infection rate. They also showed that a myc-tagged VHHGFP could be 
delivered into cells and bind EGFP fusions (Ittig et al., 2015). We would like to apply NLS- or degron-
tagged nanobodies to sequester and inactivate proteins in the nucleus or by the proteasome, respectively. 
Using such an approach, we could in principal inactivate one or two proteins simultaneously and figure 
out their interdependence and possibly concerted action. We have already tried such an approach by 
relocalizing clathrin (EGFP-CLCa or HA-FKBP-CLCa) to the nucleus by delivering a plasmid encoding 
NLS-VHHGFP-FLAG-NLS or NLS-FRB-NLS by transient transfections. Preliminary results showed that this 
seemed to work and we are wondering whether we can follow a similar strategy to inactivate two 
proteins at the same time using the type III delivery tool (Fig. S12). 
Within the scope of our discussion regarding the interdependence of AP-1 and epsinR adaptors in 
retrograde endosome-to-TGN traffic, it would be interesting to know what happens when we nuclearily 
trap one of the adaptor alone or both together (e.g. EGFP-γ-adaptin and mCherry-epsinR). As an 
alternative, we could also just stably bring a siRNA-resistant copy of mCherry-epsinR into our AP-1 KS 
EGFP reporter cell line to yield a quadruple stable cell line. Here, there is a requirement of administrating 
both rapamycin and NLS-tagged VHHmCh. 
Another planned and novel strategy to inactivate and reactivate proteins would be by delivering a 
VHHGFP-VHHmCh fusion into cells expressing both an EGFP-tagged prey and a mCherry-tagged bait protein 
using the type III delivery tool. In this case, the nanobody fusion acts as a heterodimerizer by connecting 
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both fluorophores with each other that are themselves linked to proteins of interest. Prey and bait can be 
analogues to the knocksideways system where we have a cytosolic prey and mitochondrial bait protein. 
We even think of making cleavable nanobody heterodimerizers by including a TEV cleavage site between 
the two nanobodies. Subsequent delivery of TEV protease by the type III delivery tool would allow 
reactivation of the sequestered prey protein.       
 
To round up, we have explored a broad range of applications of our nanobody-based tool or of 
nanobodies in general in basic science, and recognized its potential for other approaches. We are heading 
forward to tackle some of these ideas in the near future.  
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Table S1: Protein sequences of the main EGFP-labeled reporter proteins. Signal sequence of hemagglutinin is highlighted in red, 
EGFP in green, and the cargo sequence in blue. Asterisk (*) marks the end of the protein.    
 
EGFP reporter Protein sequence 
EGFP 
 
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPV
PWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTR
AEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVN
FKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHM
VLLEFVTAAGITLGMDELYK* 
EGFP-CIMPR 
 
MKTIIALSYIFCLVFARESMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDAT
YGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYV
QERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSH
NVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLS
TQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGLRSRAVGAVLSLLLVALT
GCLLALLLHKKERRETVINKLTSCCRRSSGVSYKYSKVSKEEETDENETEWLMEEIQ
VPAPRLGKDGQENGHITTKAVKAEALSSLHGDDQDSEDEVLTVPEVKVHSGRGA
EVESSQPLRNPQRKVLKEREGERLGLVRGEKARKGKFRPGQRKPTAPAKLVSFHD
DSDEDLLHI* 
EGFP-CDMPR 
 
MKTIIALSYIFCLVFARESMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDAT
YGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYV
QERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSH
NVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLS
TQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKGTTEEKSCDLVGEKDKESK
NEVALLERLRPLFNKSFESTVGQGSDTYSYIFRVCREASNHSSGAGLVQINKSNDKE
TVVGRINETHIFNGSNWIMLIYKGGDEYDNHCGKEQRRAVVMISCNRHTLAANF
NPVSEERGKVQDCFYLFEMDSSLACSPEVSHLSVGSILLVIFASLVAVYIIGGFLYQRLV
VGAKGMEQFPHLAFWQDLGNLVADGCDFVCRSKPRNVPAAYRGVGDDQLGEE
SEERDDHLLPM* 
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Table S1 (continued): Protein sequences of the main EGFP-labeled reporter proteins. Signal sequence of hemagglutinin is 
highlighted in red, EGFP in green, and the cargo sequence in blue. Asterisk (*) marks the end of the protein.    
   
EGFP reporter Protein sequence 
EGFP-TGN46 
 
MKTIIALSYIFCLVFARESMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDAT
YGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYV
QERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSH
NVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLS
TQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKGTATESVKQEDAGVRPSAG
NVSTHPSLSQRPGGSTKSHPEPQTPKDSPSKSSAEAQTPEDTPNKSGAEAKTQKDS
SNKSGAEAKTQKGSTSKSGSEAQTTKDSTSKSHPELQTPKDSTGKSGAEAQTPED
SPNRSGAEAKTQKDSPSKSGSEAQTTKDVPNKSGADGQTPKDGSSKSGAEDQTP
KDVPNKSGAEKQTPKDGSNKSGAEEQGPIDGPSKSGAEEQTSKDSPNKVVPEQPS
RKDHSKPISNPSDNKELPKADTNQLADKGKLSPHAFKTESGEETDLISPPQEEVKSS
EPTEDVEPKEAEDDDTGPEEGSPPKEEKEKMSGSASSENREGTLSDSTGSEKDDLYP
NGSGNGSAESSHFFAYLVTAAILVAVLYIAHHNKRKIIAFVLEGKRSKVTRRPKASD
YQRLDQKS* 
TfR-EGFP 
 
MMDQARSAFSNLFGGEPLSYTRFSLARQVDGDNSHVEMKLAVDEEENADNNTK
ANVTKPKRCSGSICYGTIAVIVFFLIGFMIGYLGYCKGVEPKTECERLAGTESPVREEP
GEDFPAARRLYWDDLKRKLSEKLDSTDFTSTIKLLNENSYVPREAGSQKDENLALY
VENQFREFKLSKVWRDQHFVKIQVKDSAQNSVIIVDKNGRLVYLVENPGGYVAYS
KAATVTGKLVHANFGTKKDFEDLYTPVNGSIVIVRAGKITFAEKVANAESLNAIGV
LIYMDQTKFPIVNAELSFFGHAHLGTGDPYTPGFPSFNHTQFPPSRSSGLPNIPVQTI
SRAAAEKLFGNMEGDCPSDWKTDSTCRMVTSESKNVKLTVSNVLKEIKILNIFGVI
KGFVEPDHYVVVGAQRDAWGPGAAKSGVGTALLLKLAQMFSDMVLKDGFQPS
RSIIFASWSAGDFGSVGATEWLEGYLSSLHLKAFTYINLDKAVLGTSNFKVSASPLLY
TLIEKTMQNVKHPVTGQFLYQDSNWASKVEKLTLDNAAFPFLAYSGIPAVSFCFC
EDTDYPYLGTTMDTYKELIERIPELNKVARAAAEVAGQFVIKLTHDVELNLDYERY
NSQLLSFVRDLNQYRADIKEMGLSLQWLYSARGDFFRATSRLTTDFGNAEKTDRF
VMKKLNDRVMRVEYHFLSPYVSPKESPFRHVFWGSGSHTLPALLENLKLRKQNNG
AFNETLFRNQLALATWTIQGAANALSGDVWDIDNEFRTRIDMVSKGEELFTGVV
PILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGV
QCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNR
IELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQL
ADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLG
MDELYK* 
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Table S2: Protein sequences of the functionalized nanobodies applied in this study. T7 epitope is highlighted in turquoise, HA 
epitope in orange, BAP epitope in yellow, hexahistidine in blue, TEV cleavage site in brown, myc epitope in violet, the tyrosine 
consensus sequence in red, APEX2 in olive, and mCherry in pink. Asterisk (*) marks the end of the protein.    
  
Nanobody Protein sequence 
VHHGFP- 
control 
 
MASMTGGQQMGRGSDQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWY
RQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDT
AVYYCNVNVGFEYWGQGTQVTVSSTSEFDYPYDVPDYAGAQPARSGGGLNDIF
EAQKIEWHEGALEHHHHHH* 
VHHGFP- 
TEV-control 
 
MASMTGGQQMGRGSDQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWY
RQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDT
AVYYCNVNVGFEYWGQGTQVTVSSTSENLYFQSEFDYPYDVPDYAGAQPARSG
GGLNDIFEAQKIEWHEGALEHHHHHH* 
VHHGFP- 
myc 
 
MASMTGGQQMGRGSDQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWY
RQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDT
AVYYCNVNVGFEYWGQGTQVTVSSTSEQKLISEEDLEFDYPYDVPDYAGAQPAR
SGGGLNDIFEAQKIEWHEGALEHHHHHH* 
VHHGFP- 
1xTS 
 
MASMTGGQQMGRGSDQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWY
RQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDT
AVYYCNVNVGFEYWGQGTQVTVSSTSSAEDYEYPSEFDYPYDVPDYAGAQPARS
GGGLNDIFEAQKIEWHEGALEHHHHHH* 
VHHGFP- 
2xTS 
 
MASMTGGQQMGRGSDQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWY
RQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDT
AVYYCNVNVGFEYWGQGTQVTVSSTSSAEDYEYPSAEDYEYPSEFDYPYDVPDYA
GAQPARSGGGLNDIFEAQKIEWHEGALEHHHHHH* 
VHHGFP- 
TEV-2xTS 
 
MASMTGGQQMGRGSDQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWY
RQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDT
AVYYCNVNVGFEYWGQGTQVTVSSTSENLYFQSSAEDYEYPSAEDYEYPSEFDYP
YDVPDYAGAQPARSGGGLNDIFEAQKIEWHEGALEHHHHHH* 
VHHGFP- 
APEX2 
 
MASMTGGQQMGRGSDQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWY
RQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDT
AVYYCNVNVGFEYWGQGTQVTVSSTSGKSYPTVSADYQDAVEKAKKKLRGFIAE
KRCAPLMLRLAFHSAGTFDKGTKTGGPFGTIKHPAELAHSANNGLDIAVRLLEPLK
AEFPILSYADFYQLAGVVAVEVTGGPKVPFHPGREDKPEPPPEGRLPDPTKGSDHLR
DVFGKAMGLTDQDIVALSGGHTIGAAHKERSGFEGPWTSNPLIFDNSYFTELLSGE
KEGLLQLPSDKALLSDPVFRPLVDKYAADEDAFFADYAEAHQKLSELGFADAEFDY
PYDVPDYAGAQPARSGGGLNDIFEAQKIEWHEGALEHHHHHH* 
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Table S2 (continued): Protein sequences of the functionalized nanobodies applied in this study. T7 epitope is highlighted in 
turqouise, HA epitope in orange, BAP epitope in yellow, hexahistidine in blue, TEV cleavage site in brown, myc epitope in violet, 
the tyrosine consensus sequence in red, APEX2 in olive, and mCherry in pink. Asterisk (*) marks the end of the protein.     
  
Nanobody Protein sequence 
VHHGFP- 
TEV-APEX2 
 
MASMTGGQQMGRGSDQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWY
RQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDT
AVYYCNVNVGFEYWGQGTQVTVSSTSENLYFQSGKSYPTVSADYQDAVEKAKK
KLRGFIAEKRCAPLMLRLAFHSAGTFDKGTKTGGPFGTIKHPAELAHSANNGLDIA
VRLLEPLKAEFPILSYADFYQLAGVVAVEVTGGPKVPFHPGREDKPEPPPEGRLPDPT
KGSDHLRDVFGKAMGLTDQDIVALSGGHTIGAAHKERSGFEGPWTSNPLIFDNS
YFTELLSGEKEGLLQLPSDKALLSDPVFRPLVDKYAADEDAFFADYAEAHQKLSELG
FADAEFDYPYDVPDYAGAQPARSGGGLNDIFEAQKIEWHEGALEHHHHHH* 
VHHGFP- 
mCherry 
 
MASMTGGQQMGRGSDQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWY
RQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDT
AVYYCNVNVGFEYWGQGTQVTVSSTSMVSKGEEDNMAIIKEFMRFKVHMEGSV
NGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFAWDILSPQFMYGSKAYVKHPA
DIPDYLKLSFPEGFKWERVMNFEDGGVVTVTQDSSLQDGEFIYKVKLRGTNFPSD
GPVMQKKTMGWEASSERMYPEDGALKGEIKQRLKLKDGGHYDAEVKTTYKAK
KPVQLPGAYNVNIKLDITSHNEDYTIVEQYERAEGRHSTGGMDELYKEFDYPYDV
PDYAGAQPARSGGGLNDIFEAQKIEWHEGALEHHHHHH* 
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Figure S1: Functionalization of nanobodies with streptavidin conjugates. (A) Biotinylated nanobodies were 
coupled in vitro to streptavidin Alexa 647. Since one molecule of streptavidin can bind four molecules of biotin, a reaction mixture 
with 3:1 molarity ratio of nanobody:streptavidin conjugate was prepared. A 3:1 ratio was chosen to have an excess of streptavidin 
conjugate in the reaction to saturate biotin on nanobodies. Following 1 h of incubation at RT in PBS, the reaction mixture was run 
on a mini nickel column to remove unbound conjugate. Nanobody-streptavidin conjugates were eluted, desalted and stored in PBS. 
Typically, 30 ug of nanobody:streptavidin conjugate was loaded on a SDS-PAGE, followed by Coomassie staining (monomers of SA 
are seen). The step using a mini nickel and desalting column was not necessary. Then we did not see any uptake of streptavidin 
conjugates. (B) The same as in (A), but with streptavidin gold 5 nm. (C) 2 µg/mL VHHGFP-control coupled to Alexa 647 was added 
to reporter cell lines and processed for IF. Numbers along the markers correspond to molecular weight in kDa. Scale bar: 10 µm.    
158 Supplementary Material 	  
 
Figure S2: CDMPR protein expression, Tf uptake in TfR-EGFP, and EGFP cell line. (A) HeLa cells were 
transiently transfected with SHMY-CDMPR, harvested after 24 h, and analyzed by SDS-PAGE/Western blotting. SHMY-CDMPR 
(lane 2) runs as a double band (a strong band at lower MW, and a smear at higher MW). (B) In order to find out immature and 
mature CDMPR forms, we administrated VHHGFP-control to cells stably expressing EGFP-CDMPR, where only mature EGFP-
CDMPR will internalize nanobody. To figure out, we prepared two dishes with HeLa cells stably expressing EGFP-CDMPR. While 
one dish remained untreated (here named 'After'), the other was incubated with 2 µg/mL VHHGFP-control ('Before') for 1 h at 
37°C. Cells were lysed and postnuclear supernatants (from 'After' and 'Before') were prepared. An aliquot of postnuclear 
supernatant was saved as loading control. 2 µg/mL of VHHGFP-control was then added to the untreated postnuclear supernatant 
('After'). The individual postnuclear supernatants (~ 1 mL) were subsequently incubated with 15-20 µL streptavidin beads for 1 h at 
4°C. Beads were washed and boiled in SDS sample buffer. As seen in lane 3 and 4, the lower band of EGFP-CDMPR (seen in 
lysates) is composed of two distinct CDMPR forms, one that reaches the cell surface (mature), and one that does not (immature). 
(C) HeLa cells stably expressing TfR-EGFP were mixed with parental HeLa cells and seeded on coverslips. Cells were incubated 
with 20 µg/mL Tf coupled to Alexa 568 and processed for fluorescence microscopy. Cells expressing additional TfR internalize 
more Tf, indicating that the recombinant EGFP fusion is still functional as cargo receptor. (D) Uptake of 2 µg/mL VHHGFP-mCherry 
with cells stably expressing EGFP, or a mixture of cells expressing EGFP and EGFP-CDMPR. There is no uptake by cells stably 
expressing EGFP. Scale bar: 10 µm.   
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Figure S3: Expression, purification and application of TEV site-modified nanobodies and TEV protease. 
(A) Schematic representation of VHHGFP-TEV-control. 30 µg of purified and desalted protein was loaded onto a SDS-PAGE gel 
and then subjected to Coomassie staining. VHHGFP-TEV-control can also be detected by antibodies or SA-HRP targeting specific 
epitopes. Cartoon is not drawn to scale. (B) Expression of maltose-binding protein (MBP)-tagged TEV protease. 60 µg or 20 µg of 
purified and desalted MBP-TEV, VHHGFP-control or VHHGFP-TEV-control was loaded onto a SDS-PAGE gel and then subjected to 
Coomassie staining. (C) In vitro cleavage of TEV site-containing nanobody (e.g. VHHGFP-TEV-2xTS) by TEV protease. 20 µg of the 
respective nanobodies were digested with commercial recombinant ProTEV Plus for up to 2 h according to the manufacturer’s 
protocol. While VHHGFP-2xTS was not cleaved, VHHGFP-TEV-2xTS was almost completely digested after 2 h. (D) HeLa cells stably 
expressing TfR-EGFP were incubated with VHHGFP-APEX2 or VHHGFP-TEV-APEX2 for 30 min at 4°C. To test digestion efficiency 
at 4°C, cells were incubated for up to 2 h with ProTEV Plus protease in a total volume of 400 uL according to the manufacturer’s 
instructions. Cells were lysed and analyzed by SDS-PAGE/Western blotting. Membranes were probed with anti-His6, anti-GFP and 
anti-actin antibodies. Digestion was almost completed after 2 h. Numbers along the markers correspond to molecular weight in 
kDa.       
     
  
160 Supplementary Material 	  
 
Figure S4: DAB/H2O2 cytochemistry and electron microscopy of EGFP-CDMPR and TfR-EGFP. (A)-(C) 
Same procedure as in Figure 3.9. Cells stably expressing EGFP-CDMPR (A) or TfR-EGFP (B)-(C) were incubated with 5 µg/mL 
VHHGFP-APEX2 for 1 h at 37°C to reach steady-state. After fixation with 2% glutaraldehyde, cells were treated with DAB/H2O2 to 
yield a local and productive polymerization reaction. Subfigure (A) shows the Golgi region of cells expressing EGFP-CDMPR. The 
reporter was often found in concentrated patterns of small vesicular and tubular elements adjacent to the Golgi cisternae. The 
labeled tubular elements varied in length and often had branched extensions. (B) and (C) shows local cell surface DAB polymer 
precipitations of cells expressing TfR-EGFP (two examples). Some surface regions showed DAB polymer precipitations (lined 
arrows), some not (dotted arrows), suggesting local or missing deposition and ablation reactions. An inset of every picture is 
highlighted. Straight bar lines correspond to 1000 nm, dotted lines to 380 nm. Legend: E, endosome; G, Golgi; MVB, multivesicular 
body; N, nucleus; VTN, vesicular-tubular network.  
Supplementary Material 161 	  
 
Figure S5: Nanobody is only taken up by EGFP reporters presenting an EGFP moiety at the cell surface. 
HeLa cells stably expressing EGFP, or transiently expressing EGFP-calnexin (CNX) or EGFP-ERGIC53 were incubated with 2 
µg/mL VHHGFP-2xTS for 1 h at 37°C, and processed for immunofluorescence microscopy. VHHGFP-2xTS was detected using an 
anti-HA antibody. The figure shows that proteins expressed either in the cytosol (EGFP) or in the early secretory pathway (CNX 
or ERGIC53) do not take up any nanobody. Scale bar: 10 µm.               
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Figure S6: Comparison of sulfatable nanobodies. Cells stably expressing EGFP-CDMPR (lanes 1-3) or TfR-EGFP (lanes 
4-6) were starved in sulfate-free medium for 1 h at 37°C and 7.5% CO2, and then pulse-labeled with sulfate-free medium 
reconstituted with 0.5 mCi/mL [35S]sulfate supplemented with 2 µg/mL of either VHHGFP-1xTS, VHHGFP-2xTS or TS-VHHGFP-TS for 
60 min. Equal amounts of postnuclear supernatants were taken and incubated with Nickel beads to affinity-isolate nanobodies. 
Proteins were separated using gel electrophoresis and prepared for autoradiography. There was higher sulfate incorporation into 
VHHGFP-2xTS than into TS-VHHGFP-TS using cells expressing EGFP-CDMPR. As reported before, no sulfated nanobody was 
detected from cells expressing TfR-EGFP.    
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Figure S7: Rapamycin treatment moderately affects mTOR signaling in AP-1 KS cells. (A) Parental HeLa (1-
12) and AP-1 KS HeLa (13-24) were treated with DMSO (1-6, 13-18) or 500 nM rapamycin (7-12, 19-24) for up to 75 min. 
Following postnuclear supernatant preparation, samples were analyzed by SDS-PAGE/Western blotting. Membranes were probed 
with anti-phospho S6, anti-S6 (total S6) and anti-actin antibodies. While parental HeLa cells showed a significant decrease in S6 
phosphorylation, AP-1 KS cells were only moderately affected after 75 min of rapamycin treatment. (B)-(D) In order to see 
whether the moderate decrease in S6 phosphorylation (less mTORC1 activity) is caused by mitochondrial rerouting of 
endogenous FKBP12, Mitotrap-expressing cells were incubated with 500 nM rapamycin for 30 min. None of the antibodies (BD 
Biosciences (B), Clontech (C), Santa Cruz (D)) could detect endogenous FKBP12. Mitotrap was labeled with an anti-FLAG 
antibody. Scale bar: 10 µm.            
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Figure S8: AP-1 knockdown or knockout does not affect localization of TPST1-EGFP and TPST2-EGFP. 
(A)-(B) HeLa cells stably expressing TPST1-EGFP (A) or TPST2-EGFP (B) were treated for 96 h with siRNA targeting AP-1, 
seeded on coverslips, fixed and processed for immunofluorescence microscopy. (C)-(D) Parental or AP-1 KO HeLa cells were 
transiently transfected with TPST1-EGFP (C) or TPST2-EGFP (D) for 24 h, seeded on coverslips, fixed and processed for 
immunofluorescence microscopy. Cells were costained with EEA1. An AP-1 knockdown or knockout did not significantly alter the 
steady-state localization of TPST1-EGFP or TPST2-EGFP towards early endosomes. However, as previously reported by Schu and 
colleagues (Meyer et al., 2000), the distribution pattern of EEA1 was slightly changed in AP-1-depleted cells. Scale bar: 10 µm.                         
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Figure S9: Localization of cargo proteins in AP-1 KO HeLa cells. (A) Parental and AP-1 KO HeLa cells were mixed, 
seeded on the same coverslip, and prepared for immunofluorescence microscopy. AP-1 KO cells were identified by the lack of γ-
adaptin expression. Cells were stained for AP-1 and GM130 or TGN46. GM130 (a peripheral early Golgi protein) and TGN46 
(TGN) were not affected in their steady-state distribution in AP-1 KO cells. GM130 was used as reference marker. (B) Same as in 
(A), but parental and AP-1 KO HeLa cells were seeded on different coverslips. (C) Parental and AP-1 KO HeLa cells were 
prepared for an anti-CIMPR antibody uptake assay and processed for immunofluorescence microscopy. While anti-CIMPR antibody 
localizes to the perinuclear compartment in control cells, this looks less impressive in AP-1 KO cells, suggesting that retrograde 
endosome-to-TGN transport of CIMPR is affected. (D)-(E) Parental and AP-1 KO HeLa cells were prepared for 
immunofluorescence microscopy. Cells were stained for GM130 and vti1a (D) or vti1b (E). In agreement with previous literature 
(Hirst et al., 2004), there is a shift in the steady-state localization for both proteins in AP-1-depleted cells. (F) Same as in (A), but 
parental and AP-1 KO HeLa cells were seeded on different coverslips. Scale bar: 10 µm.    
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Figure S10: Sulfation analysis of GalT-EGFP and EGFP-APP695. HeLa cells stably expressing EGFP-tagged reporters 
were starved in sulfate-free medium for 1 h at 37°C and 7.5% CO2, and then pulse-labeled with sulfate-free medium reconstituted 
with 0.5 mCi/mL [35S]sulfate supplemented with 2 µg/mL of either VHHGFP-1xTS, VHHGFP-2xTS or TS-VHHGFP-TS for 60 min. Equal 
amounts of postnuclear supernatants were taken and incubated with Nickel beads to affinity-isolate nanobodies. Proteins were 
separated using gel electrophoresis and prepared for autoradiography. As reported in Figure S6, there was higher sulfate 
incorporation into VHHGFP-2xTS than into TS-VHHGFP-TS (apart from GalT). Apart from the already tested EGFP reporters, GalT-
EGFP (lanes 4-6) and EGFP-APP695 (lanes 19-21) were also analyzed. There was a strong sulfation for the former, while no 
sulfation could be reported for the latter. These results suggest that GalT returns to the compartment of sulfation, while APP695 
does apparently not. 
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Figure S11: Expression of additional functionalized anti-GFP (VHHGFP) and anti-mCherry (VHHmCh) 
nanobodies. (A) Bacterial expression of functionalized nanobodies. 30  µg of purified and desalted protein was loaded onto a 
SDS-PAGE gel and then subjected to Coomassie staining. Most of the shown nanobodies are fused to fluorophores. The color 
code indicates which nanobody is meant, green when fused to VHHGFP, pink when fused to VHHmCh. (B) HeLa cells transiently 
expressing mCherry-CDMPR or TfR-mCherry were incubated with VHHmCh-EGFP and processed for fluorescence microscopy. As 
already observed for functionalized VHHGFP nanobodies, functionalized VHHmCh derivatives are also internalized. Scale bar: 10 µm.     
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Figure S12: Rerouting of proteins to the nucleus. (A) HeLa cells were transiently transfected with HA-EGFP-CLCa 
alone, or cotransfected with both HA-EGFP-CLCa and NLS-VHHGFP-FLAG-NLS (NucleoTrap 1). In cells with no nuclear trap, HA-
EGFP-CLCa localizes to a perinuclear compartment and the plasma membrane. Cells with coexpressed NucleoTrap I show HA-
EGFP-CLCa as well as parts of endogenous CHC17 to be removed from the cytosol. Overexpressed HA-EGFP-CLCa mainly 
localizes to the nucleus in cells with coexpressed NucleoTrap I, CHC17, however, cannot be dominantly found in the nucleus. The 
reason for this is unknown. It might be that CHC17 is rapidly degraded in the nucleus, since CHC17 is also involved in mitosis. 
Nuclear localization of CHC17 in interphase might cause dysregulation of the cell cycle. (B) HeLa cells were transiently 
cotransfected with HA-FKBP-CLCa and NLS-FRB-NLS (NucleoTrap 2). Addition of the rapalog AP21967 caused most of HA-
FKBP-CLCa to be trapped in the nucleus after 4 h. Scale bar: 10 µm.  
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List of Abbreviations 
 
A 
ADP  Adenosine diphosphate  
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid  
ANTH  AP180 N-terminal homology domain 
ANK  Progressive ankylosis protein 
AP-1, -2, -3, -4, -5  Adaptor protein complex-1, -2, -3, -4, -5 
APP  Amyloid precursor protein 
APEX  Ascorbate peroxidase 
APP Amyloid precursor protein 
AR  Ankyrin repeat 
ARF  ADP-ribosylation factor  
ARH Autosomal recessive hypercholesterolemia  
ASGPR  Asialoglycoprotein receptor  
ATP  Adenosine trisphosphate  
ATP7A/B  ATPase copper transporting type A/B 
 
B 
BACE β site APP cleavage enzyme 
BAP Biotin acceptor peptide 
BAR Bin/Amphiphysin/Rvs 
β2AR  β2 adrenergic receptor  
BCA  Bicinchoninic acid  
BFA  Brefeldin A 
BG  Benzylguanine  
BSA Bovine serum albumin 
 
C 
CARTS Carriers of the TGN to the cell surface 
Cas9 CRISPR-associated protein 9 
CAV1/2  Caveolin-1/2 
CCP Clathrin-coated pit 
CCV  Clathrin-coated vesicles  
CDE  Clathrin-dependent endocytosis 
CDR Complementarity-determining regions  
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CDMPR  Cation-dependent mannose-6-phosphate receptor  
CHC  Clathrin heavy chain 
CIE Clathrin-independent endocytosis 
CIMPR  Cation-independent mannose-6-phosphate receptor 
CLC Clathrin light chain 
CLIC Clathrin-independent carriers  
CLINT  clathrin interactor 1  
CME  Clathrin-mediated endocytosis 
CNX Calnexin 
COG Conserved oligomeric complex 
COPI and II  Coatomer protein I and II 
COX IV  cytochrome C oxidase IV 
CPY  Carboxypeptidase Y 
CRISPR Clustered regularly interspaced short palindromic repeats  
CSC Cargo selective complex 
CRC Cargo recognition complex  
 
D 
DAB  3,3’-Diaminobenzidine  
Dab2  Disabled homolog 2 
DAPI 4’,6-Diamidino-2-phenylindole 
DARPins  Designed ankyrin repeat proteins 
DMSO  Dimethyl sulfoxide 
DMT1  Divalent metal ion transporter 1  
DTT  Dithiothreitol 
 
E 
EE Early endosome 
EEA1 Early endosomal antigen 1 
EGF  Epidermal growth factor 
EGFP Enhanced green fluorescent protein 
EGFR Epidermal growth factor receptor  
EM  Electron microscopy 
ENTH  Epsin N-terminal homology domain 
EPS15 Epidermal growth factor receptor (EGFR) pathway substrate 15 
ER Endoplasmic reticulum 
ERGIC ER-Golgi intermediate compartment  
ESCRT  Endosomal sorting complex required for transport  
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F 
Fab Antigen-binding fragments  
FACS Fluorescence-activated cell sorting  
FCH  Fer/Cip4 homology domain 
FCHO Fer/Cip4 homology domain-only 
FEME  Fast endophilin-mediated endocytosis 
FIC  Filamentation induced by cAMP 
FKBP12  FK506-binding protein of 12 kDa 
FR  Framework regions  
FRB  FKBP-rapamycin binding   
 
G 
GAK  Cyclin G-associated kinase 
GalT β-1,4-galactosyltransferase 
GAPDH  Glyceraldehyde 3-phosphate dehydrogenase 
GCC185  Golgi coiled-coil protein of 185 kDa 
GDP Guanosine diphosphate 
GEEC  GPI-AP enriched endocytic compartments  
GEF  Guanine nucleotide exchange factor 
GET  Guided entry of tail-anchored proteins  
GFP  Green fluorescent protein 
GGA  Golgi-localized, γ-ear-containing, ARF-binding protein 
GLUT Glucose transporter 
GPCR  G-protein coupled receptor  
GPI-AP  Glycosylphosphatidylinositol-anchored protein 
GSC  GLUT4 storage compartments  
GTP  Guanosine trisphosphate  
 
H 
H1  Homologous polypeptide 1 of ASGPR 
HA Hemagglutinin 
hcAb  Homodimeric heavy chain antibodies 
HRB  HIV Rev-binding protein (HRB) 
HRP  Horseradish peroxidase 
Hsc70  Heat shock cognate 70 
Hsp  Heat shock protein 
Hrs  Hepatocyte growth factor-regulated tyrosine kinase substrate  
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K 
kapp Apparent rate constant 
KD  Knockdown 
KO  Knockout 
KS  Knocksideways 
 
I 
IF  Immunofluorescence  
IgG  Immunoglobulin G 
IgNAR  Immunoglobulin new antigen receptor  
IL-2  Interleukin-2 
IL-2R Interleukin-2 receptor 
ILV Intraluminal vesicles 
IPTG Isopropyl-β-D-thiogalactopyranosid 
 
L 
LAMP-1  Lysosome-associated membrane protein-1  
LDL Low-density lipoprotein 
LDLR  Low-density lipoprotein receptor 
LMP Lysosomal membrane proteins 
 
M 
ManII  α-mannosidase II 
MBP  Maltose-binding protein 
MPR/M6PR Mannose-6-phosphate receptor 
MTCO2  Mitochondrially encoded cytochrome C oxidase II 
MVB Multivesicular bodies 
MW  Molecular weight 
 
N 
NAE  Nuclear envelope-associated endosomes 
NLS Nuclear localization signal  
NMDA N-methyl-D-aspartate  
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P 
PAPS 3’-Phosphoadenosine-5’-phosphosulfate  
PAPST  3’-Phosphoadenosine-5’-phosphosulfate transporter  
PBS  Phosphate-buffered saline 
PE  Pseudomonas exotoxin A 
PIC Protease inhibitor cocktail 
PIP Phosphatidylinositol phosphate 
PI(3)P  Phosphatidylinositol-3-phosphate  
PI(3,5)P Phosphatidylinositol-(3,5)-bisphosphate  
PI(4)P  Phosphatidylinositol-4-phosphate  
PI(4,5)P  Phosphatidylinositol-(4,5)-bisphosphate  
PLIN-3  Perlipin-3 
PM  Plasma membrane  
PMSF  Phenylmethylsulfonyl fluoride  
PPi  Pyrophosphate  
POI  Protein of interest 
PTM  Posttranslational modification  
PX  Phagocytic oxidase (phox) homology domain 
 
R 
Rab  Ras-related proteins in/from rat brain 
RME-8  Required for receptor-mediated endocytosis 8 protein 
RNAi  RNA interference  
ROI  Region of interest 
RT  Room temperature 
 
S 
SA  Streptavidin  
SAP  Sphingolipid activator proteins 
scFV  Single-chain variable fragment 
SD  Standard deviation 
sdAb  Single-domain antibody  
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
sgRNA  Single guide RNA 
shGalT  Short version of β-1,4-galactosyltransferase 
SiaT  α-2,6-sialyltransferase 
SNARE  Soluble N-ethylmaleimide-sensitive factor attachment receptor   
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SNX  Sorting nexin 
SLC  Solute carrier family 
SorLA  Sortilin-related receptor with LDLR class A repeats 
STX  Syntaxin 
STxB  Shiga toxin subunit B 
 
T 
T Time of steady-state (total cell)  
TBS Tris buffered saline 
TEN Tubular endosomal network 
TEV Tobacco etch virus 
Tf  Transferrin 
TfR  Transferrin receptor 
TGN  Trans-Golgi network 
TIRF  Total internal reflection fluorescence  
TIP47  Tail-interacting protein 47  
TOR  Target of rapamycin 
TPST Tyrosylprotein sulfotransferase  
TS  Tyrosine sulfation 
 τ1/2  Half-life of steady-state (total cell) 
 
V 
VHH  Variable homodimeric heavy-chain antibody 
VHHGFP Anti-GFP nanobody 
VHHmCh  Anti-mCherry nanobody 
Vps  Vacuolar protein sorting protein 
vti1a  Vesicular transport through interaction with t-SNAREs homolog 1a 
vti1b Vesicular transport through interaction with t-SNAREs homolog 1b 
VTN  Vesicular tubular network 
 
W 
WB Western blotting 
WGA  Wheat germ agglutinin  
WLS Wntless
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